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Abstract 
Gut microbial composition and activity exert a strong influence on the metabolic 
phenotype of the host, and variation in the metabolic phenotype is a major factor 
underlying inter-individual variation in drug responses. In this thesis, the role of gut 
microflora on the mammalian metabolic system was explored with specific focus on 
the influence on xenobiotic metabolism and toxicity. Systems biology approaches were 
utilised to examine microfloral-mammalian interactions and mechanisms of drug 
toxicity. 
Multi-omic techniques, namely transcriptomics and metabonomics, were employed to 
characterise animal models used for investigating microfloral-mammalian interactions. 
These included germ-free, antibiotic-treated, and `conventional' rats. The utility of 
applying systems biology approaches to elucidate mechanisms of toxicity was 
demonstrated in conventional animals administered methapyrilene using metabonomic 
and protein-analysis techniques. Finally, the influence of the gut microbiota on the 
metabolism and toxicity of hydrazine was explored using an integrated transcriptomic 
and metabonomic approach. 
Microfloral absence modulated host metabolism directly and indirectly at the 
transcriptome and metabonome level, specifically drug, lipid and energy metabolism. 
Temporary suppression of the microbiota through antibiotic treatment did not disrupt 
the biological system greatly but minor disruption was observed upon re-colonisation. 
Methapyrilene dosing modified the structure and activity of a urea cycle enzyme and 
by integrating metabonomics and focused assays the potential for these protein 
modifications to be a mechanism of toxicity were investigated. In germ-free animals 
the effect of hydrazine was variable, with toxicity enhanced in two of the three 
members compared to conventional animals. This highlights the potential for 
microbiota to influence host susceptibility towards drug toxicity and shows that toxic 
responses can be diverse in the absence of a functional microbiome. These studies 
demonstrate the use of applying systems biology approaches to investigate complex 
biological systems and indicate that gut microorganisms can modulate host 
metabolism and potentially be a factor in idiosyncratic drug responses. 
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Thesis aims and description 
Thesis aims 
The aim of this thesis was to gain further understanding into the role of the gut 
microflora on the mammalian metabolic system and to determine what influence the 
gut microflora may have upon the metabolism and toxicity of xenobiotics. To examine 
microfloral-mammalian interactions and to explore mechanisms of drug toxicity a 
systems biology approach has been applied. Ultimately this will provide a more 
comprehensive knowledge of the impact of microflora in models of mammalian 
biocomplexity. 
Objectives 
0 To characterise and integrate the transcriptomic and metabonomic profiles of 
germ-free and conventional rats with respect to understanding differences in 
both endogenous and especially drug metabolism. 
9 To characterise and compare the transcriptomic and metabonomic response 
of conventional rats to antibiotic treatment with respect to modulation of gut 
microflora. 
9 To demonstrate the use of applying systems biology techniques in parallel to 
focused assays to investigate mechanisms of methapyrilene toxicity in 
conventional rats. 
9 To characterise and compare the transcriptomic and metabonomic response 
of conventional and germ-free rats to hydrazine dosing. 
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Chapter One: Introduction 
1.1 General background and introduction 
The biological challenges facing the human population are vast, diverse, and 
aggressive, with both genetic and environmental factors implicated in many of these 
challenges. To determine the causes of human disease, improve drug discovery and 
development, and understand drug toxicity, accurate and comprehensive modelling 
of the mammalian system must be achieved. 
To model the mammalian system is an exceptionally difficult task as the variety of 
different cell types, their spatial heterogeneity and interactions between the cells all 
contribute towards mammalian biocomplexity. Several platforms have emerged to 
help model this system by measuring multiple systemic variables at different levels of 
biomolecular organisation. These platforms include transcriptomics, proteomics, and 
metabonomics, which measure global gene expression, protein translation, and 
metabolite networks respectively. Collectively these techniques have been termed 
`systems biology' and together these tools paint a more holistic view of the biological 
system. As the accuracy of these techniques and the variables able to be measured 
increase, so too does the resolution and predictive power of the model. 
A variable that significantly extends mammalian biocomplexity, but which is usually 
unaccounted for in systems biology, is the microbiota. The term `microbiota' or 
`microflora' refers to the community of living micro-organisms residing in a particular 
ecological niche of a host individual. Approximately 100 trillion (1014) cells live in or 
on humans, outnumbering the somatic and germ cells by a factor of ten'. Of these, 
the vast majority reside in the gastrointestinal tract and maintain a symbiotic 
relationship with the host, contributing towards host physiology, biochemistry and 
immunology. The collective genomes (the `microbiome') of these symbionts contain 
100 times as many genes as the human genome and encode numerous metabolic 
pathways important for human metabolism2. The pooled metabolic activity of the gut 
microflora has been recognised as being equal to that of a virtual organ3, and thus 
mammals can be considered as a `super-organism' whose metabolism is the sum of 
both host and microbial metabolism4. 
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Microfloral-mammalian interactions are extremely diverse due to the array of micro- 
organisms involved. These interactions can be temporary or persistent, accidental or 
compulsory, and can result in subtle or intense cellular responses5. Variation in the 
gut microflora is becoming increasingly recognised as a factor that influences human 
and animal health and it also has a pronounced effect on host metabolic profiles and 
can modulate the metabolic fate of some xenobiotics6. This growing awareness of 
the microfloral influence on disease progression in human is reflected in the 
increasing research in this area, with the gut microflora implicated in obesity', 
inflammatory bowel disease including Crohn's disease8,9, insulin resistance10, food 
allergies, and the association of particular strains of enteric bacteria with certain 
cancers". Understanding the interactions between the mammalian host and its 
internal residents and also, how variations in the microflora impact upon the host, 
may be essential to understanding the development and expression of some disease 
processes. 
If systems biology is going to be used to accurately model the mammalian system, 
then the `whole system' must be measured; this includes environmental factors such 
as the microflora. This all-embracing approach is termed `global' systems biology12. 
Before the microbiota can be sufficiently factored into global systems biology a 
greater understanding of the microfloral influence on the host biological system is 
required. The purpose of this thesis is to investigate what influence the gut microflora 
exerts upon the host's transcriptome and metabolome and specifically what effect 
this has upon the metabolism and toxicity of xenobiotics. 
1.2 Gut microflora 
1.2.1 Gastrointestinal tract 
The gastrointestinal (GI) tract is displayed in figure 1.1; this is essentially a tubular 
passage extending from the mouth to the anus, divided into several functional 
compartments. The upper GI tract comprises the mouth, pharynx, oesophagus, and 
stomach and the lower GI tract includes the small and large intestines and the 
rectum. Accessory organs to the GI tract include the liver, gall bladder and pancreas. 
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Every region of the GI tract consists of the same cell layers; mucosa, submucosa, 
muscularis externa, and serosa. These differ in composition depending upon the 
function of the compartment. The mucosa is the innermost tissue layer and 
surrounds the lumen; it is in direct contact with the contents of the GI tract and has 
an important function in absorption and secretion. Along the intestines this layer has 
many folds, to produce finger-like projections termed villi and microvilli, these greatly 
expand the absorptive surface area of the tract to approximately 400 m213. This layer 
also contains secretory glands that secrete mucus to lubricate the food and to protect 
the gut wall, and hydrochloric acid to kill micro-organisms. The next layer, the 
submucosa, is dense connective tissue that contains blood and lymph vessels that 
carry absorbed nutrients to the rest of the body. This layer also contains the 
submucosal plexuses, part of the enteric nervous system that directly controls the 
movements of the gut. Surrounding the submucosa are circular and longitudinal 
muscles collectively termed the muscularis externa. The circular muscles constrict 
the lumen whilst the longitudinal muscles shorten the gut length inducing movement 
in the gut. This is also the location of the myenteric plexuses, another component of 
the enteric nervous system. Finally, the serosa is a fibrous coat that surrounds the 
gut and continues onto the mesentry. This contains nerves, and supplies the gut with 
blood and lymph vessels. 
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Figure 1.1: Gastro-intestinal tract (www. wikipedia. org) 
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Ingested food enters the GI tract at the mouth and travels to the stomach, this is an 
acidic chamber involved in the mechanical churning of ingested material. Here, 
nutrients are stored, dissolved, and digested. The stomach contains water, pepsin, 
mucus, and hydrochloric acid giving the stomach a highly acidic internal environment. 
The material that leaves the stomach is termed chyme and can contain proteins, 
carbohydrates, and fat droplets. 
Chyme leaves the stomach to enter the small intestine; this compartment is further 
divided into the duodenum, jejunum and ileum. The small intestine is the principal 
site of absorption for nutrients, water and xenobiotics, to aid this absorption a range 
of metabolic machinery, including phase I and phase II enzymes and transporters, is 
expressed in this region. In addition to the GI tract enzymes, the liver and pancreas 
also secrete substances that flow via ducts into the duodenum. Bile, containing bile 
salts, bile pigments, bicarbonate ions, cholesterol and phospholipids, is secreted by 
the liver into the lumen, this improves digestion and absorption of dietary fats. 
Pancreatic secretions contain digestive enzymes, such as trypsin and nuclease and 
also bicarbonate ions. Bicarbonate ions in these secretions neutralise acid derived 
from the stomach and therefore, increase luminal pH. Small molecules such as 
amino acids and sugars are able to absorb into the blood capillaries that in turn flow 
to the liver via hepatic portal vein, whilst the remaining material moves into the large 
intestine. 
The large intestine consists of the cecum, colon, and rectum. Passage of processed 
material from the small intestine into the colon is regulated by the cecum; this also 
prevents toxic material from the colon travelling into the small intestine. Material 
entering the colon is typically free of nutrients and so this region is primarily 
concerned with the absorption of water and inorganic ions from the material. Once 
optimum absorption has occurred the remaining matter is excreted as semi-solid 
faeces. 
1.2.2 Gut microfloral establishment and composition 
The GI tract plays host to a diverse ecosystem of symbiotic microbes, collectively 
termed the gut `microbiota' or gut `microflora'14. These are bacterial societies built 
upon the gut mucosal surfaces of an individual and they display an incredible degree 
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of spatial and temporal complexity and have a profound influence on nutritional, 
physiological and immunological processes in the host15 
The gut of the foetus is sterile at birth but colonisation begins upon delivery as the 
gut becomes exposed to bacteria from the mother's faecal and vaginal flora, and 
from the extrinsic environment16. In the first year of life the intestine of the neonate 
becomes progressively more colonised with a succession of microbial populations 
fluctuating as the diet changes and the host develops. During weaning, as the 
facultative anaerobes reduce the redox potential of the gut, obligate anaerobes 
become established'. Major factors that influence early colonisation patterns are 
vaginal delivery versus caesarean delivery 17,18, breast-feeding versus bottle- 
feeding 19-21 
, and antibiotic usage. It appears that the initial colonisers of the gut are 
able to modulate host gene expression to create more favourable conditions along 
the tract and restrict the growth of other bacteria22. After weaning the opportunistic 
early colonisers lose their foothold in the intestinal tract and become replaced by 
adult-type bacteria presumably due to the enhanced ability of the adult flora to form 
stable communities and to dominate over these less adapted bacteria. By adulthood 
the gut microbiota generally stabilises to a complex climax community dominated by 
strict Gram-negative anaerobic bacteria (97%) and small amounts of aerobic bacteria 
(facultative anaerobes), and consists of both permanent (autochthonous) members 
and transient (allochthonous) colonisers. These allochthonous flora are micro- 
organisms unable to establish a community under standard conditions in that 
particular niche and may have been dislodged from another proximal niche, or may 
4,22 14,22 from environmental sources, such as food" 
All three domains of life are represented in the adult mammalian GI tract, but it is the 
domain of Bacteria that achieves the greatest density. Analysis of distal gut microbiota 
from healthy individuals revealed that over 99% of the colonic microbiota belonged to 
just two bacterial divisions (phyla), the Bacteroidetes and Firmicutes, and one 
prominent member of methanogenic Archaeon, Methanobrevibacter smithii. 23 Whilst 
diversity is low at the divisional level, it is at the species and strain level where 
diversity is markedly increased. Each individual can have a microbial blend of 
approximately 500 - 1000 different species, with greater than 7000 different strains, 
and this variety makes the microbiota unique to the host24. Composition of the 
microbiota varies along the length and also across the diameter of the tract, with 
different populations inhabiting the gut mucosa and lumen. Distinctive microbial 
societies (niches) form along the tract each with characteristic membership15. These 
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comprise mainly anaerobes and include species of the genera Bacteroides, 
Bifidobacterium, Clostridium, Escherichia, Eubacterium, and Lactobacillus, in addition 
to yeasts and other micro-organisms23. 
Microbiologically the GI tract can be considered in three major compartments, the 
stomach, the small intestine, and the colon. As the pH gradient increases from the 
stomach to the colon so to does the bacterial density. The low luminal pH of the 
stomach restricts bacterial colonisation (approximately 103 micro-organisms per ml) 
to only certain acid-tolerant lactobacilli, streptococci and yeast16. In the small 
intestine the bacterial load increases from the proximal to the distal regions in 
addition to the degree of anaerobiosis. Duodenum bacterial numbers are 104 cells 
per ml with these numbers increasing markedly in the distal ileum to 106 cells per ml. 
Facultative anaerobic and aerotolerant bacteria including, streptococci, lactobacilli, 
and staphylococci dominate the proximal regions, whilst in the distal ileum while 
lactobacilli and streptococci are still predominant, populations of Bacteroides and 
Enterobacteria increase. The principal site of microbial colonisation is the colon with 
numbers reaching 1012 cells per ml. This comprises an estimated 400 - 500 species 
and colonic flora are predominantly strict anaerobes such as Bacteroides spp., the 
clostridia, Bifidobacterium spp., peptococci, and Atopobium spp. 25-27. 
1.2.3 Shaping factors of the microbiota 
In a stable gut system, indigenous microbes occupy all available niches and 
allochthonous components are unable to colonise and therefore pass through the 
tract. At these niches climax communities establish that appear to be unique to the 
individual and because allochthonous flora are unable to colonise, the species 
composition and population levels remain relatively stable throughout adulthood. Strict 
membership rules are exerted by the host to develop a climax community that 
converges on an evolutionary stable ecosystem. The fitness of the bacteria for a 
particular niche can depend upon its ability to adhere to that niche, produce enzymes 
to harness the nutrients available, appease the immune system, and the ability to 
adapt and to grow rapidly. 
The components of the microbiota exist in an open ecosystem that is in a dynamic 
ecological equilibrium governed by natural selection at both the host and microbial 
level. At the microbial level, microbe-microbe interactions can lead to competitive 
21 
exclusion, whilst at the host level a variety of intrinsic and extrinsic factors can exert 
selection pressures. Monozygotic twin studies have shown that the host genome 
exerts significant control over the microbiome and this is suggested to dominate over 
the control exerted by the diet28' 29. Other intrinsic factors include pH of the 
microenvironment in which the flora resides, mucosal immune responses, and bile and 
pancreatic secretions in the small intestine's 
Extrinsic host factors that can influence microbial constitution include those dictated by 
host lifestyle choices. These include diet, which defines the luminal nutrient availability 
for the micro-organisms, antibiotic and drug therapy, which can selectively attenuate 
bacterial species and enable the population growth of allochthonous species, and also 
the health status of the host. Other factors such as psychological and physical stress, 
alcohol consumption, radiation, and altered GI tract peristalsis can also manipulate the 
30 health and composition of the microbiota 
1.2.4 Influence of the microbiota 
physiology 
on host morphology and 
A healthy gut microbial compliment is required to achieve a conventional phenotype. 
In the absence of autochthonous flora, features can develop known as germ-free 
animal characteristics and by considering the germ-free animal (an animal free of gut 
microbes) the influence of floral absence on morphology and physiology can be 
highlighted. 
The most prominent morphological change is the size of the cecum. In the germ-free 
animal model, the absence of bacteria results in cecal enlargement31. This 
enlargement has been largely attributed to the accumulation of intestinal mucus due 
to the lack of mucus-degrading bacteria, and the build up of urea due to absence of 
floral ureases32. In work carried out by Gordon and Kokas, a brown iron-containing 
material was isolated from the cecal content of germ-free rodents, this substance 
was a polypeptide, termed a-pigment, and had strong catecholamine-inhibitory 
properties. This excessive catechol-inhibitory substance in the circulation of the 
germ-free animal causes a significant reduction in metabolic rate. This reduction is a 
consequence of the inhibitory effect of a-pigment on norepinephrine. Prevention of 
norepinephrine-controlled dissipation of metabolic energy from the brown adipose 
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tissue results in a shift in metabolic homeostasis to increased efficiency in the use of 
dietary energy, reducing the metabolic state. In conventional animals substantially 
reduced amounts of a-pigment that were in an inactive form were found, presumably 
inactivated in the gut by the microflora33 
Reduced basal metabolic rate lowers the resting oxygen consumption in germ-free 
rats and also lowers cardiac output. These factors in addition to reduced regional 
blood flow produce smaller sized hearts, livers, and lungs in germ-free rodents. 
These effects are more pronounced in young germ-free animals due to the relatively 
large cecum but once out of the growth phase these consequences persist34 
The microbiota have the capacity to extract calories from ingested food for the host 
that would otherwise be unobtainable. To compensate for floral absence the germ- 
free animal must consume more food to maintain body mass, and the body weight of 
the germ-free animal is significantly smaller in comparison to the conventional 
animal35. Regulation of fat storage is also modulated by the microbiota, through the 
induction of lipoprotein lipase (LPL). Increased LPL activity leads to increased 
cellular uptake of fatty acids and triglyceride accumulation in adipocytes. The 
microflora promote LPL production by modulating transcriptional factors and 
suppressing the expression of fiaf (fasting-induced adipose factor or angiopoietin-like 
protein 4), a secreted protein that inhibits LPL 36 
Continual close contact between the microflora and the GI tract means that the 
bacteria are intrinsic to the development and functionality of a conventional GI tract. 
In the absence of bacterial stimulation germ-free animals possess thinner villi and 
lamina propria, and have a reduced rate of villous epithelial renewal34,3' The 
intestinal surface area is also reduced in germ-free animals, and peristalsis is slower, 
causing longer transit times in the absence of the microbiota38. 
Gut bacteria have been demonstrated to influence the absorptive capacity of the GI 
tract. Stappenbeck et al. reported that the gut microbiota contribute to the 
development of the capillary network density of the small intestine, increasing the 
absorptive capacity of the intestine through the promotion of angiogenesis39. 
Conversely, Reddy et al. observed that in the absence of gut microflora the reduced 
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intestinal motility eased the absorption of some nutrients, specifically, calcium and 
magnesium; a result of this being greater deposition of calcium in the bones of germ- 
free anima lsao 
1.2.5 Microfloral influence on host metabolism 
Combinatorial metabolism is a multi-parametric metabolic process involving the 
metabolic systems of both the host and microorganisms. This produces an array of 
metabolic products that are diverse in nature41. The range of biotransformation 
possibilities contributed by the microflora greatly enhance the host's metabolic 
capabilities and the collective metabolic activities of the flora cover hydrolysis, 
reduction, degradation, and synthesis42. 
Due to their location and metabolic capacity, the microbiota hold an important role in 
digestion. Bacterial fermentation provides an important salvage mechanism by 
fermenting non-digestible dietary components. This anaerobic fermentation can be 
both saccharolytic and proteolytic and important end products are short chain fatty 
acids (SOFA) and electron sink products43. Major SCFA include acetate, propionate 
and butyrate, and are essential for cell cycle arrest, apoptosis, inhibition of protein 
synthesis, and as an energy source for the host44. Butyrate specifically, is known to 
play a crucial role in mucosal physiology and metabolism, supplying 50% of the daily 
energy required by the colonic mucosa45. Electron sink products such as lactate, 
pyruvate, ethanol and succinate act as fermentation intermediates and help to 
maintain redox balance during fermentation 46. Proteolytic action of the flora allows 
the recovery of metabolic energy from peptides and proteins for the host47, and 
bacterial synthesis can also provide vitamin B12 and K for the host. 
Specific inspection into the genome of a member of Bacteroidetes, B. 
thetaiotaomicron, reveals the largest collection of genes involved in carbohydrate 
metabolism (glycobiome), of all bacteria sequenced so far. The mammalian genome 
does not include many of these genes and is therefore deficient in the enzyme 
activities required for degradation of common components of dietary fibre, including 
-51 xylan-, pectin-, and arabinose-containing polysaccharides 
A major impact of the microbiota is on host cholesterol and bile acid metabolism. 
Hepatocytes metabolise cholesterol to bile acids, which via enterohepatic circulation 
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are cycled as bile salts between the liver and the gut. These detergents emulsify 
cholesterol, fat-soluble vitamins and lipids, and aid their absorption. Metabolites 
produced by hepatic and microbial processing recycle back to the gut for further 
microbial metabolism and structural modification. This mechanism can prolong 
pharmacological events and improve excretion but can also potentiate toxicity or 
increase hepatotoxic effects by increasing hepatic concentrations of compound s52,53 
1.2.6 Influence of the microbiota on host immunity 
A mutually dependent relationship exists between the host mucosal immune system 
and the indigenous flora. Bacteria contribute to the development of humoral and 
cellular immune responses54, whilst the host defences permit tolerance to the 
bacteria allowing a symbiotic state to establish 
Histological observations show that the absence of bacteria results in reduced 
secondary lymphoid organs. The size of the spleen from germ-free rodents is 
decreased and under-developed55, Peyer's patches are decreased56, and the 
mesenteric lymph nodes from conventional mice are noted to contain significantly 
more blast cells and antibody-producing cells than those from germ-free mice57. 
A protective function of the native gut flora is as a natural defence barrier preventing 
exogenous pathogens from colonising the GI tract and causing disease. This 
bacterial antagonism is achieved through the displacement of pathogens from the 
intestinal milieu, competition for nutrients and space (epithelial binding sites), and the 
production of antimicrobial factors58. 
Environmental antigens such as those of the gut flora drive the development of the 
humoral immune system59. The microflora diversify the host's antibody repertoire60, 
increasing circulating specific and natural antimicrobial antibodies. The `hygiene 
hypothesis' has been raised, attributing the increased standard of domestic hygiene 
in recent years to the rise in incidence in allergies, where reduced exposure to 
certain beneficial bacterial antigens alters the susceptibility of the host to 
immunological intolerances' 
The germ-free animal has a lower serum gammaglobulin fraction than its 
conventional counterpart. Immunoglobulin (Ig) M is present, but there are only small 
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levels of IgG and no IgA62.63 IgA is the dominant antibody isotype of the mucosal 
immune system. Both IgA and IgM bind to and neutralise gut pathogens and their 
toxins. IgA has a protective role promoting biofilm formation in commensal bacteria, 
and is essential for reducing the expansion and translocation of intestinal pathogenic 
bacteria 64-66. It has been suggested that B cells require a bacterial product, such as 
Iipopolysaccharide, to convert the production from IgM to IgA67 
Stimulation by commensal bacterial antigens is essential for the development of a 
normal mucosal immune system and the maintenance of tolerance. Residential 
bacteria continuously pass in low numbers across the mucosal barrier into underlying 
tissue or mesenteric lymph nodes. In a healthy gut these translocating bacteria are 
usually eliminated before they reach other sites, but during this process they come 
into contact and provide antigenic stimulation for the lymphocytes68. Dendritic cells 
also stimulate the T- and B-lymphocytes, these project from the lamina propria into 
the lumen, sampling the resident bacteria or antigens. This continuous activation of 
the T- and B-lymphocytes with foreign antigens primes the intestinal mucosa, 
maintaining a state of controlled physiological inflammation. This `readiness' allows a 
rapid response to occur in the event of pathogenic bacteria. 
This restrained inflammation must be tightly regulated, and discriminate between 
commensal and pathogenic bacteria. One proposed method is the induction of a Toll- 
like receptor (TLRs) signalling pathway following bacterial entry into the mucosal 
system. Bacterial factors generate a signal by functioning as ligands for TLRs on 
immune cells; activation leads to the production of cytokines, triggering inflammation. 
Chronic infiltration by commensal flora across the epithelial barrier would maintain a 
weak signal unable to manifest in inflammation, but in the case of pathogenic 
bacteria, the uncommon bacterial factors would evoke strong stimulation of antigen- 
presenting cells and provoke and sustain an inflammatory response69. In a healthy 
gut, the extent and duration of TLR signalling is carefully regulated and the host 
inflammatory responses are controlled by the transcription factor, nuclear factor (NF)- 
KB. Certain commensal bacteria are capable of limiting (NF)-KB signalling nullifying 
'o the pro-inflammatory responses induced by pathogenic bacteria' 71 
The absence of microfloral stimulation restricts the immune system, where its 
capabilities remain at a background level. Acclimatisation of germ-free animals has 
been shown to be sufficient to restore the mucosal immune system72,73. 
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1.3 Host xenobiotic metabolism and toxicity 
Mammalian host metabolism can be considered a continuum of metabolic and non- 
enzymatic transformations with endogenous metabolism at one end and xenobiotic 
metabolism at the other. Endogenous metabolism has an intrinsic biological function 
and is under the direct control of host gene and protein expression. Conversely, 
xenobiotic metabolism is the metabolism of compounds that are alien to endogenous 
processes but can interact with them. Xenobiotics include drugs, pollutants, food 
additives, and pesticides, and have the capacity to be toxic to the host. Various 
interactions from components such as the microbiota have led to intermediary 
classes of metabolites being defined: 
" Sym-endogenous metabolites are metabolites essential to host biological 
function but which cannot be synthesised by the host and must be acquired 
through the diet or via microfloral metabolism. 
" Sym-xenobiotics are of extra-genomic origin that are not necessarily essential 
to the host but which can incorporate into and influence endogenous 
processes. 
" Trans-xenobiotics are of extra-genomic or chemical origin which are 
converted by endogenous biotransformation to endogenous metabolites12, '4 
Xenobiotic, or drug metabolism, is the focus of this thesis, and is essentially the 
host's method of detoxifying foreign compounds that enter the biological system. 
There exists a two-way interaction of a xenobiotic with a biological system: the effect 
of the system on the compound, and that of the compound on the system. For the 
latter case the compound or its metabolites can interact with cellular apparatus such 
as proteins, macromolecules, and receptors and have major effects on endogenous 
processes and possibly induce a toxic response. The interplay of the biological 
system on the xenobiotic can be viewed in four phases, absorption, distribution, 
metabolism and excretion. A drug must be absorbed to enter the systemic circulation 
and elicit an effect. In most cases foreign compounds are orally ingested and hence 
the gastrointestinal tract becomes an important site for absorption. Once a xenobiotic 
has penetrated the body it enters the bloodstream and becomes distributed 
throughout the body. The liver is exposed to the highest concentrations of 
xenobiotics as compounds absorbed from the gastrointestinal tract enter the portal 
vein that subsequently flows to the liver. Prior to excretion a drug typically undergoes 
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host biotransformation; this primarily occurs in the liver but may also occur in other 
extrahepatic tissues. Biotransformation, or drug metabolism, is the body's 
mechanism to increase the polarity of these foreign substances in order to assist 
their excretion into urine or into bile and reduce their potential for toxicity. 
In general the enzymes involved in xenobiotic metabolism have broader substrate 
specificity than those involved in endogenous processes, and are predominantly 
localised to the smooth endoplasmic reticulum (SER). The SER has a diverse range 
of enzymes and functions that include protein synthesis, and lipid and fatty acid 
metabolism, and as such these drug metabolising enzymes are not exclusive to 
foreign compounds but can also participate in a wide range of endogenous 
processes. Biotransformation can be separated into two main phases, phase I and 
phase II. The reactions categorised into these phases are shown in table 1.1. These 
two phases do not necessarily have to be sequential, and phase II reactions may 
occur prior to phase I, and phase I metabolism may occur to a compound that has 
already undergone phase II metabol ism75 
Table 1.1: Reactions classed as phase I and phase II metabol iSM76 
Phase l Phase II 
Oxidation Glucuronidation/glucosidation 
Reduction Sulfation 
Hydrolysis Methylation 
Hydration Acetylation 
Dehalogenation Amino acid conjugation 
Isomerisation Glutathione conjugation 
Fatty acid conjugation 
Condensation 
1.3.1 Phase I metabolism 
Phase I reactions are in effect functionalisation reactions; they include oxidation, 
reduction, and hydrolysis and transform the toxic compound into a more hydrophilic 
molecule, thereby increasing the water solubility of the compound. In many instances 
phase I is considered to modify the xenobiotic structure to expose a chemically 
reactive group on which phase II reactions can occur. 
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Mono-oxygenase enzymes, often referred to as microsomal enzymes, carry out the 
majority of the oxidation reactions. These reactions are predominantly catalysed by 
one specific enzyme system, the cytochrome P-450 mono-oxygenase system. Phase 
I metabolism is dominated by the cytochrome P450 enzymes and this family is 
involved in a range of both exogenous and endogenous compounds including the 
metabolism of steroid hormones, thyroid hormones, fatty acids and prostaglandins. 
These enzymes are classified as haem-containing enzymes with iron protoporphyrin 
IX as the prosthetic group that utilise molecular oxygen for the oxidative metabolism 
of a wide range lipophilic organic chemicals". Another enzyme, NADPH cytochrome 
P-450 reductase, forms part of the cytochrome P450 system, acting as an electron 
donor to supply the two electrons required by the cytochrome P450 enzymes to 
carryout oxidation. 
The cytochrome P450 (CYP) gene superfamily comprises many gene families with 
the CYP1, CYP2, and CYP3 families specifically important for xenobiotic metabolism. 
The CYP4 family is also involved in xenobiotic metabolism, but is primarily involved 
in fatty acid metabolism. The diversity of these isoenzymes expands the substrate 
specificity and enables the biotransformation of a broad range of xenobiotics. 
1.3.2 Phase II metabolism 
Phase II reactions are conjugation reactions, where one or more endogenous polar 
molecules are connected to the toxic compound to produce a complex with increased 
solubility to enhance excretion. These include a diverse set of enzymes that are 
largely found in the cytoplasm, and the conjugation reactions they catalyse are 
shown in table 1.2. Conjugation reactions involve the activation of either the 
endogenous group (type 1) or the foreign compound (type 2) and create a high 
energy intermediate. 
Conjugation with sugar is the most common conjugation reaction due largely to the 
abundance of the cofactor, uridine diphosphate glucuronic acid (UDPGA). This is a 
type 1 conjugation where UDPGA is an activated form of glucuronic acid and is 
formed in the cytosol from glucose-1-phosphate. Conjugations of this variety 
generally reduce the biological activity of a compound, although there are some 
cases where this step can potentiate toxicity75 
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Table 1.2: Conjugation reactions76 
Reaction Enzyme Functional group 
Glucuronidation U DP-Glucuronyltransferase -OH 
-COOH 
-NH2 
-SH 
Glycosidation UDP-Glycosyltransferase -OH 
-COOH 
-SH 
Sulfation Sulfotransferase -NH2 
-SO2NH2 
-OH 
Methylation Methyltransferase -OH 
-NH2 
Acetylation Acetyltransferase -NH2 
-SO2NH2 
-OH 
Amino acid conjugation -000H 
Glutathione conjugation Glutathione-S-transferase Epoxide 
Organic halide 
Fatty acid conjugation -OH 
Condensation Various 
Glutathione conjugation is one of the most important conjugation reactions in the 
cellular defence against toxic compounds, protecting the cells against reactive 
metabolites. Glutathione is a tripeptide consisting of glutamic acid, cysteine and 
glycine and is considered a protective compound abundant in the liver. Conjugation 
of a xenobiotic with glutathione is a type 2 conjugation reaction where the xenobiotic 
is generally in an activated form, this can be catalysed by an enzyme (glutathione-S- 
transferase) or can occur spontaneously by a chemical reaction. Glutathione S- 
transferases are located in the cytosol of the liver, gut, kidney and other tissues. 
These conjugates are typically excreted into the bile75. 
1.3.3 Phase III metabolism 
An additional phase of drug metabolism is the excretion of both parent drugs and 
their metabolites out of the cell. Transport is regulated by transporter proteins that 
are located on the sinusoidal and the apical membrane of hepatocytes, the intestine, 
and the kidney, and excrete compounds into the bile, blood, intestinal lumen, and 
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urine. Major membrane transporters have been classified into the solute carrier 
(SLC) transporter family and the ATP-binding cassette (ABC) transporter family. In 
human intestines, there are different gradient patterns along the tract, with the 
density of certain transporters increasing in the distal direction. 
1.3.4 Factors affecting metabolism and toxicity 
The metabolic outcome of the total biological system operates on a statistical basis. 
In a complex biochemical system, such as a cell, all molecules (endogenous and 
xenobiotic) act as tumbling charged shapes that interact with the cellular components 
in a manner dictated by their molecular physico-chemical properties, collisions with 
reactive moieties, and their molecular motion. The result of these collisions or 
reactions, are dependent on the laws of thermodynamics and kinetics. Through 
evolution most metabolic machinery has been optimised towards the processing of 
endogenous metabolites but an additional capacity exists to transform xenobiotics via 
generalised approaches. Many metabolic reactions organised into a series (where A 
must go to B, prior to B going to C) are considered to occur based on conditional 
probabilities and hence, follow Bayesian statistical rules. These optimised 
endogenous reactions have evolved so that there is a high probability and functional 
efficiency towards the `correct' reaction, whereas in the case of xenobiotics the 
metabolic machinery is generalised to grant broad substrate specificity and so a 
variety of different pathways may be possible, these may also interact with 
endogenous metabolic pathways. The micrometabolism hypothesis proposed by 
Nicholson and Wilson states `if a plausible biotransformation reaction can be 
postulated that results in a chemically-viable metabolite, then that transformation will 
occur at some cellular level'12. If a particular reaction has a high probability of 
occurring then this will be a major route of metabolism for the xenobiotic whereas, if a 
reaction has a low probability of occurring it will represent a minor route of 
metabolism and will result in minor or micro-metabolites. The fate of a xenobiotic can 
be considered the sum of all possible combinations of metabolic and chemical 
reactions78. 
Factors that modulate metabolic pathway probabilities contribute to individual 
variability, and may determine the metabolic fate of compounds, including 
idiosyncratic toxicities. Modulation can be caused by alterations to enzyme presence 
or activity either through differential expression of a particular enzyme system, 
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genetic polymorphism, the affinity of the compound for the metabolising enzyme or 
the thermodynamic/kinetic favourability of the reaction78. Introduction of other 
metabolites such as sym-xenobiotics and trans-xenobiotics may also disrupt 
metabolic routes and hence, modify the metabolic fate of a drug. Some of these 
metabolites can be derived from the gut microbiota. 
1.3.4.1 Microfloral participation in xenobiotic metabolism 
The metabolic phenotype of rats is strongly influenced by gut microbial composition 
and activity, and individual metabolic phenotypes can be closely related to variation 
in drug metabolism and toxic responses6. The microbiome is enriched with genes 
involved in xenobiotic metabolism, and the remarkable diversity in bacterial strains 
provides a vast range of biotransformation possibilities. Gut microbes can also 
modulate host metabolism in the gut at both a genetic and protein level. Work by 
Mutch et al. observed genes relating to oxidoreductase and carboxylesterase activity 
were increased in the presence of gut bacteria in the mouse79, and Kawai and 
Morotomi identified indigenous bacteria influenced enzyme regulation in the GI tract 
of the host80. 
Co-evolution between host and the microbiome has seen the development of a 
symbiotic relationship between the host and it's microorganisms in many species 81 - 
In most cases the host has adapted to harness the metabolic capacity of the 
microorganisms and manage their potentially harmful microbial metabolites. As such, 
a microbiome-host metabolic axis exists between the host and microbiome 
connected by the enterohepatic circulation (figure 1.2). This has been defined as `the 
multi-way exchange and co-metabolism of compounds between the host organism 
and the gut microbiome resulting in transgenomically regulated secondary 
metabolites, which have biological activity in both host and microbial compartments82. 
This exchange has expanded the biotransformation possibilities available to the host, 
increased the diversity of the metabolic products to which the host is exposed to, and 
overcome the metabolic limitations of the host genome. Increased diversity of 
metabolic products from various microbiomes has possibly contributed to the 
evolution of a diverse xenobiotic detoxifying system. 
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Figure 1.2: Microbiome-host metabolic axis74. In a serves of six hypothetical mammalian cell types (A-F) 
the transcniptomes (At-Ft), proteomes (Ap-FP) and host metabolomes (Am-Fm) are under the control of the 
host genome. Each cell type has a characteristic intracellular metabolome according to biological 
function, and there are constant exchanges with the extracellular environment. The extracellular pool 
incorporates secretions and excretions, some of which are subject to recycling processes, including the 
liver-bile-gut enterohepatic recirculation. The gut microbiome consists of many different species 
(hypothetical species 1-6). Each species has a specific transcriptome (1 r-6r), proteome (1 p-6P), and 
intracellular and extracellular metabolome (1m-6m) that contribute to the gut (enteron) contents. These 
sym-xenobiotic co-metabolites might be co-metabolised by the host and multiple metabolites that are 
derived from both host and microbial processes are then returned to the gut by the bile and possibly 
other secretory routes for further metabolism and/or excretion. 
Whilst the liver is considered the major drug metabolising organ of the body, any 
orally ingested xenobiotic must first traverse the intestine where it is the substrate for 
both host and bacterial enzymes. Given the convenience of oral administration, this 
route of drug treatment is the most common. Bioavailability of xenobiotics can be 
influenced in the GI tract through bacterial biotransformation and clearance83. 
Endogenous and exogenous substances can enter the intestine either orally, via the 
bloodstream or via the biliary tract and the diversity of bacterial reactions enables the 
metabolism of a broad range of substrates; some examples of bacterial reactions and 
their substrates are given in table 1.384. Extensive microfloral contribution to 
metabolism has led to this indigenous population being regarded as a stand-alone 
metabolic organ and reactions of the flora can be considered complimentary and in 
some cases, antagonistic to those of the liver. Intestinal microorganisms favour 
hydrolysis and reduction transformations due to the oxygen-free environment in 
which they reside, whereas the liver performs oxidation, dependent upon the 
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availability of molecular oxygen, and conjugation reactions. Generally, the metabolic 
reactions performed by the liver are reversed by the flora74,85. Additionally bacterial 
hydrolysis of conjugates from the liver allow reabsorption of the compound and can 
significantly increase half-life and change drug elimination rates6. 
Table 1.3 Metabolic reactions of the intestinal bacteria (table taken from Shamat84) 
Reactions Example Reference 
Reductions 
Nitro compounds 
Sulphoxides 
21-Hydroxycorticoids 
Double bonds 
Azo compounds 
Hydrolysis 
Nitrate esters 
Sulphate esters 
Succinate esters 
Amides 
Glucuronides 
Glucosides 
Removal of functional groups 
N-Dealkylation 
Deamination 
Other reactions 
Heterocyclic ring fission 
Side-chain cleavage 
clonazepam Elmer and Remmel (1984)86 
sulindac Strong et al. (1987)87 
aldosterone Miyamori et al. (1988)88 
digoxin Reuning et al. (1985)89 
prontosil Gingell et al. (1971)90 
glyceryl trinitrate Shamat and Beckett (1983)91 
sodium picosulphate Jauch et al. (1975)92 
carbenoxolone Iveson et al. (1971 )93 
methotrexate Valerino et al. (1972 )94 
Morphine glucuronide Walsh and Levine (1975 )95 
sennosides Kobashi et al. (1980)96 
methamphetamine Caldwell and Hawksworth (1973)97 
flucytosine Harris et al. (1986)98 
levamisole Shu et al. (1991)99 
Steroids Cerone-McLernon et al. (1981)100 
Metabolism of xenobiotics by the microbiome can either potentiate or reduce the 
toxicity of a compound. In some cases this intervention can lead to the generation of 
carcinogens and bioactivation of toxic metabolites. In the case of dimethylarsinic 
acid, bacterial metabolism is considered causal to the carcinogenicity of the 
compound, with a bacterial metabolite implicated in urinary bladder 
carcinogenesis'o' In contrast, Upreti et al. identified the microbiome to have a 
significant role in the detoxification and elimination of chromium102. Digoxin is a highly 
toxic cardiac drug and is inactivated by gut bacterial conversion to reduced 
metabolites. Gut microbial populations differ geographically and it was shown that 
digoxin is inactivated by a greater part of the North American population (36%) than 
the South Indian population (13.7%)103 This demonstrates how deviations in gut 
microbial populations influence the metabolic fate of a compound and potentially elicit 
a different response. 
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1.3.5 Toxins 
In this thesis, the mechanisms of methapyrilene toxicity in the conventional rat, and 
the influence of the gut microflora on the metabolism and toxicity of hydrazine were 
studied. 
1.3.5.1 Methapyrilene 
Methapyrilene (MP) is a first generation Hi-receptor antihistamine (see figure 1.3). It 
was discovered in the late 1940s, and was commonly used in many over-the-counter 
sleep aids and cold allergy medications104 In the 1980s a carcinogenesis bioassay 
concluded that MP was strongly carcinogenic for the liver of rats exposed to 1000 
ppm. It was discovered that MP induced liver neoplasms, mainly hepatocellular 
carcinomas and cholangiocarcinomas at an incidence rate of nearly 100%105,106 
s 
ftJ 
Figure 1.3: Chemical structure of methapyrilene ([N-dimethyl-N' pyridyl-N'(2-thienylmethyl)- 
1,2-ethanediamine]). 
The proposed metabolic scheme for MP is displayed in figure 1.4. MP is metabolised 
in the rat by direct dealkylation (II, XVI), ring hydroxylation (XII, XIX), side chain 
oxidation and subsequent removal (IX, X, XIX), and N -oxidation (III). The majority of 
pathways involved in MP metabolism appear to be mediated by cytochrome P450 
and in-vivo studies suggest that the metabolic removal of the 2-thiophenemethylene- 
moiety from MP, forming IX and XIX, is a significant metabolic pathway' 07 
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Figure 1.4: Proposed metabolic scheme for methapyrilene biotransformation 'o' 
In both acute and chronic administration, periportal lesions characterised by 
inflammation, bile duct hyperplasia, hepatocyte hypertrophy (due to mitochondrial 
proliferation) and hepatocyte mitosis were observed105,108 It is proposed that the 
sustained increase in cell proliferation (a compensatory hyperplasia to replace 
necrotic cells) is a contributing factor to the increased incidence of neoplasms 
witnessed in chronic exposure105. Extensive testing, employing a variety of 
mutagenicity assays both in vivo and in vitro found MP to be a non-genotoxic 
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(epigenetic) carcinogen. Epigenetic carcinogens often exhibit organ-, and species- 
specific effects, this is particularly true of MP as it targets specifically rat livers109. No 
evidence has been found of MP-associated carcinogenesis in mice, guinea pigs, 
hamsters, or humans. 
Mechanistic studies performed on isolated rat hepatocytes showed the mitochondria 
exhibited fluctuations in functionality, evident as a loss in cellular ATP. This loss 
correlates with alterations to their morphology (covalent modification of a number of 
mitochondrial proteins). Following several studies, the cytochrome P450 isoform, 
CYP2C11, has been identified as the major candidate involved in the generation of 
reactive metabolites; this bioactivation is a prerequisite for MP hepatotoxicity. 
Furthermore, MP administration significantly increased hepatic reduced 
glutathione'04,108 
1.3.5.2 Hydrazine 
Hydrazine (figure 1.5) is a commonly used model steatotic hepatotoxin in animal 
studies. It is a teratogenic, mutagenic compound, which can induce tumours in 
various organs upon repeated doses at a toxic level. It can be found in a wide variety 
of applications ranging as far as herbicides to rocket fuelllo, 111 
H H 
/ N-N 
i HH 
Figure 1.5: Chemical Structure of hydrazine. 
Hydrazine is basic and is a strong reducing agent. One of its derivatives hydralazine 
can be administered as an anti hypertensive drug and another, isoniazid, can be used 
as an antituberculosis drug. Hydrazine has also been employed in cancer therapy to 
counteract cachexia in terminal ill patients12 
Due to the small molecular size of the compound, hydrazine is rapidly distributed to 
and eliminated from, most tissues. High doses of hydrazine are acutely toxic, 
inducing liver damage and causing severe disturbances in the central nervous 
system. Hydrazine doses administered to laboratory animals have been known to 
cause a drop in body weight, hypoglycaemia, anaemia, and convulsions. After the 
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administration of sub-lethal doses, hydrazine has been shown to affect lipid, protein 
and carbohydrate metabolism. Alterations to carbohydrate metabolism include 
depletion of glycogen in the liver, and reduction in blood glucose levels"', and 
distortion to lipid metabolism induces a dose dependent accumulation of fat 
(steatosis). Several mechanisms have been proposed for this accretion of 
triglycerides in the liver, these include; increased synthesis of triglycerides, increased 
mobilisation of free fatty acids, and accumulation of triglycerides due to decreased 
secretion of lipoproteins from the liver' 3 Other hydrazine-related alterations include 
inhibition of gluconeogenesis, specifically the inhibition of phosphoenolpyruvate 
carboxykinase (PEPCK) a gluconeogenic enzyme1'4, inhibition of the urea cycle, and 
depletion of ATP15 
1.4 Systems biology 
The suffix -omics is generally applied to describe the study of a complete set of 
biological molecules. Where: 
e Genomics is the study of the complete set of genes within an organism 
(genome). 
0 Transcriptomics is the study of the entire set of transcripts in a cell or tissue 
(transcriptome). 
0 Proteomics is the complete identification of proteins and protein expression 
patterns of a cell or tissue (proteome). 
" Metabonomics is the identification and measurement of the total low 
molecular weight metabolites (metabolome) in a cell or tissue or organism. 
These `omic' technologies represent a move away from traditional hypothesis-led 
strategies, which investigate one variable at a time, and instead allow a global 
assessment of complex systems at various levels of biomolecular organisation. This 
new mindset for assessing a biological system is termed a `top-down' approach, and 
creates a birds-eye view of the behaviour of a system at a particular level. The goal 
of this approach is to expose and characterise molecular mechanisms underlying the 
process under investigation16 
38 
Omic technologies have emerged due to advancements in data-rich analytical 
techniques that simultaneously measure multiple variables in parallel, and also the 
development of statistical approaches that permit clearer interpretation of the 
generated data. These techniques follow the principle that as the number of 
parameters measured increase, so to does the potential to capture the inherent 
complexity of a biological system. To identify which of the variables in these 
extensive datasets may relate to the process under scrutiny, multivariate statistical 
analysis is applied; this may also highlight relationships between the variables. 
Systems biology involves the integration of these `omics' technologies to help one 
more clearly understand multi-cellular biological systems. In most investigations one 
omic technology is typically applied' 17 , however it is clear that a combination of these 
omic technologies can provide great advantages to the analyst allowing the system 
to be observed at multiple tiers of biological organisation. A criticism often directed 
towards transcriptomics, is that it merely represents potential, where, unless the 
observed change in gene expression is translated into a change in the concentration 
of the encoded protein it is not biologically significant. No provision exists in 
transcriptomics for determining this or factors such as post translational changes to 
the protein. A constraint of metabonomics is that although metabolic profiles 
represent the functional status of the host, in some cases where changes occur it can 
be difficult to elucidate the mechanism that underlies the observed changes. Hence it 
is logical to integrate transcriptomics and metabonomics so that the two techniques 
may be mutually validating. 
1.4.1 Transcriptomics 
Transcriptome is the collective term for all mRNA molecules or `transcripts' contained 
within a cell or a population of cells. This term can also be adhered to the complete 
set of transcripts contained within a specific cell type or within an organism. As the 
transcriptome encompasses all mRNA transcripts in the cell, this can reflect the 
genes that are actively expressed at any given time. Transcriptomics can therefore, 
be used to study patterns of global gene expression within a biological system in 
response to stimuli. 
Most systems that comprise a living organism exist at a steady state or are diverging 
on a steady state' 8, whereby metabolic intermediates are maintained at close to 
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constant concentrations. This is accomplished by the control of cellular processes via 
homeostatic mechanisms. This control can be subtle, such as the modulation of 
pathway kinetics through modifications to existing cellular proteins, or if the system is 
significantly perturbed, a more pronounced response. This greater homeostatic 
response includes changes to gene expression to help re-organise metabolic 
pathways, and at any given moment the transcriptome reflects the cells attempts to 
maintain or recover homeostasis. 
For a change in gene expression to manifest in a functional change at the level of the 
protein a complex process must ensue. The regulation of gene expression itself is a 
complicated process and the most significant part is the initiation of transcription. 
This involves protein factors, referred to as transcription factors, which interact with 
defined sequences within the non-coding regions of genes and initiate transcription of 
that gene. These regions of defined sequence include the promoter sequences, 
CCAAT and TATA boxes which are recognised and bound by RNA polymerase II. 
Other sites on the gene include enhancer elements, which enhance the stability of 
the RNA polymerase DNA complex by binding to the transcription factors, and 
repressor elements, which shield the promoter sequences to impede the RNA 
polymerase. Another level of control in gene expression is the prevention of protein 
complexes that assist transcription by the physical structure of the chromatin in the 
cell nucleus. 
Hetero nuclear RNA (hnRNA) is the first transcript to be generated after the initiation 
of transcription, however, before this transcript is functional it must be processed into 
messenger RNA (mRNA). For this conversion the eukaryotic hnRNA is 5' capped 
and 3' polyadenylated, and the non-coding regions (introns) between the exons are 
removed. Several different distinct transcripts are able to be formed from one gene 
through differential slicing of the introns and exons. Once fully processed the mRNA 
then migrates from the nucleus into the cytoplasm to be translated into a protein. The 
stability of the mRNA once in the cytoplasm can be varied. 
In the cytoplasm the mRNA is translated into a protein by the ribosome. This 
transcription initiates from a start codon, AUG, which encodes methionine. In some 
transcripts multiple methionine codons exist and the ability of the ribosome to 
decipher which codon is the correct starting position can impact upon the expression 
of the gene product. After translation the protein can undergo post-translation 
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changes and must be transported to the appropriate compartment in order to be 
functional. Proteins themselves also have varied stabilities within the cytoplasm. 
1.4.2 Metabonomics 
Metabonomics is defined as `the quantitative measurement of the dynamic 
multiparametric metabolic response of living systems to pathophysiological stimuli or 
genetic modification' 19. This technique facilitates the elucidation of vast amounts of 
metabolic information from biological fluids, intact tissue, and tissue and cell extracts. 
Biological systems that exist at steady state, maintain relatively constant 
concentrations of endogenous metabolites. Pathological processes and toxic insults 
perturb homeostasis in the cell, and result in disruptions to cellular processes, 
inducing a change in the flux of the cellular metabolites. The metabolic response to a 
perturbation can be highly specific to the nature and site of the stimulus and 
metabonomics permits the measurement of metabolic profiles allowing inferences to 
be drawn regarding the functional biochemical status of the system at a specific time- 
point. 
High-resolution 1H nuclear magnetic resonance (NMR) spectroscopy or liquid 
chromatography-mass spectrometry (LC-MS) are the techniques of choice for most 
metabonomic investigations. The spectra generated via NMR spectroscopy contain 
thousands of signals that can relate structurally to hundreds of endogenous 
metabolites. Other analytical techniques are applicable to metabonomic studies but 
information-rich NMR spectroscopy has the ability to quantify a range of metabolites 
simultaneously and without bias. To interpret these metabolic profiles and identify 
inherent differences across an array of profiles mathematical modelling is applied to 
the complex spectra, reducing complexity, easing interpretation and classification, 
granting a clearer insight into the pathological processes occurring. Further 
advantages of metabonomics include the application of sophisticated pattern 
recognition techniques to spectra for a range of experimental time points to create a 
timeline exposing the metabolic fluctuations during the onset, evolution and recovery 
of toxicity. Metabonomics is a high-throughput technique that has been used in a 
wide range of biomedical applications, ranging from animal toxicology to 
investigations into parasitology. 
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1.5 Research strategy and approach 
Initial work is aimed at characterising the biological systems, at both the 
transcriptome and metabonome level, of animal models used for exploring 
microfloral-mammalian interactions. These animal models include germ-free and 
antibiotic-treated animals, and animals harbouring a `conventional' microfloral 
compliment. Following this, the mechanisms of methapyrilene toxicity will be 
investigated in conventional animals to observe the benefits of using a metabonomic 
approach in unison with classical molecular toxicology techniques. Finally, a second 
hepatotoxin, hydrazine, will be administered to the germ-free and conventional 
animal models. The influence of the gut microbiota on drug metabolism and toxicity 
can then be assessed using transcriptomic and metabonomic techniques. 
The research strategy for the project has been summarised in a flow diagram in 
figure 1.6. 
Chapter 1 
Introduction to thesis 
Chapter 2 
Methodology 
Chapter 3 
Transcriptomic and metabonomic investigation into 
the influence of the microbiota on the mammalian Chapter 4 
system. Comparing the biological systems of Metabonomic and enzyme-related investigation 
germ-free, antibiotic-treated, and conventional animals into the mechanisms of methapyrilene toxicity in 
conventional animals 
Chapter 5 
Transcriptomic and metabonomic investigation into 
the influence of the gut microbiota on the metabolism and toxicity 
of hydrazine in germ-free and conventional animals. 
Chapter 6 
Discussion and conclusions 
Figure 1.6: Flow diagram illustrating the research strategy and approach for the project. 
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Chapter Two: Methodology 
2.1 Transcriptomics 
2.1.1 Microarray technology 
Microarray technology is based upon the concept that two complimentary sequences 
of nucleic acids will hybridise together. This binding is highly specific to the nucleic 
acid sequence and any non-complimentary nucleic acids will only weakly associate. 
Optimisation of experimental parameters such as temperature and oligonucleotide 
length, allow the extent of this binding specificity to be manipulated, increasing the 
specificity of this pairing and denying the weaker interactions from being maintained. 
A microarray, or gene chip, consists of DNA fragments (oligonucleotides) of known 
sequence chemically synthesised at specific addresses on a solid support material. 
These DNA fragments are termed probes and the specific location of where each 
probe is synthesised is referred to as a feature. There are 16-20 probes per probe 
set and each probe set is designed to monitor the gene expression of a given 
transcript. A number of commercial microarray systems are available, this thesis 
uses Affymetrix Rat Genome 230 2.0 arrays. These are whole-genome arrays 
designed to interrogate over 31,000 probe sets that represent approximately 28,700 
rat genes. 
When fluorescently labelled cRNA fragments (derived from sample mRNA templates) 
are introduced onto the gene chip, they hybridise to their complimentary probes and 
emit a fluorescent signal from the location of that probe. The intensity of this emitted 
signal is proportional to the amount of fluorescently labelled cRNA present at that 
feature. With the nucleic acid sequence of each feature known, microarrays can 
provide a parallel assessment of the relative abundances of gene transcripts 
contained within a sample. 
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Figure 2.1 illustrates the microarray process. Following the Affymetrix scheme, 
mRNA is first extracted from tissues; this is reverse transcribed to double stranded 
DNA and subsequently cRNA. The nucleotides in this cRNA are labelled with biotin- 
UTP. The sample is introduced onto the probe set and hybridisation occurs, any 
unbound (non-complimentary) nucleic acids are washed from the chip and a 
streptavidin based stain is applied which binds strongly to the biotin groups. In order 
to amplify the signal from low concentration cRNAs to a detectable level an antibody 
to biotin is applied in addition to a biotinylated antibody to the first antibody. This step 
increases the amount of biotin binding sites, and finally a streptavidin stain is 
reapplied. 
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Figure 2.1: Overview of the microarray technique (Affymetrix website http: //www. affymetrix. com). 
2.1.2 Quantitative-Polymerase Chain Reaction (Q-PCR) 
Quantitative Polymerase Chain Reaction (Q-PCR), or Real-Time Polymerase Chain 
Reaction (RT-PCR) as it is sometime referred, is a technique that allows the 
amplified PCR product to be measured throughout the reaction. This technique relies 
upon the fact that there is a quantitative relationship between the amount of starting 
target sample and the amount of PCR product at any given PCR cycle number 120 
Figure 2.2 shows the four phases of a PCR experiment. 
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" Phase 1 is where the initial exponential amplification is hidden beneath the 
background signal. 
" Phase 2 is the detectable exponential growth phase where an exact doubling 
of product is occurring every cycle. 
" Phase 3 is the linear phase where the reaction components are being 
consumed and the reaction is slowing down. 
" Phase 4 is where the reaction plateaus out to a halt due to lack of synthesis 
material. 
I . 10 
Ü 40 
O 
-+ 
yý 
Y. 
üf 
0 
h; C 
4th phase 
3rd phase 
10 
1st phase 
2nd phase 
- background level 
40 
real-time PCR cycle 
Figure 2.2 The 4 phases of Q-PCR, the blue arrows indicate the region where data is collected (Baylor 
College of Medicine website www. bcm. edu). 
It is in the exponential growth phase (phase 2), when the fluorescence reaches the 
point of detection (comparative threshold, CT) that data is accumulated. The higher 
the starting copy number of the nucleic acid target, the quicker the signal reaches CT. 
The Q-PCR method used throughout this thesis was the TaqMan system (Applied 
Biosystems). This method uses fluorogenic-labelled probes to detect specific 
amplification products. These probes utilise the 5' nuclease activity of Taq DNA 
polymerase to liberate the fluorescent component upon polymerisation (figure 2.3). 
TaqMan probes contain a reporter dye linked to the 5' end of the probe and a non- 
fluorescent quencher (NFQ) at the 3' end. When the probe is intact the close 
proximity of the NFQ to the reporter dye imparts a quenching effect on the reporter 
fluorescence. This suppression is primarily due to fluorescence resonance energy 
transfer (FRET) and as such no fluorescence is produced121. During PCR, two 
unlabelled primers designed to amplify the sequence of interest are extended. 
TaqMan probes anneal between these reverse and forward primers to their 
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complimentary sequences and as the TaqMan DNA polymerase releases the 5' end 
of the probe, the reporter dye escapes the quenching effect of the NFQ and 
fluoresces, producing a signal. Through the evolutionary cycles of PCR this signal 
increases to the point of detection (CT). CT times can be used to indicate relative 
starting abundances or samples can be quantified using a reference sample of 
known concentration. 
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Figure 2.3: 5' nuclease reaction showing the mechanism of probe cleavage resulting in a fluorescent 
signal122. 
Q-PCR was employed in this study as a complimentary technique to microarray 
technology, allowing the results obtained from the microarray approach to be 
validated against a secondary technique. Whilst Affymetrix microarrays monitor 
global, parallel gene expression, Q-PCR measures the expression of specific targets 
raised by the affymetrix microarray. By ensuring both techniques share the same 
expression trends, Q-PCR provides confidence in the result obtained through the 
microarray technique. 
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2.2 Protein-analysis methods 
2.2.1 Sodium Dodecyl Sulphate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) 
Electrophoresis is the migration of charged molecules in solution in response to an 
applied electric field. The extent of this migration relates to the size, shape and net 
charge of the molecules, in addition to the strength of the field and the viscosity, ionic 
strength and temperature of the medium through which it is passing. Electrophoresis 
permits a simple, rapid and highly sensitive technique for separation. 
In general the mediums preferred for protein separation are agarose and 
polyacrylamide gels. These inert and porous gels enable the separation of proteins 
based upon molecular size, where the pore size of the gels can be adjusted to retard 
the migration of the protein of interest. 
Reduced sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
is the method used for separation in this thesis. Here, the solution of proteins to be 
analysed is mixed with the anionic detergent sodium dodecyl sulphate (SDS) and 
boiled in the presence of a sample reducing agent, usually dithiothreitol or 2- 
mercaptoethanol. This step denatures the proteins by reducing disulfide linkages, 
unravelling tertiary folding and destroying quaternary protein structures. This reduces 
the proteins to their linear primary structures and applies a negative charge to the 
proteins in a specific mass ratio of 1.4: 1. This causes separation through the gel to 
be based primarily upon charge (molecular weight) and not shape. 
The denatured proteins are loaded into wells located at one end of a gel submersed 
in a buffer. A current is applied across the gel and the negatively charged proteins 
migrate towards the anode. Smaller proteins will not have their movement restricted 
to the same extent as larger ones and so in a given time will travel further through the 
gel matrix. Marker proteins of known molecular weight are also run through the gels. 
The distance of their migration is used as a reference to ascertain the molecular 
weights of unknown proteins. 
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Once the proteins have been separated through the gel, they are transferred onto a 
membrane. This membrane binds the proteins tightly as they migrate from the gel 
and once all the proteins have been transferred the membrane is removed. This 
membrane (blot) now contains all the proteins separated into the same locations as 
they were in the gel but in a more stable state. 
2.2.2 Western Blotting 
In order to visualise the proteins (antigens) on the membrane, antibodies are applied 
in a technique known as Western blotting. A primary antibody is first applied to the 
membrane which is directed against the protein of interest; this adheres to the protein 
and forms a protein-antibody complex. To detect the bound primary antibodies a 
secondary antibody is applied. The secondary antibody is an anti-immunoglobulin 
antibody that is coupled to a reporter group. These secondary antibodies adhere to 
the primary antibodies and when incubated in a reaction mix, emit light from the 
reporter group. This emitted light can be monitored by photographic film or by an 
LCD cooled camera. The intensity of this signal can be indicative of specific protein 
quantities contained within a sample. This technique is also useful for observing any 
post-translational size alterations that might have occurred to a specific protein. 
2.2.3 Enzyme Activity Assays 
Enzyme activity assays are simple in principle and measure the rate of catalysis by 
the enzyme of interest. This can be measured by either the amount of reaction 
substrate consumed or the amount of reaction product formed. 
2.2.3.1 Carbamoyl Phosphate Synthetase I (CPS I) assay 
Carbamoyl phosphate synthetase I (CPS I) is involved in the first reaction of the urea 
cycle, catalysing the formation of carbamoyl phosphate (CP) from free ammonia. 
This reaction occurs via three steps (figure 2.4). First the bicarbonate is activated by 
Mg+ ATP molecule to yield carboxyphosphate. Simultaneously with activation of 
bicarbonate, glutamine is hydrolysed to glutamate and ammonia. The ammonia 
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reacts with carboxyphosphate to produce the unstable intermediary carbamate, 
which with a second ATP molecule yields the product, CP. 
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O 
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Carbamoyl phosphate Carbamate 
Figure 2.4: Scheme of the reaction catalysed by carbamoyl phosphate synthetase I (CPS /) 123 
To measure CPS I activity a sensitive colorimetric assay is used. A reaction mixture 
containing, ATP, magnesium acetate, N-acetyl-L-glutamate, dithiothreitol, 
triethanolamine and the substrate ammonium bicarbonate is combined with an 
appropriate amount of enzyme preparation. The reaction is allowed to proceed for a 
set time and CP is formed. 
To quantify the rate of this reaction, the CP produced is converted to hydroxyurea by 
the addition of hydroxylamine. CP and its principle decomposition product, cyanate, 
are quantitatively converted (>98%) to hydroxyurea in this manner. Hydroxyurea is 
then quantified using a chromogenic reagent that produces a yellow chromophore. 
This chromophore is measured by a spectrophotometer and the absorbance is 
converted to a concentration by the construction of a standard curve. Enzyme activity 
is quoted in CP produced (nmol)/protein (mg)/min. 
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2.2.3.2 Alanine aminotransferase (ALT) assay 
Alanine aminotransferase (ALT), also known as glutamate pyruvate transaminase, 
belongs to a group of enzymes known as the aminotransferases. These enzymes 
catalyse the transference of the amino group from an amino acid onto a a-ketoacid, a 
process termed transamination. The majority of ALT activity occurs in the liver. 
The ALT assay is a routine assay in clinical chemistry laboratories and is usually 
applied to serum and plasma samples. Hepatic disease and organ damage can 
cause a leakage of the aminotransferases into the plasma, and so plasma ALT levels 
can be useful indicators in the diagnosis of such events. In this work the ALT assay 
has been carried out on plasma samples and protein extracts taken from the liver. 
The principle of the assay works in a two-step reaction and is measured by UV. The 
sample is initially combined with a mixture containing the substrate L-alanine, Tris 
buffer, NADH and the enzyme, lactate dehydrogenase (LDH). The reaction is 
initiated with the addition of the substrate 2-oxoglutarate: 
ALT 
2-oxoglutarate + L-alanine L-glutamate + pyruvate 
ALT is responsible for catalysing this equilibrium reaction and the pyruvate increase 
is measured by an indicator reaction catalysed by LDH. 
LDH 
L-lactate + NAD+ Pyruvate + NADH + H+ b- 
NADH is oxidised to NAD+ and the rate of this NADH disappearance is determined 
photometrically. The rate of NADH oxidation is directly proportional to the rate of 
formation of pyruvate and thus the activity of ALT (Roche ALT protocol). 
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2.3 Metabonomics 
2.3.1 Nuclear Magnetic Resonance (NMR) theory 
Spectroscopy is the measuring of the interaction of energy with an atom or molecule. 
When atoms absorb energy with a frequency, v, an electronic or mechanical change, 
DE, occurs in the molecule. 
This relationship can be defined as: 
LE= by 
where h is a universal constant known as Planck's constant (approximately 6.626 x 
1034 
In nuclear magnetic resonance (NMR), which is reliant on the property of spin (see 
below) it is natural to state things as angular units, where frequencies are quoted in 
Hz, which is the same as `per second'. The time taken for a point at the edge of a 
circle moving at a constant speed, to precess through a 3601 rotation (returning to it's 
initial position) is called a period ('x)124 
The frequency, v, is simply the inverse of the period: 
v= lit 
Here we use the basis that 3600 is 21r radians, to convert the frequency into the 
angular frequency (co). Therefore when a point completes a rotation in i seconds, we 
can state that it has rotated 2m radians in i seconds. The angular frequency, w, is 
given by: 
co = 2ir/ i 
The units of this frequency are given as `radians per second'. 
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Nuclear spin is a fundamental property of nature, and is characterised by a nuclear 
spin quantum number (I). All atoms possess a spin quantum number that may take 
the value of greater than or equal to zero, and are multiples of '/2. Those atoms 
where I=0 do not have a nuclear spin, so cannot achieve nuclear magnetic 
resonance, and cannot be visualised in NMR spectra. 
This spin quantum number is dependent upon the values of protons and neutrons 
present in the atom. 
Number of protons and number of neutrons both even =I=0 
Number of protons plus number of neutrons odd =I= 1/2,3/2,5/2 
Number of protons and number of neutrons both odd =I=1,2,3 
When a nucleus is spinning it possesses an angular momentum (P) and, because it 
has an associated charge, it also generates a small electric current. The motion of 
this charge creates a small magnetic moment (µ). This associated magnetic moment 
(µ) is found by: 
µ= yP 
Where y is the gyromagnetic ratio, a proportionality constant which differs for each 
nucleus and defines the direction of spin, clockwise or anticlockwise. 
If a spinning nucleus is subjected to an external, static magnetic field (B0), the 
population of nuclear magnets experiences a torque and these moments align 
themselves with the external field. For a spin of magnetic quantum number I there 
are 21 +1 possible spin states. Therefore a nucleus with a spin of '/2 has two possible 
spin states, these are +%z, and -'/2. This is in effect two possible orientations when in 
the external magnetic field (Bo) (Figure 2.5). The nucleus may either align parallel (a- 
state, lower energy) or antiparallel (ß-state, higher energy) to the static field and the 
population of these spin states follows the Boltzman distribution, which is given by 
the following expression: 
Na/Nß= eAE/KT 
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Where Na and NR are populations in the states a and ß, K is the Boltzman constant, T 
is the temperature in Kelvin and LIE is the difference in energy between the two spin 
states a and P. 
Direction of direction of 
external field (Bo) precession 
a state or aligned 
P state or opposed 
Figure 2.5: Precession of nuclei with a spin Y2 in an external magnetic field (Bo). Nuclei can precess 
either parallel or anti parallel to the fleld125 
Once aligned the nuclei precess about the applied field in their separate orientations, 
this precession is termed the Larmor precession and the rate is given by: 
w=yB0rads"1 
or 
v=yBo/27r 
Here, v is known as the Larmor frequency of the nucleus and the direction of motion 
is given by the sign of y. Resonance is achieved when a nucleus absorbs a quantum 
of energy and changes its spin state. This energy is supplied as electromagnetic 
radiation and the energy required is the difference in energy between the a-state and 
ß-state when in the applied magnetic field (B0), this is given by: 
AE=by =hyBo/21r 
Where h is Planck's constant. A Bo of 14.1 tesla is commonly used in commercial 
instruments and gives a value of 600 MHz for v. The greater the value for Bo, the 
greater the energy difference. 
We can see that the energy required to achieve resonance is the Larmor frequency. 
When a population of spin-'/2 nuclei are subjected to an applied magnetic field, the a 
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orientation has a faintly lower energy than the ß orientation and as a result there is a 
slight excess of nuclei in the lower energy state. This relatively small excess in the 
population of nuclei in the a-state causes a resultant bulk magnetisation vector (Mo) 
that is in the same direction as Bo. 
It is this bulk magnetisation vector from the low energy state that is measured, and 
this is the basis of an NMR measurement. A radiofrequency energy pulse (B1) is 
applied along the x-axis, which causes this bulk magnetisation vector to be drawn 
from the z-axis to the y-axis, and so precesses about the x/y plane (see figure 2.6). 
This new orientation begins to relax back towards the equilibrium distribution and 
whilst doing so induces a voltage in a radiofrequency detection coil. This recovered 
signal is known as the free induction decay (FID). 
Z 
Mo 
X vý 
Figure 2.6: Effect of a RF pulse (B1) along the x-axis on a collection of nuclear spins at equilibrium. This 
126 causes a rotation of the magnetization away from the z axis into xly plane. 
The FID consists of two independent components characteristic of nuclear relaxation. 
Longitudinal relaxation time, T1, also referred to as spin lattice relaxation, and 
transversal relaxation time, T2. The longitudinal relaxation time is the time constant 
for recovery of magnetisation along the direction of Bo and the transversal relaxation 
time is the time constant for decay of magnetisation in the x-y plane. Decay of T2 
occurs approximately 5-10 times more rapidly than T, recovery and these relaxation 
times are dictated by the speed of molecular rotation and its size. 
Fourier transformation of the FID (time domain) converts it into a spectrum 
(frequency domain) (figure 2.7). This enables the individual signals from molecules 
in different molecular environments to become separated based upon their 
frequency12a 
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Figure 2.7: An example of a single frequency detected by NMR spectroscopy converted by Fourier 
transformation into a frequency domain signal. 
Protons absorb energy at different frequencies depending upon their chemical 
environments, specifically their electron density. Electrons shield protons and a 
higher electron density causes a proton to absorb energy at a lower frequency. 
Neighbouring atoms that cause fluctuations in the electronegativity influence this 
electron density. If a neighbouring atom has a high electronegativity it will draw the 
electron density from the nucleus of interest to itself deshielding this observed 
nucleus causing a higher resonance frequency, v. These frequency deviations allow 
inferences to be drawn regarding the chemical environment into which the nuclei 
reside. The total effective field, Beff, experienced at the nucleus can be written: 
Beff = BO (1 - ß) 
Where a represents the contribution of the small secondary field generated by the 
electrons and is dependent upon the structure of a compound. 
The frequencies measured in NMR spectroscopy are considered relative to the signal 
of an internal standard, usually sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 (TSP) 
for 'H spectroscopy. TSP is used in the NMR spectroscopy of biofluids because it is 
one of the most shielded molecules (absorbs energy at low frequency so does not 
overlap with analytes of interest), it is water soluble, chemically stable and produces 
a singlet resonance peak. The movement of a spectral peak from this internal 
standard is termed the chemical shift (S) and is made frequency independent by 
dividing by the Larmor frequency of the internal standard. 
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6= (V - Vref) - 106 / Vref 
Where, v is the frequency of the studied nucleus and vref is the frequency of the same 
nucleus in the internal standard (TSP). The chemical shift is expressed in parts per 
million (ppm). Chemical shifts allow quick and reliable assignments of spectral peaks 
to metabolites, and also allow the standardisation of spectra, which permits the use 
of pattern recognition and grants their use in metabonomics. 
In most cases an NMR spectrum does not comprise exclusively singlet peaks but 
also doublets, triplets and even multiplets. These variations in peak types arise from 
an NMR spectroscopy trait known as spin-spin coupling. This is where the energy 
states of neighbouring protons alter the NMR signal resulting in a splitting of the 
spectral line resonance into two or more components. This is best explained by 
considering two nuclei, A and X, joined by a covalent bond. The two possible 
orientations of A (Aa and Aß) result in two slightly different local fields experienced at 
X. Therefore two frequencies exist for the transition of the X spins, one resulting from 
the Aa state and one from the Aß state. Boltzman distribution approximates there will 
be equal population of spins in the two states, and so the signal derived from the X 
nuclei will be split into two equal lines or a doublet. The same splitting will apply for A 
as X. This splitting endures even when the magnitude of coupling increases, such as 
AX2 and AX3. The multiplicity of splitting follows the general rule of n+1, determined 
by the number of protons (n) on the adjacent atoms. For example, a nucleus with two 
neighbouring protons gives a resonance peak with a triplet form. The distance 
between the peaks of these multiplets remains constant, this value is referred to as 
the coupling constant, J; this is measured in Hz124,126 
Another useful NMR characteristic is that peak intensity is proportional to analyte 
concentration allowing the quantification of analytes. The absolute concentrations of 
a signal can be determined from the intensity of the respective signal from the 
internal standard of known concentration, or relative concentrations can be 
determined from the intensity of a signal in relation to an endogenous signal. 
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2.3.2 NMR of tissues 
The difficulties in trying to analyse tissue samples by NMR arise from both a 
restriction in the motion of particles and also physical heterogeneity within the 
sample. In a solution particles are free to move about and change rotational 
orientation in a process referred to as molecular tumbling. This molecular tumbling 
averages out orientations to produce a single isotropic signal. The restricted motion 
of particles in tissue prevents molecular tumbling from occurring, and so a range of 
anisotropic interactions occur to produce a broad signal. The most dominant of these 
anisotropic interactions is dipolar coupling, D, and is given by the equation: 
Docr3(3cos20-1) 
Where r is the inter-nuclear separation and 0 is the angle between the static field and 
the inter-nuclear vector. 
Molecular tumbling serves to average the angular term (3 cost 0- 1) to zero. In order 
to reproduce the elimination of the angular term in tissues, the sample is loaded into 
a zirconium rotor and rapidly rotated about the `magic angle' (0 = 54.7°) with respect 
to Bo. This effectively reduces the angular term to zero and simulates the motion of 
particles in a solution. This technique is termed magic angle spinning (MAS) and 
produces interpretable spectra of the tissue samples with more defined and sharply 
resolved peaks124. MAS NMR permits the investigation of solid tissue without the 
need for extensive sample preparation or extraction methods. The use of rotors 
makes this technique non-destructive and sample retrieval is possible for additional 
analysis. 
2.3.3 Pulse programs 
Different pulse sequences can be employed to selectively attenuate unwanted 
signals to enhance the clarity of the signals of interest. These can be applied to both 
solid and solution state NMR experiments 
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2.3.3.1 One dimensional NMR spectroscopy (1 D NMR) 
One-dimensional NMR spectroscopy has been applied throughout this work and 
consists of essentially two steps, pulse and acquire. In the simplest form, a single 
radiofrequency pulse generates a response, the FID, which can then be acquired. 
This radiofrequency pulse covers a wide range of frequencies at once. This 
sequence can then be repeated numerous times to improve signal to noise ratio, 
reducing background noise; the signal to noise ratio improves as the square of the 
number of scans. Between consecutive pulses a delay time, D1, is used to allow 
complete T, relaxation to occur. Without sufficient relaxation the signal intensity will 
be unable to fully recover before the next pulse and will be diminished or saturated 
making quantitation of analytes less accurate. 
2.3.3.2 Water presaturation 
Utilising the fact that a signal will be reduced if complete relaxation is prevented, a 
low energy pulse of approximately 50 Hz (where B, can be 25 KHz) can be applied to 
reduce the intensity of a discrete region of the spectrum. This presaturation pulse is 
applied prior to the 900 pulse, during D1, and at a frequency matching those at which 
the protons from the water precess. Through this approach the resonance of the 
water peak can be saturated. 
2.3.3.3 Carr-Purcell-Meiboom-Gill (CPMG) 
This experiment is utilised to produce a clearer spectrum of low molecular weight 
components. Signals are produced that are weighted according to T2, and the limited 
translational motion of large molecules such as lipids, proteins and other 
macromolecules means they tend to have shorter T2 relaxation times. The signals 
from macromolecules with shorter T2 relaxation times are able to be reduced through 
this experiment. 
De-phasing is a loss in the synchronisation of hydrogen atoms due to these atoms 
precessing at different speeds. When these individual atoms are not synchronised 
they are said to be out of phase and the total signal is diminished. 
CPMG is a cycle 
of pulses employed to counteract dephasing 
by creating pulse echoes. Here, an 
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initial 90° pulse tilts the magnetisation into the x-y plane and the protons precess in 
unison generating a strong signal. Due to inhomogeneity in these protons they 
precess at different frequencies and rapidly lose phase. Following a delay time of T, a 
180° pulse is applied to reverse the direction of precession and after another short 
period (i) the protons come back into phase producing another strong signal called 
an echo. These protons then quickly lose phase coherence again but can be re- 
phased by another 180° pulse. This process can be repeated many times with the 
magnitude of the echo diminishing with time due to molecular relaxation 
mechanisms. Those nuclei with shorter T2 relaxation times disappear faster allowing 
a clearer visualisation of smaller molecular weight molecules. 
2.3.3.4 Diffusion-edited spectroscopy 
Diffusion-edited spectroscopy is a useful experiment for focusing on the resonances 
of proteins and lipids. These larger molecules have slower molecular diffusion 
coefficients than smaller molecules and lower translational motility. This experiment 
attenuates the signals from these smaller molecules. 
2.4 Data analysis 
2.4.1 Data sets 
Throughout this work both univariate and multivariate experimental techniques have 
been used. Univariate techniques are hypothesis driven and interrogate a specific 
variable; this includes work such as enzyme assays and western blotting. These 
techniques do not require complex data analysis, and comparisons across the 
sample set, using a student's t-test to ascertain the statistical significance, are 
generally sufficient for data interpretation. Multivariate techniques such as microarray 
technology and NMR analysis however, tend to be exploratory rather than hypothesis 
driven and provide a simultaneous measurement of numerous variables. The result 
of this multi-parametric investigation is the generation of extensive data sets. 
From a statistical standpoint, an experiment has n, objects, and k, parameters. In 
univariate analysis k is 1 and n equals the sample set, producing a long thin dataset. 
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Multivariate analysis usually has far greater values for k than for n, producing 
relatively short fat datasets. As the value of k increases so too does the complexity of 
the data. The following sections will focus only on the data analysis techniques 
required to interrogate multivariate datasets. 
2.4.2 Pattern recognition 
In order to extract information from multivariate datasets mathematical tools are 
employed. Visual investigation of spectral data alone is not sufficient to prize out 
subtle relationships contained within the data or to assess the extensive variables 
(>28,000) contained within a microarray dataset. 
In NMR, the samples typically contain a mass of metabolites all of varying 
concentrations, and the large number of signals generated from these metabolites 
can often overlap, resulting in some peaks becoming masked by others. This 
diminishes the clarity of the results and makes accurate conclusions tougher to draw. 
The preferred method for interpreting spectra is the appliance of multivariate 
statistical analysis or pattern recognition (PR). PR is capable of identifying latent 
patterns of observations and variables within data sets. 
There are two fundamental types of PR, supervised and unsupervised techniques. 
Unsupervised techniques include statistical methods such as Principal Components 
Analysis (PCA) and Non-Linear Mapping. These methods work via the assumption 
that there is no a priori knowledge regarding class membership and that any patterns 
or groupings that arise from their application are dependent upon experimental 
variables. Unsupervised methods grant an overview and simplify the complex dataset 
making it more interpretable. 
Supervised techniques include Partial Least Squares-Discriminant Analysis, and K- 
Nearest Neighbour analysis. These methods are termed supervised because they 
assign group membership to one of (n) classes; the sample class is then used as a 
parameter to maximise class separation. Validation is a necessary step with 
supervised methods to establish the robustness of the technique. Supervised 
techniques provide an insight into which variables are accountable for class disparity. 
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In this work due to the relatively low number of samples per data set the 
unsupervised technique, PCA has been used to avoid over-fitting of the data. 
2.4.3 Transcriptomic data analysis 
To obtain the transcriptomic data, the microarray chips are first scanned at maximum 
resolution and a grid is automatically aligned to the chip image. The chip image can 
then be digitised to provide an intensity value for each probe cell. Microarray suite 
software (Affymetrix) then calculates a single expression value for each probe set on 
the chip, combining the data from all of the respective probe cells within the probe 
set. This transcriptomic data is then normalised by the software using robust 
regression. The NetAffx database (Affymetrix) is utilised to match the equivalent 
gene to each probe set and the associated Gene Ontology information is used to 
assign probe sets to particular metabolic and functional pathways. 
A detection algorithm is applied to the chip data to calculate the `Absolute call' for 
each transcript. A probe set is made up of probe pairs comprised of Perfect Match 
(PM) and Mismatch (MM) probe cells. These probe pair intensities are used to 
generate a Detection p-value for a given probe set. This value is then compared to a 
predefined threshold value to determine whether a transcript is reliably detected 
(Present, P) or not detected (Absent, A). 
Transcriptomic data is most frequently applied to directly compare two experimental 
conditions, whereby the transcriptome under condition A is compared to the 
transcriptome under condition B. In this instance, a straight comparison of the 
individual transcripts across the two groups can be performed, with the analyst 
selecting strict criteria to define what is considered a change in a gene transcript. 
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This approach has been adopted for handling the transcriptomic data in this thesis 
and the criteria incorporates: 
"A transcript must have a mean intensity value of greater than 50 in the 
sample set in which it is expressed higher. This is to ensure that a transcript 
is present in sufficient quantity to permit protein synthesis. 
"A fold change difference in the mean intensity of the two experimental groups 
for each transcript (typically greater than 2 fold, higher or lower expressed). 
" The difference must be statistically significant (P < 0.05), measured by a 
student's unpaired t test. 
" All up-regulated/higher expressed transcripts must have `present' calls by 
Affymetrix `absolute call' in all samples within that sample set. 
9 All down-regulated/lower expressed transcripts must have `present' calls in 
all the samples within the sample set by which it is being compared to. 
This approach enables the shrinking of a data set comprising 1000s of variables into 
a more interpretable data set containing only relevant information describing what 
transcripts are significantly different across the two sample sets. The genes from this 
data set can then be grouped into those relating to similar processes, i. e. drug 
metabolism or carbohydrate metabolism, in this scheme, if several genes relating to 
similar pathways or cell functions are altered, confidence can be taken that this 
pathway or function is perturbed. 
2.4.4 Metabonomic data analysis 
2.4.4.1 Pre-processing of NMR spectral data 
Pre-processing of spectral data is essential to make accurate comparisons across a 
sample set. Upon acquisition of the spectrum, the frequency must first be adjusted to 
the internal reference standard, TSP (S 0.0). This provides confidence that the 
chemical shifts of metabolites are the same across all spectra. Other spectral 
adjustments include the process of phasing the spectra to provide good quality peak 
shape and accurate peak integration, and baseline corrections to remove systemic 
offsets. 
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In order to carryout PR the spectral data are digitised into a data matrix, consisting of 
n observations (samples) and k variables (chemical shifts). Digitisation integrates the 
spectrum into a series of intervals (buckets). These intervals are the variables and 
relate to the chemical shift. The integral value of each bucket equates to the peak 
intensity and the width of these buckets can be adjusted to alter the resolution of this 
spectral digitisation. The spectral regions that possess no real diagnostic information 
or information that disrupts other spectral data is removed. The region 4.5-6.0 ppm is 
removed as this includes the resonances of the water and urea signals. Where group 
sizes are small, the use of bucketed or binned data prevents chemical shifts from 
having too great an influence on the analysis, otherwise the full resolution spectra 
would be more appropriate as an input data matrix. 
Once the redundant spectral regions have been discarded each observation needs to 
be normalised. Normalisation is a mathematical correction applied to experimental 
data in an attempt to adjust for uncontrollable systematic technical variation (bias) 
that may impose an influence upon the data. This includes factors such as variation 
in urinary excretion volumes. This enables the modified data to more realistically 
reflect the biological differences occurring within the data. The principle of 
normalisation is to identify some aspects of the data, which are invariant in relation to 
the processes under scrutiny, and to display all measurements in terms of this 
aspect. 
Normalisation to unit area is the most commonly used technique and is the approach 
applied throughout this thesis. It works in a ratio-like fashion whereby each spectral 
integral is divided through by the sum of all the integrals and this ratio is then 
multiplied by target intensity. In most cases the target intensity selected is 100, 
representing each observation as a percentage of the overall data. This approach is 
beneficial in that regardless of baseline noise the total sum of each spectrum is equal 
to 100%. This permits comparison between the data allowing specific peaks to be 
compared to one another across different spectra. Due to variable urinary volumes 
voided, it is especially important to normalise urine spectra prior to further analysis. 
After normalisation the data is mean centred to improve the interpretability of the 
model. Mean centering works on the principle of calculating the mean of each 
variable and then subtracting this value from the data set. This technique is good for 
identifying large metabolite differences but can suffer identifying discrete metabolite 
changes (Figure 2.8) 
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Figure 2.8: Demonstrating the effect of mean centering on a data swarm that has 3 variables. 
Subtraction of the average values repositions the swarm so that the average point coincides with the 
125 origin of the co-ordinate system. Adapted from Tsang 
2.4.4.2 Principal Components Analysis (PCA) 
PCA is a multivariate statistical technique capable of reducing the dimensionality of a 
data matrix. The work originates from a data matrix (X) that comprises n rows 
(observations) and k columns (variables). In order to best explain the processes 
involved in PCA a geometric approach is required. The k variables are viewed as 
axis of a graph (whereby k=2 is 2 dimensional (2 axis) and k=3 is 3 dimensional (3 
axis)), and the space within a graph of k axis is termed the k-space. 
When handling multivariate data matrices, k can commonly exceed 250, although 
this is difficult for the human mind to visualise, mathematically this is possible. In this 
mindset, each row of the matrix can be considered a coordinate within this k space. 
In the advent of a large collection of observations a data swarm would be seen in this 
k-space. This is where PCA deciphers the cloud to expose groupings or patterns 
within this swarm. 
PCA discovers the direction of this data swarm that illustrates the maximum degree 
of variation and sets this as the first principal component (PC1); this variance vector 
must pass through the average point (origin as mean centred) (figure 2.9a). The 
second principal component (PC2) describes the second greatest direction of 
variation and must be orthogonal to PC1 (figure 2.9b), the subsequent PCs are 
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var. 1 
calculated in the same fashion with each component exhibiting progressively less 
variance, and are orthogonal to the first and all other components12'. 
Once the necessary principal components have been derived they represent a plane 
in the k-space, the observations can then be projected onto this low-dimensional 
plane converting them into an interpretable plot, this new graphical representation 
constitutes the scores plot (t) of the PCA model. For a given observation the distance 
from the origin to this point is the score value of that observation for that particular 
PC. The scores plot provides information regarding relationships between the objects 
(trends, groupings). 
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Figure 2.9: Principal components analysis. (a) Principal component (PC) or latent variable, is the line 
that best accounts for the data set and passes through the mean, 0. (b) Additional PC's are calculated 
that are orthogonal to the previous PC. (c) Observations may be visualised on a lower dimensioned 
plane, referred to as the score plot. (d) For observation ia new co-ordinate value is obtained from its 
projection to the PC, the distance from this point to the origin is its score value125. 
Principal components loadings (p) describe the original variables importance for a 
respective PC. This is a measure of similarity in direction between the original 
PC I (tip, I) 
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variable and the PC. This similarity is calculated by taking the cosine of the angle 
between the original variable and the PC (Figure 2.10). As the direction of the 
variable dive rges upon the PC (the closer the similarity in direction), the angle 
between the two becomes smaller, increasing the weighting. The corresponding 
loadings plot (p) represents the contribution of the variables to the respective PCs 
used in the s cores plot and provides an explanation for the relationships exposed in 
the scores plot. 
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Figure 2.10: Principal components loadings values. (a) the loadings value for a particular variable in 
respect to the PC is given by the cosine of the angle between the variable and the PC. b) A situation 
whereby the largest direction of variation in the data coincides with variable 1. This means that the 
direction of the first PC coincides with variable 1. 
The advantage of PCA is that it takes into consideration all the variables involved 
simultaneously whilst allowing the data to presented in a two or three dimensional 
plot. When PCA is applied to a digitised NMR spectrum the loadings correspond to 
spectral frequencies, which correspond to specific metabolites. From here individual 
metabolite fluctuations may be monitored and their interaction with other metabolites 
assessed, this forms the basis of metabonomics. 
2.4.4.3 R2 and Q2 values 
For each PCA model, an R2 and Q2 value is given. The R2 value provides a 
quantitative measure of the goodness of fit, indicating the degree of variation within 
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the data set that can be explained by the model. If many components are generated 
to attempt to fit a model well, R2 becomes arbitrarily close to the optimal value of one, 
and the model is said to be over-fitted. This cannot happen with the Q2 value, which 
is a measure of how accurately the model can predict the X data, as the addition of 
latent variables may introduce components which are uncorrelated with the patterns 
within the data set and the predictive ability of the model will be reduced128. High 
values for R2 and Q2 are preferred and a high R2 value is a prerequisite for a high Q2, 
the number of PCs are selected to maximise these values. 
2.4.4.4 Detection of outliers 
Abnormal observations or outliers can be problematic to multivariate analysis due to 
their ability to bias the model by drawing principal components toward them. As such 
these outliers must be identified and removed from the analysis. One statistical 
approach to detect outliers in the data set is via the Hotelling's T2 ellipse. Hotelling's 
T2 is a multivariate generalisation of the Student t-test and is represented in the 
scores plot as an ellipse that marks the 95% confidence interval based upon normal 
distribution (figure 2.11). It follows therefore, 5% of all observations will fall outside 
this ellipse, but it is those observations that lie significantly outside that are excluded 
from the analysis. Moderate outliers can exist due to experimental issues such as 
poor water suppression, or dilution differences in the samples. These can generally 
remain in the model if they do not cause any bias. 
Principal Components Scores Plot 
Outlier 
LI 
üf 
L1 
eQ 
A 
.7 
A ee 
A 
eý 
AA 
oe a 
Ellipse defining 
95% confidence limit 
ýC 
M 
_1 
ti 
=12 -D .8 -6 4 -2 0246ö l1 Y 
t(l) 
Figure 2.11: PCA scores plot with outlying or abnormal observations indicated by the Hotelling's T2 test. 
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Chapter Three: Influence of the gut microbiota on the 
mammalian system 
3.1 Aims and objectives 
The influence of the gut microbiota on the mammalian system was studied. In this 
investigation two animal models have been compared to conventional animals, germ- 
free rats and conventional rats administered antibiotics to suppress the activity of the 
microbiota. Microfloral recovery, once antibiotic treatment ceased, was also 
investigated to monitor the effect of bacterial re-establishment on the host. These 
animal models were evaluated using a systems biology approach to assess the 
influence of the microbiota on the host transcriptome and metabonome. The 
objectives were: 
0 To characterise the germ-free rat model and antibiotic-treated rat model using 
transcriptomic and metabonomic approaches, and compare these to a 
conventional animal model to elucidate the influence of the microbiota on the 
host. 
0 To assess the impact of bacterial recolonisation in conventionally raised 
animals using transcriptomic and metabonomic approaches. 
" To evaluate the use of such models for in vivo studies aimed at investigating 
interactions of the microflora on host drug metabolism and toxicity. 
3.2 Introduction 
As previously discussed in chapter one, the gut microbiota can be regarded as a 
stand-alone organ in terms of metabolic function and position in host welfare 
129 
Autochthonous flora contribute to the morphology, physiology, biochemistry, and 
immune status of the host, these contributions have been termed microflora- 
associated characteristics. Germ-free and antibiotic-treated animals allow 
the 
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influence of the microbiota on the host transcriptome and metabolic profile to be 
studied; both models have positive and negative aspects and are discussed here. 
3.2.1 Germ-free animals 
The term `germ-free' or `axenic' animal refers to a host devoid of other life forms, 
including bacteria, viruses, fungi, and protozoa. To achieve axenia, animals can 
either be born via caesarean section into a sterile environment or bred from a sterile 
colony and raised within germfree isolators. Given the complexity and dynamic 
nature of the gut microbiota the germ-free animal model provides a simplified test 
model for investigating this intestinal ecosystem. A drawback of this model is that 
these animals lack the developmental features associated with harbouring an 
established microflora throughout life, therefore, when using this test system it is not 
solely the influence of the microflora that is being assessed but also these germ-free 
structural characteristics. Differences between the germ-free and conventional 
animals are given in table 3.1. 
Table 3.1: Morphological, physiological, biochemical and immunological differences of the 
germ-free animal in comparison to the conventionally raised animal' 
62,130-132 
Morphological/physiological Enlarged cecum 
Reduced heart size (lower cardiac output) 
Smaller liver and lungs 
Lower body weight 
Intestinal structure/function Poorly developed villi 
Reduced mucosal cell turnover 
Decreased digestive enzyme activity 
Reduced intestinal motility 
Metabolism Lower basal metabolic rate 
Reduced SCFA concentrations 
Reduced electron sink products 
Reduced vitamins B12 and K 
Immunity Decreased spleen size 
Absence of bacterial antagonism 
Reduced diversity and circulation of antibodies 
Lower serum gammaglobulin fraction 
(Lower IgG and absence of IgA) 
Numerous omic studies have been carried out on germ-free animals, including the 
effect of acclimatisation on germ-free rats133, impact of colonising germ-free mice 
with human baby flora82, and transcriptomic assessments of 
intestinal sections taken 
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from germ-free mice134' 135 These studies demonstrate the use of this animal model 
for exploring the complex microfloral-mammalian interactions and also the benefits of 
applying omic approaches to explore such interactions. 
3.2.2 Antibiotic treated animals 
Temporary sterilisation of the GI tract may involve selective or absolute elimination of 
the microbiota. Elimination of the bacterial flora through the oral administration of 
antibiotics was first described by Van der Waaij and Sturm 136 A combination of 
bacitracin with kanamycin, neomycin or streptomycin was administered in the 
animal's drinking water and was noted to effectively decontaminate the digestive 
tract. Subsequent studies administered combinations of bacitracin and streptomycin 
sulphate137, and later streptomycin sulphate and penicillin138. In this study the 
streptomycin sulphate and penicillin combination was employed. Streptomycin is 
highly effective against Gram-negative bacteria and penicillin is most effective 
against Gram-positive bacteria. This dosing regime has been shown to reduce the 
total aerobic cecal bacterial population from 106 to <102 colony forming units 
bacteria/g cecum13$ 
The use of antibiotic-treated animals in future studies may be preferred over germ- 
free animals, as the activity of the flora is suppressed yet microfloral associated 
characteristics persist, enabling a focused view into the direct interactions between 
the host and the flora. The main benefit of this model in pharmaceutical studies is 
that temporary sterilisation of the gut via administration of antibiotics is comparatively 
low in cost and in-house strains can be used, whereas germ-free animals are costly 
to purchase or breed and maintenance is laborious and expensive. The potential 
hazards of using this model in drug metabolism studies is the use of antibiotics 
themselves, which may influence the metabolism and absorption of xenobiotics 
through binding, or interference of host metabolism and/or physiology. 
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3.3 Materials and methods 
3.3.1 Study design 
3.3.1.1 Germ-free animal study 
Germ-free male Sprague-Dawley (SD) rats (group 1) were supplied by Charles River, 
France (n = 4). Conventional male SD rats (group 2) were supplied by Charles River, 
UK (n = 4). All animals were 7-8 weeks old and sacrificed by halothane inhalation 
immediately upon arrival from supplier to prevent any colonisation occurring to the 
germ-free animals. 
Table 3.2: Study plan for the germ-free animal study. 
Group Animal No. Animal Type Time of Sacrifice (h) 
1 1-4 Germ-Free 0 
2 5-8 Conventional 0 
3.3.1.2 Antibiotic-treated animal study 
Male, Wistar derived AlpkHsdRccHan: WIST rats (n = 18) were obtained from the 
Rodent Breeding Unit at AstraZeneca, Alderley Park. Animals were approximately 
ten weeks old, and housed three per cage. Food (standard rat and mouse diet No. 1 
modified irradiated diet; Special Diet Services) and water were available ad libitum 
and all animals were subjected to 12-hour light, 12-hour dark artificial light cycle. 
Animals were acclimatised to these housing conditions prior to the start of the dosing 
regimen. 
Animal work was carried out by the In-life phase department at AstraZeneca, 
Alderley Park. Rats were separated into three groups of six (see table 3.3) and 
antibiotic treatment was carried out following the protocol of Guo et al. 138. The 
antibiotic solution, containing 4 mg/ml Streptomycin and 2 mg/ml Penicillin was 
provided in the animals' drinking water. The drinking water of group I, the control 
group, contained no antibiotics. Group II were given free access to the antibiotic- 
water for the first four days and were then switched to antibiotic-free water for the 
remaining four days of the study to allow recolonisation to occur. Group III were given 
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free access to the antibiotic-water for the full eight days of the study. All animals were 
euthanased by halothane inhalation on the eighth day of the study. 
Table 3.3: Antibiotic-treated animal study. 
Group Animal Concentration of Concentration of Days of 
numbers Streptomycin Penicillin antibiotic 
(mg/ml) (mg/ml) treatment 
1-6 000 
II 7-12 424 
III 13 - 18 428 
Decontamination of the cecum was measured by quantitative cultures of the content 
taken from the large intestine at necropsy. Samples taken from the large intestine 
were transferred to a culture broth (YT broth) and weighed. The broth was 
homogenised and spun (100 xg for 5 minutes) to remove particulates. The sample 
was then diluted 1/100 with YT broth and 100 pl was applied to a MacConkey agar 
plate and incubated overnight at 37 °C. The colonies that formed on the plate were 
counted and this number was adjusted to represent colony forming units per mg wet 
weight of intestinal contents. 
3.3.2 Sample Collection 
3.3.2.1 Germ-free animal study 
Immediately after sacrifice the liver and sections of the GI tract (duodenum, jejunum, 
ileum, cecum, and colon) were excised, snap frozen in liquid N2, and stored at -80°C. 
The cecum of the germ-free animals was noted to be enlarged, consistent with 
previous observations. Whole blood was taken at necropsy and sent to Clinical 
Pathology at AstraZeneca, Alderley Park. Plasma was also prepared from whole 
blood for further analysis. Urine was unable to be collected from either animal strain 
due to the immediate sacrifice of these animals. 
3.3.2.2 Antibiotic-treated animal study 
For the antibiotic study, urine was collected overnight for 16 hours on days -2 to -1,3 
to 4, and 7 to 8. This was collected over dry ice and stored at -80 °C. Whole blood 
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was taken at necropsy and sent to Clinical Pathology at AstraZeneca, Alderley Park, 
with plasma also prepared from the whole blood for further analysis. After sacrifice, 
the liver and sections of the GI tract (duodenum, jejunum, ileum, cecum, and colon) 
were removed and snap frozen in liquid N2, and stored at -80°C. 
3.3.3 Transcriptomics 
3.3.3.1 RNA extraction 
RNeasy mini kits from Qiagen were used to isolate RNA from liver, duodenum, 
jejunum, ileum, cecum and colon tissue. The reagents contained in these kits are 
given arbitrary names by the manufacturer and so are referred to as they are in the 
protocol. Here: 
" 50 mg of tissue was homogenised in 1 ml of RLT solution with 10 pl ß- 
mercaptoethanol added. The RLT solution is a highly denaturing guanidine 
isothiocyanate (GITC) containing buffer, which inactivates RNases to allow for 
the recovery of intact RNA. 
9 The homogenate was spun at 16,100 xg for 3 minutes and the supernatant 
was transferred to a new eppendorf (600 NI). 
9 An equal volume of ethanol (70% v/v) was applied. With 700 pl of the mixture 
applied to the RNeasy mini column and then centrifuged for 15 seconds at 
9,300 x g. The flow through was reapplied to the column and centrifuged 
again at 9,300 xg for 15 seconds. The flow through was then discarded. 
9 The solution labelled RW1 was then applied to the column (700 pl) and spun 
for 15 seconds at 9,300 x g. 
" The RNeasy column was then transferred to a new collection tube and 500 pl 
of RPE solution was added, spun 15 seconds at 9,300 x g, flow through 
discarded, followed by another 500 pl of RPE applied. This time followed by a 
9,300 xg spin for 2 minutes to dry the column. 
0 The column was then transferred to a new collection tube and spun for 1 
minute at 9,300 x g. 
" Finally the column was transferred to a 1.5 ml collection tube, 50 pl of RNase- 
free water was added and spun for 1 minute at 9,300 x g. The flow-through 
reapplied and spun again for 1 minute at 9,300 x g. 
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The concentrations of the RNA extracts were ascertained using the Perkin-Elmer 
Nanodrop. This derives the concentration of RNA using spectrophotometry. The 
concentration of RNA was determined from 1 pl of sample by measuring the 
absorbance at 260 nm, the concentration is given in ng per pl. Proteins absorb at 280 
nm and the 260/280 ratio provides a measurement of protein contamination. For 
quality control only RNA extracts with a 260/280 ratio above 1.6 were accepted. For 
further quality control all samples were run on a 1% denaturing agarose gel with 
ethidium bromide staining, this enabled visualisation of ribosomal bands and size 
distribution allowing the integrity of the RNA to be verified. 
3.3.3.2 Affymetrix sample preparation 
The tissues analysed via Affymetrix gene expression profiling were the liver, ileum 
(small intestine) and colon (large intestine). Due to the high cost of this technique 
three animals from each group were selected. 
Sample preparation required for Affymetrix gene expression profiling can be divided 
into two sections. The first is to convert the RNA extracted from the tissues into 
labelled cRNA that is then hybridised onto the gene chip. The second is to capture 
the image of the hybridised chip in order to carryout data analysis and observe how 
the genes accounted for on the chip are expressed. 
The One-cycle cDNA synthesis kit from Affymetrix was used for cDNA synthesis. For 
each sample, 5 pg of total RNA was mixed with 2 pI T-7-Oligo(dT) primer and 2 pi 
poly-A RNA controls. Each eukaryotic gene chip probe array includes probe sets for 
several B. subtilis genes that are not present in eukaryotic samples. The poly-A RNA 
controls are polyadenylated transcripts for the B. subtilis genes. These are included 
prior to cDNA synthesis and therefore undergo amplification and labelling the same 
as the sample. This provides an internal standard to monitor the efficiency of the 
target synthesis and hybridisation independent of the quality of the starting RNA 
sample. This primer mix was then incubated at 701C for 10 minutes then cooled to 
4°C for 2 minutes. 
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The first strand master mix was made up of: 
" 4p1 of 5X 1St Strand Reaction Mix 
" 2NIDTT, 0.1M 
"1 NI of dNTP, 10 mM. 
To the cooled primer mix, 7 pl of this master mix was added, mixed thoroughly, and 
heated at 42°C for 2 minutes. After heating for 2 minutes 1 pl of SuperScript II was 
added, mixed thoroughly then incubated for 1 hour at 42°C. The sample was cooled 
to 4°C for at least 2 minutes and then second strand cDNA synthesis was carried out. 
The second strand master mix consisted of: 
" 91 NI of RNase-free water 
" 30 NI of 5X 2"d Strand Reaction Mix 
" 3pIofdNTP, 10mM 
"1 NI of E. coli DNA ligase 
"4 pI of E. coli DNA Polymerase I 
"1 pI of RNase H. 
To each first-strand synthesis sample 130 pl of second strand master mix was 
added to give a final volume of 150 pl. This was incubated for 2 hours at 16°C, then 
2 pl of T4 DNA polymerase was added to each sample and incubated for 5 minutes 
at 16°C. Following this incubation 10 pl of EDTA, 0.5 M, was added and the samples 
(now double stranded cDNA) were cleaned up. 
To purify the double-stranded cDNA the GeneChip Sample Cleanup Module was 
used. 
" First 600 pi of cDNA Binding Buffer was added to the double-stranded cDNA 
sample and mixed by vortexing for 3 seconds. 
" Next 500 pl of the sample was applied to the cDNA Cleanup Spin Column 
and centrifuged for 1 minute at 9,300 x g. The flow through was discarded 
and the remaining sample (260 pl) was loaded onto the column and again 
spun at 9,300 xg for 1 minute. 
" The flow through and collection tube were discarded and the spin column was 
transferred to a new collection tube, 750 pl of cDNA Wash buffer was applied 
to the spin column and spun for 1 minute at 9,300 x g. The flow through was 
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discarded and the column was dried by spinning at 16,100 xg for 5 minutes 
with the spin column open. 
" The column was transferred to a new collection tube and 14 pl of cDNA 
Elution buffer was added to the column membrane, incubated for 1 minute at 
room temperature, and then spun at 16,100 xg for 1 minute to elute. 
To generate biotin-labelled cRNA from the cleaned-up double-stranded cDNA, 12 pl 
of template cDNA was combined with 4 pl of 1OX IVT Labelling Buffer, 12 pl IVT 
Labelling NTP Mix, and 4 pl IVT Labelling Enzyme Mix. The mixture was then 
incubated at 37°C for 16 hours. 
The biotin-labelled cRNA solution was made up to 100 pl with RNase-free water and 
then 350 pl of IVT cRNA Binding Buffer was added. The lysate was mixed by vortex 
and then 250 pl of 100% ethanol was added. The sample (700 pl) was then applied 
to the cRNA Cleanup Spin Column and spun for 15 seconds at 9,300 x g. The flow 
through was discarded and the spin column was transferred into a new collection 
tube. Next 500 pl of IVT cRNA Wash Buffer was pipetted onto the column and spun 
for 15 seconds at 9,300 x g. After discarding the flow through 500 pl of 80% ethanol 
(v/v) was applied to the column and spun at 9,300 xg for 15 seconds. The flow 
through was discarded and the column was spun with the cap open for 5 minutes at 
maximum speed (16,100 x g) to completely dry the membrane. The column was 
transferred to a new collection tube and 11 pl of RNase-free water was applied 
directly onto the membrane. This was spun for 1 minute at 16,100 xg and then 
another 10 pl of RNase-free water was added, the column was spun for 1 minute at 
16,100 xg and the concentration of the cRNA solution was measured using the 
Perkin-Elmer Nanodrop. 
Fragmenting the cRNA has been shown to allow optimal assay sensitivity. The 
fragmentation buffer supplied with the Affymetrix kit fragments the cRNA into 35 to 
200 base fragments by metal-induced hydrolysis. For fragmentation, 25 pg of cRNA 
was initially taken and combined with 10 pl of fragmentation buffer and heated at 
94°C for 35 minutes. After this period the sample was placed on ice. To ensure 
fragmentation had taken place the fragmented sample was run next to the un- 
fragmented sample on a 1% denaturing agarose gel with ethidium bromide staining. 
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The hybridisation cocktail contained: 
"5 pl Control Oligonucleotide B2 controls 
" 15 pl 20X eukaryotic hybridisation controls 
"3 pl Herring sperm DNA 
" 3pIBSA 
" 150 pl 2X hybridisation buffer 
" 30pIDMSO 
" 64 pl nuclease-free water 
This cocktail (total volume 270 pl) was added to 30 pl (15 pg) of fragmented cRNA 
and heated to 99 °C for 5 minutes and then 45 °C for a further 5 minutes. Following 
heating the sample was spun at maximum speed in a micro centrifuge for 5 minutes. 
Meanwhile each chip was wet with 250 pl of 1X MES hybridisation buffer (5.38 g 
MES hydrate, 16.11 g MES sodium salt in 1000 ml of RNase-free water) and 
incubated at 45 °C for 10 minutes at a rotation speed of 60 rpm. The buffer was 
removed from the chip and 250 pl of the sample hybridisation cocktail was added. 
Chips were incubated at 45 °C for 16 hours at a rotation speed of 60 rpm. 
After 16 hours the hybridisation cocktail was removed from the chip and replaced 
with non-stringent wash buffer (6X SSPE (0.9 M NaCl, 0.06 M NaH2PO4,0.006 M 
EDTA), 0.01 % Tween 20). A GeneChip fluidic station operated by software provided 
by Affymetrix was used for the washing and staining of the chips. The fluidic station 
was primed using a priming protocol in the software and then the chips were washed 
and stained using the EukGE_Ws2v5_450 protocol provided by Affymetrix. This 
protocol washed the chip with non-stringent wash buffer and then stringent wash 
buffer (100mM MES, 26 mM NaCl, 0.01% Tween 20) and stained the chip with a 
Streptavidin Phycoerthrin (SAPE) solution. An additional antibody solution (300 pI 2X 
stain buffer, 266.4 pl of water, final concentration 2 mg/ml BSA, 0.1 mg/ml normal 
goat IgG, and 3 pg/ml biotinylated antibody) was added followed by a second 
antibody stain, to amplify signal intensities. Washed and stained chips were then 
stored at 4 °C and shielded from light until scanned. 
The chips were scanned using the GeneArray scanner (Affymetrix) controlled by the 
Affymetrix microarray suite software and the data was processed as outlined in 
chapter two (section 2.4.3). 
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3.3.3.3 Quantitative - Polymerase Chain Reaction (Q-PCR) 
Q-PCR involves two steps, the reverse transcription reaction and the PCR 
amplification. RNA was first reverse transcribed into complimentary DNA (cDNA) 
using the Superscript III first-strand synthesis system (Invitrogen). Here, 1 pg of 
sample RNA was combined with 1 pl 10mM dNTP mix, 1 pl random hexamers and 
made up to a final volume of 10 pI with nuclease-free water. Two solutions were 
assembled for each sample and all solutions were incubated at 65 °C for 5 minutes 
and then transferred immediately onto ice for longer than 1 minute. Meanwhile an RT 
mastermix was prepared containing 2 pl 10X RT buffer, 4 pl 25 mM MgCI2,2 pl 0.1M 
DTT, 1 pl RNase OUT, and 1 pl of Superscript III (reverse transcriptase, RT). A -RT 
control mastermix was also prepared containing the same constituents except the 
Superscript III was replaced with nuclease-free water. For each sample, 10 pl of the 
RT mastermix was added to one solution and 10 pl of -RT mastermix was added to 
the other. Both solutions were incubated at 25 °C for 10 minutes, followed by 
incubation at 50 °C for 50 minutes. The enzyme was then inactivated by heating at 
85 °C for 5 minutes and then chilled on ice. RNase H (1 pl) was added to each 
solution prior to incubation at 37 °C for 20 minutes to remove template RNA. Finally 
180 pI of nuclease-free water was added to each sample to give a 1: 10 dilution. RNA 
was isolated and cDNA was generated from the liver, duodenum, jejunum, ileum, 
cecum, and colon of all animals from the germ-free animal study and from four 
members of each group from the antibiotic study. 
The resulting cDNA was used as a template for PCR. Genes to be assessed via Q- 
PCR were selected according to their pattern of gene expression raised by the 
microarray data. In this study the following transcripts were analysed (where possible 
the Applied Biosystems assay ID is given): 
" Constitutive androstane receptor (CAR) (Rn00576085_ml ) 
" Pregnane X receptor (PXR) (Rn01444226_m1) 
" ATP-binding cassette B1 (ABC B1) (Rn00591394_ml ) 
" Cytochrome P450 2B1 (CYP 2B1) - Taqman primers and probe 
sequences are given in Meredith et al. 139 
For each transcript three sets of reactions were set-up, the sample to be analysed, a 
calibration curve, constructed by taking an aliquot from all samples of each sample 
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type and then diluted to a logarithmic scale, and a -RT control. The -RT control 
indicates whether there was contamination of the sample by genomic DNA. 
To carryout PCR, the 'qPCR Mastermix plus low rox' kit (Applied Biosystems) was 
used. Here, 1 pl of each cDNA template was applied to a well plate and then a 
mastermix containing (per reaction) 10 pl 2X reaction buffer, 1 pl probe (specific to 
the transcript being analysed), and 8 pl of nuclease-free water was assembled. Using 
a multi-pipette 19 pl of the mastermix was then added to each well. The plate was 
covered to avoid contamination and spun at 100 xg for 1 minute to collect the 
reactions at the bottom of the well. The well plate was then placed into the 
Stratagene MX4000, a combined thermal cycler and fluorescence detector enabling 
real time measurements to be obtained. 
A thermal cycling program optimised for the TaqMan probe system was selected. For 
CAR, PXR and ABC B1 this consisted of one 10 minute cycle at 95 °C, followed by 
40 cycles of (95 °C for 15 seconds - 60 °C for 1 minute). For CYP 2B1, one 95 °C 
cycle for 15 minutes was followed by 45 cycles of (94 °C for 15 seconds - 56 °C for 
30 seconds - 76 °C for 30 seconds). 
Q-PCR was also performed on the 18S ribosomal RNA (rRNA) gene, this was used 
as an endogenous control to normalise the RNA amounts in each sample. The 
amount of target gene was divided by the 18S rRNA amount to calculate a 
normalised target value. 
3.3.4 Metabonomics 
3.3.4.1 Biofluid sample preparation 
For 'H-NMR spectroscopic analysis, an aliquot of urine (480 pl) from each sample 
was placed in an eppendorf to which phosphate buffer (240 pl) at pH 7.4 containing 
10% D20 and 0.05% sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 (TSP, an internal 
standard, chemical shift 8 0.0) was added. The sample was centrifuged to remove 
particulate matter (3000 for 4 minutes) and transferred to a5 mm outer 
diameter 
NMR tube. Plasma samples (240 pl) were combined with 480 pl of saline containing 
10% D20, centrifuged and then placed in a5 mm NMR tube. Chemical shifts in the 
plasma spectra were referenced to the anomeric proton of 
ß-glucose at 6 5.223. 
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3.3.4.2 One-dimensional 1H NMR spectroscopy of biofluids 
All samples were analysed on a Bruker DRX-600 NMR Spectrometer at 300 K 
operating at 600.13 MHz for 1H observation. For the urine samples, a standard one- 
dimensional NMR spectrum was acquired with water peak suppression using a 
standard pulse sequence (recycle delay-90°-tl-90°-tm-90°-acquisition). The recycle 
delay was set at 2s and the mixing time (tm) 100 ms. For each urine sample, 8 
dummy scans were followed by 64 scans and collected into 64K data points. A 
spectral width of 20 ppm and an acquisition time per scan of 3.41 s were used. 
One-dimensional 1H NMR spectra of plasma were acquired with 128 transients after 
8 dummy scans collected into 32 K data points using the same standard pre- 
saturation pulse sequence as for urine. Water suppressed Carr-Purcell-Meiboom-Gill 
(CPMG) spin-echo spectra were acquired for the plasma samples with 8 dummy 
scans followed by 128 scans collected in 32K data points, with a spectral width of 20 
ppm and an acquisition time per scan of 1.36 s. The mixing time was 100 ms and the 
recycle delay was 2 s. Diffusion-edited spectra were acquired with 8 dummy scans 
followed by 64 scans collected in 64K data points, and a recycle delay of 2s and a 
mixing time of 80 ms were used. 
3.3.4.3 Tissue Extraction 
To acquire the aqueous extracts of the liver samples, 100 mg of frozen liver tissue 
was weighed out and homogenised in 1 ml of acetonitrile: water (1: 1) in a glass vial. 
The tissue was homogenised using a mechanical homogeniser set at full speed and 
the homogenate was then centrifuged for 6 minutes at 9,300 x g. The supernatant 
was transferred to an eppendorf and the acetonitrile was allowed to evaporate off. 
Once the organic solvent was removed the water was removed by lyophilisation prior 
to storage at -80°C. For the lipophilic extract, the pellet remaining from the aqueous 
step was homogenised in 1 ml of chloroform: methanol (3: 1) in a glass vial and then 
centrifuged for 6 minutes at 9,300 x g. The supernatant was transferred to a new 
glass vial and the organic solvent was blown off using N2. 
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3.3.4.4 Preparation of liver aqueous and lipophilic extracts for 1H 
NMR spectroscopy 
For 1H NMR spectroscopic analysis, the lyophilized aqueous sample was 
reconstituted in 700 pl of D20: H2O (9: 1) containing 1mM of TSP, and the lipophilic 
sample was reconstituted in 700 pl of deuterated chloroform: chloroform (19: 1). The 
samples were vortexed to ensure reconstitution and then spun at 8,000 xg for 10 
minutes to pellet out any debris. Once free of particulate matter, 600 pl of the 
supernatant was transferred to a5 mm outer diameter NMR tube. 
3.3.4.5 One-dimensional 1H NMR spectroscopy of liver aqueous 
and lipophilic extracts 
A standard one-dimensional NMR spectrum using water peak suppression was 
acquired using a standard pulse sequence for both aqueous and lipophilic extracts. 
Each spectrum was obtained using 8 dummy scans, followed by 64 scans and 
collected into 64 K data points. Spectral width of 20 ppm, tm was set at 100 ms and 
the recycle delay at 2 s. 
3.3.4.6 Data reduction and analysis 
In-house software was used to phase the spectra and to correct for baseline 
distortions. The 1H NMR spectra (b 0.2-10.0) were digitized into consecutive 
integrated spectral regions of equal width (0.04 ppm). Although it is becoming 
increasingly common to use full resolution spectra, given the small group sizes 
employed in the current study, it was deemed expedient to use a `binning' approach 
to minimize peak positional shift due to pH variation. Each spectrum was then 
normalized to unit area. 
SIMCA-P10.5 software was utilized to perform Principal Components Analysis 
(PCA). Supervised methods were not used since the number of animals per group 
was small, in order to prevent the data being over-fitted. Here PCA is used for the 
sole purpose of visualisation of metabolic patterns within the data. 
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3.4 Results 
3.4.1 Comparison of germ-free and conventional Sprague-Dawley 
rats 
3.4.1.1 Plasma clinical chemistry results 
Significant differences in the plasma clinical chemistry results between germ-free and 
conventional animals are given in table 3.4. Germ-free plasma contained higher 
concentrations of glucose and calcium, and higher amounts of albumin and total 
protein. Conventional animals had higher total bilirubin and a greater 
albumin/globulin ratio in the plasma. Alanine aminotransferase and alkaline 
phosphatase activity were both higher in conventional plasma. Plasma cholesterol 
concentration was not significantly different between the two groups. 
Table 3.4: Plasma clinical chemistry results from germ-free (GF) and conventional (CV) 
animals. Values are mean ± SD. Significant difference from conventional by Student's t test, p 
=*: 0.05, **: 5 0.01, *** s 0.001. 
Animal Glucose Calcium Total Albumin Albumin: Total ALT ALP Cholesterol 
group (mmol/L) (mmol/L) protein (g/L) globulin bilirubin (IU/L) (IU/L) (mmol/L) 
(g/L) Ratio (pmol/L) 
GF 27.45 3.53 72.85 40.5 1.25 1 39.75 223 2.34 
± 2.36'x' ± 0.07' ± 3.13'*''` ± 1* ± 0.05'k*"` ± 0* ± 4.79'x` ± 20.25** ± 0.32 
CV 19.03 3.23 60.2 36.75 1.57 1.75 66.5 369 2.23 
± 1.23 ± 0.12 ± 1.83 ± 1.89 ± 0.09 ± 0.5 ± 9.61 ± 56.67 ± 0.24 
3.4.1.2 Transcriptomic analysis of germ-free and conventional 
tissues 
3.4.1.2.1 Transcriptomic analysis of liver tissue from germ-free and 
conventional rats 
In total there were 166 transcripts expressed at higher levels in the livers of germ- 
free animals compared to the conventional animals and 156 transcripts present at 
lower levels (for selection criteria refer back to section 2.4.3). These were 
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categorised into pathways and biological functions and the functions of greatest 
difference between the two animal strains are shown in figure 3.1. 
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Figure 3.1: Summary of the transcript differences in the liver between germ-free (GF) and conventional 
(CV) animals (n = 3). Blue represent the number of transcripts expressed higher in the GF animals and 
purple represent the number of transcripts expressed lower in the GF animals compared to the CV 
animals. 
The biological function with the greatest difference in liver transcripts between germ- 
free and conventional animals was lipid metabolism. There were 10 transcripts higher 
and 43 lower in the germ-free animals compared to the conventional animals, a 
selection of these are displayed with their protein function in table 3.5. Several 
transcripts encoding proteins involved in steroid and cholesterol biosynthesis 
appeared lower in germ-free animals, as do those involved in the mevalonate 
pathway. Additionally, two transcripts encoding proteins involved in lipid transport 
(ATP-binding cassette (ABC) B4 and ABC G8) were lower in the germ-free compared 
to the conventional animals. Transcripts for sterol regulatory binding protein (SREBP) 
1, a protein involved in transcription regulation to maintain proper levels of 
intracellular lipids, specifically fatty acid metabolism140, were higher in the germ-free 
liver. Transcripts for cytochrome P450 (CYP) 7A1, an enzyme involved in bile acid 
biosynthesis, were higher in the germ-free livers. CYP7A1, also known as cholesterol 
7a-hydroxylase, is the rate-limiting enzyme in the synthesis of bile acid from 
cholesterol, catalysing the formation of 7a-hydroxycholesterol. 
There were four 
transcripts related to peroxisomes that were lower in the germ-free liver compared to 
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the conventional liver. Peroxisomes have an important role in the metabolism of fatty 
acids, and contain enzymes that rid the cell of toxic peroxides. 
Table 3.5: Differential expression of transcripts involved in lipid metabolism in the livers of 
germ-free rats relative to the conventional rats. 
Gene name Fold change Function 
3-HMG-CoA synthetase -3.3 Mevalonate pathway/cholesterol biosynthesis 
3-HMG-CoA reductase -4.7 Mevalonate pathway/cholesterol biosynthesis 
Phosphomevalonate kinase -2.3 Mevalonate pathway/cholesterol biosynthesis 
Farnesyl diphosphate farnesyltransferase -2.2 Steroid/cholesterol biosynthesis 
Squalene epoxidase -13.4 Steroid/cholesterol biosynthesis 
7-dehydrocholesterol reductase -2.4 Cholesterol biosynthesis 
CYP 7A1 3.6 Bile acid biosynthesis 
CYP 17A1 -2.0 Hormone biosynthesis 
20-a-hydroxysteroid dehydrogenase 3.6 Hormone biosynthesis 
ABC B4 -2.7 Lipid transport 
ABC G8 -6.1 Lipid transport 
SREBP 1 6.5 Transcription regulation of lipid metabolism 
Transcripts related to immune function were also notably different between the two 
animals strains (22 higher and 12 lower in the germ-free group compared to 
conventional group). This reinforces the importance of the microbiome in the immune 
status of the host. The majority of these differences between the animal strains were 
transcripts involved in antigen presentation. 
Energy metabolism transcripts were different between germ-free and conventional 
animals (table 3.6). Gluconeogenesis appeared differentially regulated with 
transcripts for phosphoenolpyruvate carboxykinase (PEPCK) lower in the germ-free 
liver and glucose-6-phosphatase higher compared to the conventional liver. The role 
of glucose-6-phosphatase is to dephosphorylate glucose-6-phosphate to enable free 
glucose to be exported into the blood. Alanine-glyoxylate aminotransferase 2, alanine 
aminotransferase 2, and serine dehydratase were higher in the germ-free livers. 
Malic enzyme 1, an enzyme that catalyses the conversion of malate to pyruvate, was 
lower in the germ-free animals. Transcripts involved in the conversion of maltose to 
glucose, and galactose to glucose-1 -phosphate were lower in the germ-free animals 
compared to conventional animals. There were higher levels of transcripts 
for ABC 
C8 (SUR1) and ABC C9 (SUR2) in the germ-free livers, these sense the intracellular 
levels of ATP and ADP and help to maintain an energy balance 
141 
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Table 3.6: Energy metabolism gene expression differences in the germ-free liver compared to 
the conventional liver. 
Gene name Fold change Function 
Alanine-glyoxylate aminotransferase 2 
Serine dehydratase 
Malic enzyme 1 
Glucose-6-phosphatase 
PEPCK 
Maltase-glucoamylase 
Galactokinase 
Galactose-4-epim erase 
ABC C8 (SUR1) 
ABC C9 (SUR2) 
2.3 Pyruvate synthesis 
17.0 Pyruvate synthesis 
-5.0 Malate metabolism/pyruvate synthesis 
5.6 Gluconeogenesis 
-3.0 Gluconeogenesis 
-9.9 Glycogen metabolism/glucose synthesis 
-2.1 Galactose metabolism 
-2.6 Galactose metabolism 
3.4 ATP/ADP sensors 
3.0 ATP/ADP sensors 
A low number of transcripts relating to drug metabolism were differentially expressed 
between the livers of the two animal strains. There were three transcripts higher and 
three lower in the germ-free compared to the conventional animals. The most notable 
of these differences was a 139-fold lower transcript level for glutathione S- 
transferase Yc2 subunit in the germ-free liver. Glutathione S-transferase (GST) 
contributes to the phase II biotransformation of xenobiotics, and detoxification of 
many compounds. CYP 3A13 was higher (2.2 fold) in the germ-free animals, and the 
CYP 3A subfamily is responsible for the metabolism of >50% of all drugs142. Aldo- 
keto reductase 7A3, a protein involved in the detoxification of aldehydes and 
ketones, was lower in germ-free livers. Transcripts for the orphan nuclear hormone 
receptor, constitutive androstane receptor (CAR), were also lower in the germ-free 
liver in contrast to the conventional liver. The role of CAR as a xenobiotic sensor has 
been suggested by Zelko and Negishi143, and it has been implicated in the 
transcription regulation of the CYP enzymes 144 
3.4.1.2.2 Transcriptomic analysis of ileum tissue 
The ileum was the region sampled with the greatest difference in transcripts 
between 
the two animal strains. The ileum of germ-free animals had transcripts 
for 452 
proteins expressed higher than the conventional animals, and 
179 lower (figure 3.2). 
Transcripts for lipid, amino acid, and energy and drug metabolism appeared 
differentially expressed between the animal strains in addition to 
immune function. 
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Figure 3.2: Summary of the transcript differences between the conventional (CV) and germ-free (GF) 
ileum tissue (n = 3). Blue indicate the number of transcripts expressed higher in the GF animals 
compared to the CV animals and purple indicate the number of transcripts expressed lower in the GF 
compared to the CV animals. 
Lipid metabolism was the biological function with the greatest difference in transcripts 
between the germ-free and conventional ileum tissue. In the liver the majority of 
transcripts differences relating to lipid metabolism were lower (10 higher, 44 lower) in 
the germ-free animals, yet in the ileum the bulk of the transcripts appeared higher (40 
higher, five lower) in the germ-free animals. Some of these are listed with their 
respective protein function in table 3.7. 
Transcripts for enzymes related to cholesterol biosynthesis were higher in the germ- 
free animals; these were involved in the mevalonate pathway, isoprenoid and steroid 
biosynthesis, and hormone biosynthesis. Several transcripts involved in arachidonic 
acid metabolism were also greater in the germ-free animals with these transcripts 
linked to Ieukotriene, prostaglandin and thromboxane metabolism. There were higher 
transcripts relating to bile acid biosynthesis (CYP27A1) and also for the regulation of 
bile acid biosynthesis and cholesterol metabolism in the germ-free ileum compared to 
the conventional group. The germ-free group had increased transcripts relating to 
lipid (ABC G5) and lipoprotein (apolipoprotein C-III) transport and also for the nuclear 
receptors peroxisome pro I iferator-a ctivated receptor-y (PPARy), rev-erbß, and 
farnesoid X receptor (FXR). 
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Table 3.7: Transcripts involved in lipid metabolism that differed in the germ-free ileum 
compared to the conventional ileum 
Gene name Fold change Function 
3-HMG-CoA reductase 3.2 Mevalonate pathway/cholesterol biosynthesis 
Mevalonate kinase 2.0 Mevalonate pathway/cholesterol biosynthesis 
Squalene epoxidase 2.6 Steroid/cholesterol biosynthesis 
Sterol-C5-desaturase 2.5 Cholesterol biosynthesis 
CYP 27A1 2.1 Bile acid biosynthesis (acidic pathway) 
CYP 17A1 4.5 Hormone biosynthesis 
15-hydroxyprostaglandin 4.4 Prostaglandin metabolism 
dehydrogenase 
Phospholipase A2 m10 2.7 Arachidonic acid metabolism 
CYP 2J4 3.0 Arachidonic acid metabolism 
CYP 2J9 2.6 Arachidonic acid metabolism 
CYP 4B1 2.7 Arachidonic acid metabolism 
CYP 4F1 19.8 Arachidonic acid metabolism 
ABC G5 4.6 Lipid transport 
Apolipoprotein C-III 3.5 Lipoprotein transport 
Peroxisome proliferator-activated 3.2 Nuclear receptor 
receptor-y (PPARy) 
Farnesoid X receptor (FXR) 2.0 Nuclear receptor 
Rev-erb ß 3.9 Nuclear receptor 
There were 23 transcripts higher expressed in the germ-free ileum related to 
proteolysis, with only three transcripts expressed lower than the conventional 
animals. This may represent greater protein degradation in the germ-free rats, and 
may also correlate with the 26 transcripts relating to amino acid metabolism that were 
higher expressed in the germ-free ileum and the 16 transcripts that were lower than 
the conventional ileum. 
Transcripts relating to glycolysis (fructose-bisphosphate aldolase, and pyruvate 
kinase) were higher in the germ-free animals, as were transcripts for fructokinase. 
Fructokinase is an enzyme responsible for the conversion of fructose to fructose-6- 
phosphate, an intermediate in glycolysis. Transcripts for solute carrier (SLC) 2A5 
(also known as GLUTS), SLC 5A1 (also known as SGLT1) and SLC 5A11 were 
higher in germ-free animals and these are involved in glucose, galactose, and 
fructose transport. Aconitase 2, an enzyme involved in the TCA cycle was lower in 
the germ-free animals with malic enzyme 1 and 3 increased. These are given with 
the fold change difference to the conventional animals in table 3.8. 
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Table 3.8: Transcription differences in the ileum of germ-free rats with relation to the 
conventional rats in carbohydrate metabolism. 
Gene name Fold change Function 
PEPCK 2.9 Gluconeogenesis 
Pyruvate kinase 3.7 Glycolysis 
Fructose-bisphosphate aldolase 2.7 Glycolysis 
Fructokinase 2.7 Fructose metabolism 
Phosphoglucomutase 2.5 Glycogenolysis/glycogenesis 
Glucosidase-a -2.0 Sucrose metabolism 
Malic enzyme 1 3.6 Malate metabolism 
Malic enzyme 3 2.7 Malate metabolism 
Aconitase 2 -2.3 TCA cycle 
SLC 5A1 7.2 Glucose/galactose transporter 
SLC 5A1 1 2.8 Glucose transporter 
SLC 2A5 8.2 Fructose transporter 
In total 27 transcripts relating to drug metabolism were observed to be higher in the 
germ-free ileum than in the conventional ileum. The major differentially altered 
transcripts involved in drug metabolism are given in table 3.9. It is apparent that in 
the absence of the flora, important transcripts involved to drug metabolism are 
increased. The nuclear receptor pregnane X receptor (PXR) is noteworthy due to the 
importance of this receptor in the detection of foreign compounds and the regulation 
of xenobiotic metabolism. Glutathione S-transferase and phase III proteins such as 
ABC BIA can be up regulated by PXR. 
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Table 3.9: Transcripts relating to drug metabolism higher in the germ-free rat ileum compared 
to the conventional rat ileum. 
Name Fold change 
Phase I metabolism 
CYP2B1 4.1 
CYP2D9 4.9 
CYP2D22 4.3 
CYP2D26 9.6 
CYP3A13 2.5 
CYP3A18 5.5 
CYP4B1 2.7 
Phase II metabolism 
Glutathione S-transferase mu 5 3.1 
Glutathione S-transferase Yc2 subunit 3.6 
Glutathione S-transferase, mu 1 2.2 
Sulfotransferase 11311 3.2 
Sulfotransferase 2B1 3.3 
Epoxide hydrolase 3.1 
y-glutamyl transpeptidase 2.3 
Phase III metabolism 
ATP-binding cassette B1A 7.5 
ATP-binding cassette G2 2.1 
Nuclear Receptor 
Pregnane X receptor (PXR) 2.0 
3.4.1.2.3 Transcriptomic analysis of colon tissue 
Higher expression of 87 transcripts in the colon of germ-free animals and lower 
expression of 89 transcripts was found compared to the conventional animals. The 
majority of these were grouped based upon their respective functions and pathways 
and are shown in figure 3.3. 
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Figure 3.3: Summary of the transcription differences in the colon between germ-free (GF) and 
conventional (CV) animals (n = 3). Blue indicate the number of transcripts expressed higher in the GF 
animals compared to the CV animals and purple indicate the number of transcripts expressed lower in 
the GF compared to the CV animals 
The greatest differences in the transcripts were those relating to immune function, 
with two higher and 15 transcripts lower in the germ-free colon compared to the 
conventional colon. Lipid metabolism transcripts differed between the two animal 
groups but not to the same extent encountered in the liver and ileum, and the same 
applied for energy and drug metabolism. Transcripts for ABC B1A, a transporter 
involved in phase III metabolism, were observed to be higher in the germ-free colon. 
Transcripts implicated in drug metabolism that are differentially expressed between 
the two animal strains are listed in table 3.10. 
Table 3.10: Drug metabolism transcripts differentially expressed in the colon of germ-free 
animals comparative to the conventional animals. 
Name Fold change 
Phase I 
Aldehyde dehydrogenase 1 5.2 
CYP2B1 8.4 
CYP4B1 2.6 
Phase II 
N-acetyltransferase 2 2.2 
Glutathione peroxidise 2 -2.8 
Phase III 
ATP-binding cassette B1A 2.6 
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3.4.1.2.4 Q-PCR analysis comparing germ-free and conventional animals 
Q-PCR analysis was applied to assess the expression of constitutive androstane 
receptor (CAR) in the liver and in various sections along the GI tract (figure 3.4a and 
b). The results from this technique were in compliance with those received via the 
microarray technique, with transcripts for CAR being significantly greater in the 
conventional liver. Along the GI tract however, transcripts for this nuclear receptor 
followed a trend to be greater in the germ-free animals compared to the conventional 
animals, although the difference between the strains was not statistically significant. 
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Figure 3.4: (A) Q-PCR analysis for the expression of CAR transcripts in the liver and (B) along the Gl 
tract of germ-free and conventional rats (n = 4). Values are mean + SD. Significant difference from 
conventional by Student's t test, p=* <_ 0.05. 
Q-PCR analysis was carried out on sections of the gut to assess the expression of 
PXR, CYP2B1 and ABC BIA transcripts along the GI tract (figure 3.5,3.6, and 3.7 
respectively). From figure 3.5 it can be seen that transcripts for PXR were 
significantly higher in the germ-free ileum and cecum. 
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Figure 3.5: Q-PCR analysis of PXR for the liver and sections taken along the GI tract from germ-free 
and conventional animals (n = 4). Values are mean + SD. Significant difference from conventional by 
Student's t test, p=*: 5 0.05, **: 5 0.01. 
Inspection of the transcripts for CYP 2B1 and ABC B1A revealed that there was a 
trend for these proteins to have higher expression in the germ-free intestinal regions 
compared to the conventional regions. These differences were statistically significant 
in the ileum for both transcripts. 
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Figure 3.6: Q-PCR analysis of CYP2B1 for sections taken along the GI tract and the liver from germ- 
free and conventional animals (n = 4). Values are mean + SD. Significant difference from conventional 
by Student's t test, p=*<0.05, ** <_ 0.01. 
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Figure 3.7: Q-PCR analysis of ABC BIA for sections taken along the Gl tract and the liver from genn- 
free and conventional animals (n = 4). Values are mean + SD. Significant difference from conventional 
by Student's t test, p= *5 0.05. 
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3.4.1.3 Metabonomic analysis comparing the biological systems of 
germ-free and conventional animals 
3.4.1.3.1 Metabonomic analysis of plasma 
Both spin-echo (figure 3.8a and b) and diffusion-edited (figure 3.8c and d) pulse 
sequences were utilised to examine the plasma samples from conventional and 
germ-free animals. PCA scores plots comparing the spin-echo spectra from both 
animal strains is shown in figures 3.8e and comparison of the diffusion-edited 
spectra is shown in 3.8f, and separation could be observed in both approaches. The 
metabolite differences that explained separation in the spin-echo scores plot are 
given in table 3.11. 
Table 3.11: Metabolic differences in the spin-echo spectra from conventional and germ-free 
rat plasma. 
Metabolites higher in the germ-free plasma Metabolites lower in the germ-free plasma 
compared to the conventional plasma compared to the conventional plasma 
Lipoproteins (LDL, VLDL) (8 0.89,1.27-1.3) Lactate (6 1.33,4.12) 
Glucose (S 3.2 - 3.9) Choline (S 3.22) 
Phosphocholine (6 3.24) Creatine (8 3.04,3.94) 
Alanine (8 1.48) 
Glycine (6 3.57) 
Pyruvate (S 2.38) 
The separation witnessed in the PCA scores plot from the diffusion-edited spectra 
was due to increased resonances for lipoproteins, N-acetyl-glycoproteins and some 
lipids in the germ-free animals, and higher choline and a low density lipoprotein (LDL 
at 6 1.26) in the conventional animals. 
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Figure 3.8: Metabonomic analysis comparing the plasma metabolic profiles of conventional and germ- 
free rats. Typical spin-echo spectra from conventional (A) and gem-free (B) rat plasma and diffusion- 
edited spectra from conventional (C) and germ-free (D) plasma. PCA scores plots constructed from 
spin-echo spectra (Q2=0.289) (E) and diffusion edited (Q2=0.734) (F) spectra, showing the separation 
between germ-free animals (open triangles) and conventional animals (closed triangles). 
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3.4.1.3.2 Metabonomic analysis of liver aqueous and lipophilic extracts 
Aqueous extracts taken from the livers revealed metabolite differences between the 
two animal types (Figure 3.9). Germ-free livers had higher concentrations of taurine 
and phosphocholine compared to the conventional livers whilst the conventional 
livers possessed higher amounts of alanine, glycine, betaine, creatine, and lactate. 
Lipophilic extracts taken from the two animal strains were also noted be of different 
composition, shown in figures 3.10a, b, and c. These differences are principally 
higher amounts of unsaturated lipid in the germ-free animals and higher saturated 
lipid in the conventional animals. 
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Figure 3.9: Metabonomic analysis comparing the hepatic metabolic profiles of conventional and germ- 
free rats. Typical 'H NMR spectra of aqueous extracts taken from conventional (A) and germ-free (B) 
livers. The region 3 to 3.5 ppm is enlarged for clarity (C) and compares conventional (black) and germ- 
free (red) spectra. PC scores plot (D) contrasting the metabolite profiles of the aqueous extracts of the 
liver tissues taken from conventional (closed triangles) and germ-free (open triangles) rats (Q2=0.673) 
and the metabolites that contributed towards separation are tabulated in (E). 
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Figure 3.10: Metabonomic analysis of the lipophilic extracts taken from the liver of germ-free and 
conventional animals. 'H NMR spectra of lipophilic extracts obtained from conventional (A) and germ- 
free (B) livers. PC scores plot constructed from the conventional (closed triangles) and germ-free (open 
triangles) spectra (Q2=0.453) (C) and the corresponding loadings plot (D) explaining the separation 
witnessed in C. 
3.4.2 Impact of microfloral suppression and re-colonisation on 
the biological system of conventional rats 
Prior to the transcriptomic and metabonomic analysis of the antibiotic-treated animals 
decontamination was assessed through the quantitative culturing of the cecal 
contents. From figure 3.11 it was evident that after eight days of antibiotic treatment 
98 
(group III) the gut microbiota were significantly reduced, with no bacterial colonies 
cultured from any of the group III animals. In group II, it appears that any perturbation 
exerted by the four day application of antibiotics had recovered four days after dosing 
had ceased. It is accepted that a significant proportion of the species contained 
within the microbiota cannot be cultured, but the depletion of bacterial numbers in 
group III gives a good indication the microbiota had been reduced. 
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Figure 3.11: Bacterial counts for the large intestinal contents of control and antibiotic treated rats (n = 
6). Control (group I), Four days of antibiotic treatment followed by four days of control treatment (group 
ll), eight days of antibiotic treatment (group /ll). Values are mean + SD. 
3.4.2.1 Plasma clinical chemistry results 
Table 3.12: Plasma chemistry differences in the animals from the antibiotic study. Values are 
mean ± SD. Significant difference from group I by Student's t test, p=* <_ 0.05. Control (group 
I), four days antibiotic treatment, four days control treatment (group II), eight days of antibiotic treatment 
(group III). 
Animal group Creatinine (ppmol/L) ALP (lU/L) ALT (lU/L) 
Group I 64 ± 3.41 134.67 ± 24.32 32.67 ± 5.39 
Group II 59.17 ± 3.54* 107.17 ± 14.97* 25.33 ± 3.39* 
Group III 61 ± 3.74 127.17 ± 16.31 25.67 ± 6.89 
Plasma clinical chemistry results from the antibiotic treated animals revealed that 
creatinine was decreased in group II animals (four days antibiotic treatment, four 
days untreated) compared to the group I (control) animals. Alkaline phosphatase 
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Group I Group II Group III 
Study group 
(ALP) and alanine aminotransferase (ALT) activity was also decreased in group II 
(Table 3.12). Group III had no observed differences from the control group. 
3.4.2.2 Transcriptomic investigation into the effect of microfloral 
suppression and re-colonisation in conventional rats 
3.4.2.2.1 Transcriptomic analysis of the liver tissue 
Liver transcripts were relatively unperturbed following antibiotic treatment. The group 
administered antibiotics for four days and then allowed to recover (group II) had nine 
transcripts up-regulated and two transcripts down-regulated comparative to the 
control group (table 3.13). This included an up-regulation in the transcript for 
squalene epoxidase, an enzyme involved in steroid biosynthesis, although no other 
transcripts from this pathway appeared altered. 
Table 3.13: Hepatic transcripts altered in group II (bacterial recovery) animals comparative to 
group I (control) animals. 
Gene name Fold change Function 
Squalene epoxidase 2.1 Steroid biosynthesis 
ELOVL family member 6 2.1 Fatty acid elongation 
T4 binding globulin 2.7 Metabolic regulation 
Ng22 protein 2.3 Membrane 
Keratin 10 2.4 Structural molecule activity 
Zinc finger protein 37 2.1 Regulation of transcription 
B-cell translocation gene 2 2.1 Regulation of transcription 
Thyroid hormone-responsive protein 2.2 Regulation of transcription 
Cyclin dependent kinase inhibitor 1A 2.2 Cell cycle 
Cyclin G2 -2.1 Cell cycle 
Nuclear protein -2.1 Apoptosis 
Group III, the animals treated with antibiotics for eight days, had six transcripts 
induced and six reduced compared to the control animals (table 3.14). This included 
an up-regulation in transcripts for ABC G5, a protein involved in lipid transport. 
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Table 3.14: Hepatic transcript differences in group III (decontaminated) animals relative to 
group I (control) animals 
Gene name Fold change Function 
Purigenic receptor P2Y, G protein coupled 2 2.1 Signalling 
B-carotene 15,15-dioxygenase 2.6 Oxidoreductase activity 
T4 binding globulin 2.4 Metabolic regulation 
2', 5'-oligoadenylate synthetase 1 3.2 Immune response 
ABC G5 2.1 Lipid transport 
Hemoglobin-ß2 subunit 9.1 Oxygen transport 
A-2u globulin -3.5 Transport 
Cytochrome P450 like protein -2.2 Electron transport 
SLC 22A8 -2.7 Ion transport 
Leukotriene C4 synthase -2.4 Leukotriene metabolism 
Dynein -2.4 Nitric oxide biosynthesis 
B-cell leukaemia/lymphoma 6 -6.0 Regulation of transcription 
3.4.2.2.2 Transcriptomic analysis of the Ileum 
The transcriptome of the ileum was also observed to be relatively unperturbed by 
antibiotic administration, with group II having just 14 transcripts up-regulated and 14 
down-regulated and group III having six up-regulated and seven down-regulated 
compared to the control group. Consistent changes across the two groups included 
up-regulation of transcripts for calbindin 3, and down-regulation of transcripts for 
apolipoprotein C-III and CD7 antigen. Calbindin 3 is a calcium binding protein that 
mediates the transport of calcium across the enterocytes, and appears to affect the 
degree of calcium absorption in the intestines. Apolipoprotein C-III was also higher in 
the ileum of the germ-free animals compared to the conventional animals, this is 
involved in lipoprotein transport and suggests that up-regulation of this transcript in 
antibiotic treated animals may be influenced by a perturbation in the enteric 
microbiota. There were also some transcripts relating to immune function down- 
regulated in group II, in addition to a down-regulation of histamine N- 
methyltransferase transcript. This enzyme is involved in the metabolism of histamine, 
a metabolite involved in local immune responses, and the regulation of gut 
physiological function. 
3.4.2.2.3 Transcriptomic analysis of colon tissue 
The colon was the region that underwent the greatest disruption in the transcripts 
following antibiotic treatment. Group II had 47 transcripts up-regulated and 72 down- 
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regulated comparative to the control group, whereas group III was lesser affected 
with 12 up regulated and 42 down regulated. 
Consistent changes between group II and group III included an up-regulation in 
transcripts for neurotensin, and a down-regulation in transcripts for stearoyl- 
coenzyme A desaturase 1, sialyltransferase 7F, lactoperoxidase, carbohydrate 
sulfotransferase 4, and claudin 15. The major transcript changes in the colon of 
group II are given in table 3.15. 
Table 3.15: Major transcript alterations in the colon of group II (bacterial recovery) animals 
compared to the control animals of group I. 
Gene name Fold change Function 
CD74 antigen 4.6 Immune 
RT class II locus Dbl 3.2 Immune 
Interleukin 11P 3.6 Immune 
MHC class II 4.2 Immune 
Carbohydrate sulfotransferase 1 2.3 Inflammation 
SLC 13A1 5.1 Transport 
Carbonic anhydrase 3 -2.3 Carbon dioxide transport 
CYP 2D9 -2.1 Xenobiotic metabolism 
CYP 2D22 -2.1 Xenobiotic metabolism 
CYP 4B1 -2.6 Xenobiotic metabolism/ Fatty acid 
metabolism 
Fatty acid binding protein -2.6 Lipid metabolism 
Solute carrier 10A2 4.9 Bile acid transport 
Stearoyl-coenzyme A desaturase 1 -5.9 Lipid metabolism 
Lipoprotein lipase -3.1 Lipid metabolism 
Phospholipase A2 group 10 -2.6 Lipid metabolism 
Aquaporin 7 -2.4 Water transport 
Transcripts for CYP 2D9,2D22 and 4B1 were lower in the colons of group II animals 
compared to the control animals and were higher in the ileum of the germ-free 
animals compared to the conventional animals with CYP 4B1 also expressed higher 
in the germ-free colons. This transcript does not appear different in the animals 
treated with antibiotic for eight days. 
The major transcript differences between group III and the control group (group I) are 
given in table 3.16. There was an up-regulation in transcripts for hydroxysteroid (17- 
ß) dehydrogenase 2 in group III; these transcripts were also observed to be greater 
in the colon of germ-free animals in contrast to conventional animals. This enzyme is 
involved in androgen and estrogen metabolism. 
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Table 3.16: Major differences in transcripts of the colon for group III (decontaminated) 
animals in relation to group I (control) animals. 
Gene name Fold change Function 
Glutaminase 2.1 Urea cycle 
Actin al 2.7 Cell motility, structure, and integrity 
Hydroxysteroid (17- ß) 2.1 Androgen and estrogen metabolism 
dehydrogenase 2 
ABC B10 2.9 Herne biosynthesis 
Solute carrier 16A6 -4.0 Prostaglandin transport 
Fucosyltransferase 2 -2.2 Carbohydrate metabolism 
Aspartate ß-hydroxylase -2.1 Aspartate metabolism 
3.4.2.3 Metabonomic investigation into the effect of microfloral 
suppression and re-colonisation in conventional rats 
3.4.2.3.1 Metabonomic analysis of urine 
Inspection of the urine sampled pre-dosing (day -2 to -1), 4 days into study (day 3 to 
4) and 8 days into the study (day 7 to 8) revealed the antibiotic dosing regime was 
sufficient to induce an alteration in the urinary metabolite profile. Comparison of the 
urinary profiles from group I (control group) and group II revealed that the majority of 
animals administered antibiotics exhibited a different urinary metabolite profile to the 
control group at day four (figure 3.12e) with increased taurine, and betaine and 
decreased hippurate, phenylacetylglycine (PAG), 3-hydroxyphenylpropion ic acid (3- 
HPPA), 4-HPPA, and trimethylamine-oxide (TMAO). By day eight, after antibiotic 
administration had ceased, the majority of the urine sampled from group II differed 
from that sampled on day four with increased concentrations of PAG and formate 
and reductions in the concentration of taurine. Urine sampled from group I I at day 
eight still differed from the control group (figure 3.12f), with group II excreting higher 
concentrations of 2-oxoglutarate, creatinine, citrate, and slightly higher taurine and 
the control group excreted higher concentrations of hippurate, PAG, and 3-HPPA. At 
day eight the separation between group I and group II was not as pronounced as it 
was at day four. 
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Figure 3.12: Metabonomic analysis comparing the urinary metabolic profiles of group I and group 11 rats. 
Aliphatic region of the 'H NMR spectra from the control (group I) (A) and four-day antibiotic treated 
(group ll) (B) urine sampled at day eight. Aromatic region from the control (C) and four-day antibiotic 
treated (D) urine spectra at day eight. PC scores plot comparing urine sampled from group I (closed 
triangles) and group 11 (open diamonds) at day four (Q2=0.459) (E). PC scores plot contrasting urinary 
metabolite profiles of group / and group 11 animals at day eight (Q2=0.298) (F). 
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Metabonomic analysis of the urine from group I and group III animals identified that 
by day four the urinary metabolite profiles of group III differed from group I and this 
difference was exaggerated by day eight (figure 3.14). Taurine, citrate, 2- 
oxoglutarate, and fumarate were observed to increase after antibiotic treatment whilst 
the microbial-related metabolites, hippurate, PAG, 3-HPPA, and 4-HPPA were noted 
to decrease. TMAO, both a bacterially derived and dietary derived metabolite, was 
also observed to decrease after antibiotic administration. One animal from group III 
had a urinary metabolic profile that remained similar to the control profile throughout 
the study. 
The urinary profiles of all study animals at day four were compared via PCA analysis 
(figure 3.13). As expected, there was clear overlap in group II and III profiles 
indicating that the urinary profiles of both animal groups were of similar constitution 
after four days of antibiotic treatment and these separated clearly from the control 
animals. Separation from the controls was largely attributed to decreased microbial 
metabolites in the antibiotic treated animals. 
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Figure 3.13: PC scores plot constructed from the urinary profiles at day four of group I (control) animals 
(closed triangles), group 11 (bacterial recovery) animals (open diamonds) and group 111 (decontaminated) 
animals (open triangles) (Q2=0.481). 
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Figure 3.14: Metabonomic analysis comparing the urinary metabolic profiles of group I and group Ill 
rats. Aliphatic region of the 'H NMR spectra from the control (group I) (A) and antibiotic treated (group 
lll) (B) urine sampled at day eight. Aromatic region from the control (C) and antibiotic treated (D) urine 
spectra. PC scores plot comparing urine sampled from group I (closed triangles) and group Ill (open 
triangles) pre-dosing (black), at day four (blue) and day eight (red) (Q2=0.318) (E). Metabolites 
responsible for separation are tabulated in F. 
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3.4.2.3.2 Metabonomic analysis of plasma 
The PCA scores plot shown in figure 3.15 was constructed from the spin-echo 
spectra and indicates that there were no differences in the plasma metabolite profiles 
of any of the animals at the end of the study. There were also no observable 
differences in the diffusion-edited spectra between the animals indicating that neither 
the low molecular weight molecules nor the lipid/lipoprotein components were 
affected by antibiotic administration. 
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Figure 3.15: PC scores plot constructed from the spin-echo spectra of plasma sampled from group / 
(closed triangles), group /l (open diamonds), and group 111 (open triangles) at the end of the study (day 
eight) (Q2=0.836). 
3.4.2.3.3 Metabonomic analysis of liver aqueous and lipophilic extracts 
Aqueous extracts taken from the liver tissues of the study animals showed antibiotic 
dosing induced alterations to the hepatic metabolite profiles (Figure 3.16). 
Differences could be observed in the hepatic metabolite profiles of both group II and 
group III animals from the control group. There did not appear to be a difference 
between groups II and III suggesting that the effect of antibiotic treatment on the liver 
persisted four days after dosing ceased. The antibiotic dosing induced an increase in 
hepatic lactate, taurine, alanine and succinate and a slight decrease in glucose. 
Figure 3.17 displays a PC scores plot of the liver lipophilic extracts. This shows that 
the antibiotic dosing did not cause any difference in the lipid profiles of the liver. 
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Figure 3.17: PC scores plot comparing the lipophilic extracts of the liver tissue taken from group 
(closed triangles), group // (open diamonds) and group /// (open triangles) (Q2=0.387). 
3.5 Discussion 
3.5.1 Germ-free animal model 
The influence of the gut microbiota on the mammalian system was assessed using 
the germ-free rat model. Microbial presence was observed to influence both the 
host's transcriptome and metabonome. The microbiota had the greatest influence on 
the transcriptome of the ileum, followed by the liver and then the colon. Higher 
influence over the ileum transcripts most likely corresponds to the intimate contact 
between the microbiota and the host intestinal tissue and the cross-talk that exists 
across this surface. Given that the colon harbours the greatest population of micro- 
organisms along the GI tract it is surprising that the difference in colonic transcripts 
between germ-free and conventional animals was not greater. Although, with the 
lower metabolic capacity of the distal region of the gut it is possible that microbial 
components do not influence the host as much as they do in the proximal regions. A 
summary of the transcriptomic and metabonomic results comparing germ-free and 
conventional animals is given in table 3.17. 
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Table 3.17: Summary of the germ-free transcriptomic and metabonomic results. Arrows 
indicate direction of change in the germ-free animals comparative to the conventional 
animals. Values indicate the number of transcripts differentially regulated for each biological 
function. 
Biological Function Transcriptomics Metabonomics 
GF compared to CV GF compared to CV 
Xenobiotic metabolism Liver -3 13 
Ileum -27 0 
Colon -T54.2 
Lipid metabolism Liver -T 10 4.43 
Ileum -T 40,5 
Colon -T74.3 
Gluconeogenesis [Liver] Gluconeogenesis -T1 11 
Amino acid metabolism -T 12 j2 
Proteolysis T6 10 
T phosphocholine [Liver] 
T lipoproteins [Plasma] 
choline [Plasma] 
lactate, alanine, glycine [Liver] 
T glucose I lactate, pyruvate, 
alanine, glycine [Plasma] 
Glycolysis [Ileum] Glycolysis -T4 10 
Transport T3 10 
3.5.1.1 Microfloral influence over xenobiotic metabolism 
Transcripts for the nuclear receptor, CAR, were expressed significantly higher in the 
liver of conventional animals compared to the germ-free animals; however this was 
reversed in the GI tract with expression following a trend to be greater in the germ- 
free animals. This xenobiotic sensor is implicated in the transcription regulation of 
CYP enzymes and lower expression in the germ-free liver compared to conventional 
liver, could suggest differential exposure of the liver to exogenous compounds. 
Absorption of foreign compounds from the gut lumen into systemic circulation can 
modulate hepatic exposure, and can be influenced by the gut microflora through 
three main mechanisms. Firstly, bacteria influence the luminal environment of the 
intestine, altering the physical conditions, such as the pH, which can affect the 
solubility of the compound. Secondly, microfloral stimulation contributes to the 
development of intestinal mucosal structure and in the absence of this stimulation the 
absorptive surface area can be significantly reduced, and lastly bacterial action on 
the compound itself can influence absorption of the compound 145 These microfloral 
contributions could restrict the degree of exogenous compounds reaching the liver 
although, work by Reddy et al, has stipulated that the reduced intestinal motility in the 
germ-free animal manifests in longer transit time and permits more complete 
absorption to occur. In both the present study and that carried out by Reddy et al... 
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germ-free animals were found to have higher plasma calcium concentrations 
potentially due to higher calcium absorption in the germ-free animals compared to 
the conventional anima ls146 Morphological differences such as the smaller sized liver 
and reduced regional blood flow in the germ-free animal could also explain the lower 
expression of drug metabolising enzymes in germ-free liver, especially since germ- 
free animals are considered to have a lower metabolic rate to conventional 
anima Is147 
Higher expression of drug metabolising enzymes throughout the intestine of the 
germ-free animal compared to the conventional animal indicates that xenobiotic 
metabolism is modulated by the gut microbiota. This modulation occurred to the 
greatest extent in the small intestine (ileum) but the trend also continued into the 
colon and included phase I, II and III enzymes. Higher expression of these enzymes 
in the germ-free intestines may reflect a response by the host to compensate for the 
absence of enzymes provided by the microbiome, to manage exogenous compounds 
present in the lumen. Phase I enzymes increased in the germ-free animals included 
several CYPs, and the majority belonged to the CYP2 and CYP3 families. The 
opposite was found in a study carried out by Mutch et al. in germ-free mice, which 
found several CYPs expressed lower in the intestines of the germ-free strain, this 
included CYP2D26, and CYP3A13135 
CYP2D9, CYP2D22, and CYP2D26 are rat orthologs of the human CYP2D6 (3 out of 
9)148 This is one of the most important enzymes involved in xenobiotic metabolism in 
man and displays the largest phenotypical variation of all the CYPs. These CYPs 
were all expressed higher in the ileum of the germ-free animals comparative to the 
conventional animals, and in humans, higher expression of CYP2D6 can result in the 
individual being an ultra-rapid metaboliser, having greater than normal CYP2D6 
activity. Drug therapy is not as effective in such individuals as compounds are often 
metabolised before eliciting their effect149. Individual phenotypes are often 
determined by monitoring their metabolism of a selective CYP2D6 substrate, 
debrisoquine. An investigation into the germ-free metabolism of debrisoquine or 
another CYP2D6 specific substrate would be of interest to determine the functional 
consequence of this transcription difference. 
Interestingly the nuclear receptor PXR was expressed greater along the germ-free 
intestines compared to the conventional animals. The principal function of PXR is to 
detect the presence of foreign toxic substances and upon detection up-regulate the 
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expression of detoxification and clearance proteins to remove these substances from 
the body. PXR can be activated by both endogenous and exogenous substances, 
and modulates the expression of drug metabolising enzymes, including phase I, II, 
15o and III enzymes, 
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The transporters ABC BI A (up-regulated by PXR152) and ABC G2 were both 
expressed in higher concentrations in the ileums of the germ-free animals compared 
to the conventional animals. These are interesting as both are implicated in multi- 
drug resistance, and over-expression of particular ABC transporters are the most 
frequent cause of resistance to cytotoxic agents, including antibiotics and anti-cancer 
drugs153' 154 These function as transmembrane efflux pumps, moving xenobiotics out 
of the cell, from the enterocyte into the lumen, modulating the absorption of drugs 
and decrease bioavailability of orally administered compounds155 Transcriptomic 
data may suggest greater movement of compounds out of the enterocytes of germ- 
free animals, and could potentially result in lower exposure of the germ-free liver to 
foreign compounds. 
One hypothesis for the bacterial modulation of these drug metabolising enzymes is 
through the exposure of the host to the bacterial endotoxin lipopolysaccharide (LPS). 
LPS is a major component of bacterial outer membranes, it is present throughout the 
digestive tract and it is proportional to the number of Gram-negative bacteria present. 
LPS has been found to reduce mRNA and protein levels of PXR, CYP3A, and ABC 
B1 in the liver when injected in mice 156,157 Although differences were not observed 
for these proteins in the liver between the two strains, it is feasible that in the gut, the 
presence of LPS in the conventional GI tract could cause a lower expression of these 
transcripts in comparison to the germ-free tract where LPS would be absent. Q-PCR 
results identified that the difference in PXR transcripts between germ-free and 
conventional animals increased with the bacterial gradient along the tract (duodenum 
to colon). 
Glutathione S-transferase (GST) is noteworthy due to the protective function of this 
phase II enzyme. Glutathione has been previously identified to be present in lower 
concentrations in germ-free mouse liver compared to conventional liver82, and in this 
study transcripts for GST were markedly reduced in the liver of the germ-free rat 
(- 
139 fold). Like other drug metabolising enzymes this trend was reversed in the ileum. 
However, in this study glutathione concentrations were not observed to differ in the 
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hepatic metabolite profiles between the rat strains and so further conclusions cannot 
be drawn. Future work could utilise a more focused assay with greater sensitivity. 
The small intestine plays an important role in the first-pass metabolism of orally 
ingested drugs, and therefore the modulation of this metabolism by the enteric 
bacteria can clearly have a marked effect on the metabolic fate of compounds. 
Mucosal epithelial cells (enterocytes) express a plethora of drug biotransformation 
enzymes158, and the expression of these enzymes has shown large inter-individual 
variability, demonstrated with the variability in CYP1 A1159 and CYP3A160. Variability in 
drug metabolism between individuals may be influenced by the microbiota either 
through LPS or another microbial factor, and it is evident that microfloral influence 
over intestinal xenobiotic metabolism could have a significant impact on drug efficacy 
and may modulate toxic responses161 
3.5.1.2 Microfloral influence over lipid metabolism 
Several transcripts implicated in cholesterol biosynthesis were expressed in lower 
levels in the germ-free liver with respect to the conventional strain (figure 3.18), and 
higher in the germ-free ileum compared to the conventional animals (figure 3.19). 
The majority of cholesterol is synthesised endogenously, in both the intestine and the 
liver, but can also be obtained from the diet. The greatest proportion of cholesterol is 
used to synthesise bile acids, and as such the cholesterol balance must be tightly 
regulated through homeostatic mechanisms so that de novo synthesis is regulated to 
meet the body's demands. HMG-CoA reductase is the rate-limiting enzyme of 
cholesterol biosynthesis and in the germ-free liver this enzyme was expressed in 
lower amounts than in the conventional liver, along with several other enzymes 
involved in cholesterol biosynthesis such as those involved in the mevalonate 
pathway. Lower cholesterol biosynthesis is a likely reflection of higher concentrations 
of cholesterol in the liver of germ-free animals compared to the conventional animals. 
Higher cholesterol concentrations have previously been observed in the liver of 
germ-free animals in comparison to conventional animals, and have been attributed 
to increased levels of bile acids in the germ-free animals 162. Bile acids are 
amphiphilic compounds, and the hydrophobic/hydrophilic ratio is modified by 
conjugation. Bacterial deconjugation of a bile acid increases the 
hydrophobic/hydrophilic ratio and reduces the solubility and lipid emulsification 
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efficiency163,164 In the germ-free animal, the lack of bacterial deconjugation and the 
potential effect of reduced intestinal motility allows more complete reabsorption of 
bile acids, extending bile acid half lives, and also increasing the bile acid pools162 
This larger bile acid pool affects the rate of catabolism of cholesterol in the germ-free 
rats and therefore increases hepatic cholesterol pools. This is in agreement with the 
reduced transcript levels for cholesterol biosynthesis in the germ-free rats in 
165 comparison to the conventional rats, 
166 
Higher transcripts for bile acid production in both the ileum and liver of germ-free 
animals compared to the conventional animals indicated a greater amount of 
cholesterol was converted to bile acids in the germ-free animals. CYP7A1 
(cholesterol 7a-hydroxylase) is the rate-limiting enzyme in the classical bile acid 
pathway, and was expressed higher in the germ-free liver. The classical pathway 
may be responsible for over 50% of the production of bile acids. The alternative 
pathway for bile acid biosynthesis (the acidic pathway), involves mitochondrial 27- 
hydroxylation of cholesterol catalysed by CYP27A1 (sterol 27-hydroxylase) and can 
occur in extrahepatic tissue. Transcripts for CYP27A1 were higher in germ-free 
ileum, potentially reflecting increased bile acid synthesis in the ileum of germ-free 
animals167. CYP27A1 is stimulated by PPARy and shown to be an important defence 
mechanism against the accumulation of cholesterol 168. Higher levels of CYP27A1 
and PPARy transcripts in the ileum of germ-free animals may be induced by higher 
concentrations of cholesterol in this tissue. Greater expression of the transporter 
ABC G5 in the germ-free ileum further emphasises this proposition, since this protein 
is known to be involved in the movement of cholesterol out of the enterocyte into the 
intestinal lumen, with a key function in regulating dietary sterol absorption and 
excretion. Greater synthesis of bile acids would agree with the suggestion that bile 
acid and cholesterol pools were higher in the germ-free animals. 
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Cholesterol biosynthesis was increased in the ileum of the germ-free animals, this 
does not appear logical given the reduced biosynthesis in the liver and cannot be 
explained without further investigation. Given that the plasma chemistry results 
identified plasma cholesterol concentrations to be comparable between the two 
animal strains, this balancing of cholesterol biosynthesis and greater catabolism to 
bile acids in the germ-free animals is likely to represent a homeostatic mechanism to 
maintain systemic cholesterol concentrations in response to microfloral absence, and 
demonstrates that cholesterol anabolism and catabolism are well balanced in the 
host. 
Bacterial influence over bile acid pools has direct implications within the GI tract and 
in the impact of drugs on the host. Higher concentrations of conjugated bile acids in 
the germ-free animals also enhances solubility and lipid emulsification 82, resulting in 
the increased intestinal uptake of lipids in germ-free animals. This is in agreement 
with the metabonomic findings with differences in the hepatic lipid profiles between 
the strains, and also in the plasma with the increased lipoproteins in the germ-free 
animals compared to the conventional animals, suggesting greater transport of lipids 
out of the liver in these animals. 
An interesting transcript difference was the higher expression of FXR in the germ- 
free ileum. FXR is a receptor for bile acids and `turns off' CYP7A1, thus limiting 
classic bile acid synthesis169. Elevated FXR transcripts presumably relate to elevated 
bile acids in the germ-free ileum. CYP7A1 was not expressed in the ileum of either 
animal strain and so the up-regulation of FXR may simply reflect the increased 
concentration of bile acids in this tissue. Several naturally occurring bile acids, 
including chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), and lithocholic 
acid (LCA), are natural ligands for FXR. The primary bile acid CDCA is the most 
potent activator of FXR, and given that germ-free animals presumably have higher 
concentrations of primary bile acids than conventional rats this may explain the 
higher expression of FXR"o 
Transcripts relating to arachidonic acid metabolism and also the synthesis of 
eicosanoids (leukotrienes, prostaglandins and thromboxanes) were higher in the 
ileum of germ-free animals compared to the conventional animals. This pathway is 
involved in fatty acid metabolism, and prostaglandins modulate immune function. 
Arachidonic acid sits at the head of the arachidonic acid cascade and acts as a 
signalling path for a host of bodily functions especially inflammation. This, taken with 
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the differences observed in transcripts for immunity, may reflect basal variation in the 
immunological state of these two animal strains. 
3.5.1.3 Microfloral influence over energy metabolism 
Differences were noted regarding energy metabolism between the two animal 
strains. Transcripts relating to glycolysis were expressed higher in the germ-free 
ileum in contrast to the conventional ileum (figure 3.20) whilst in the liver, 
gluconeogenesis transcripts were expressed higher in the germ-free animals 
compared to the conventional animals (figure 3.21). 
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Figure 3.20: Transcription differences in the ileum of germ-free and conventional rats implicated in 
carbohydrate metabolism. Transcripts expressed higher in the germ-free animals compared 
to the 
conventional animals are shown in blue and transcripts expressed lower are shown in red. 
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Figure 3.21: Differential expression of transcripts relating to energy metabolism in the livers of germ- 
free and conventional rats. Blue, increased in germ-free animals with relation to conventional animals. 
Red, decreased in germ-free animals with relation to conventional animals. 
Increased glycolysis in the ileum of the germ-free animals was accompanied with 
higher transcripts for the transporters SGLT1 (SLC5A1), a glucose and galactose 
transporter, and GLUT5 (SLC2A5), a fructose transporter. Both transporters move 
sugar from the intestinal lumen into the cytoplasm of the enterocyte, and both are 
considered regulated by the diet. Higher transcripts for GLUT5 correlate with higher 
transcripts for fructokinase, the enzyme required to catalyse the conversion of 
fructose to fructose-6-phosphate. Higher expression of these transporters may 
represent greater availability of their respective substrates in the germ-free animal or 
a shift in the strategy for energy metabolism. Bacterial fermentation products, SCFA, 
provide a salvage mechanism for food unable to be digested by the host. SCFA, 
particularly butyrate, are an important respiratory fuel, used in preference to glucose 
and ketone bodies"'' 12 In the germ-free animal, glycolysis using glucose and 
fructose would be up-regulated in comparison with the conventional animals to 
overcome this deficit. 
In the liver of the germ-free animals gluconeogenesis may occur to a greater extent 
than in the conventional animals. Increased transcripts for the gluconeogenic enzyme 
glucose-6-phosphatase indicate this. This enzyme dephosphorylates glucose-6- 
phosphate to free glucose so that it can enter the bloodstream. As blood glucose 
derives from the liver, greater gluconeogenesis in the liver of germ-free animals most 
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likely explains the higher plasma glucose levels in comparison to the conventional 
animals. Gluconeogenesis is necessary when the supply of carbohydrates is not 
sufficient to meet the metabolic demands of the body. In the absence of SOFA the 
host would not be able to extract as much energy from the diet as its conventional 
counterpart, and so a difference exists in the energy metabolism between the strains. 
Transcripts relating to aminotransferases that convert alanine and serine into 
pyruvate, a gluconeogenic substrate, were also higher in germ-free animals. This 
was corroborated by lower concentrations of alanine and glycine, glucogenic amino 
acids, in the plasma and liver of germ-free animals in contrast to the conventional 
animals. The microbiota are known to provide the host with pyruvate and lactate 
(lactate is converted to pyruvate through the Cori cycle), it is feasible therefore, that 
in the absence of the gut bacteria greater amounts of amino acids would need to be 
converted to pyruvate to compensate for this deficit. This may also explain increased 
proteolysis in germ-free livers to increase the availability of free amino acids. 
Metabonomic data revealed lower concentrations of lactate in the germ-free plasma 
and liver compared to the conventional animals, and lower concentrations of 
pyruvate in the germ-free plasma. Decreased pyruvate could indicate increased 
consumption through gluconeogenesis, in addition, SCFA have been observed to 
maximise energy yield and spare pyruvate, which may explain why pyruvate was 
higher in conventional plasma in comparison to germ-free plasma 13. These findings 
suggest a shift in energy metabolism in germ-free animals to obtain energy via 
proteolytic and gluconeogenic routes. 
Overall it is clear that the microbiota has a significant influence over the mammalian 
biological system, including drug, lipid, and energy metabolism. Given the host 
specific nature of the microbiota and the selection pressures that can shape it's 
make-up, the possibility for the microflora to be an important contributory factor in the 
modulation of host metabolism and variable drug responses is evident. 
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3.5.2 Suppression of the gut microbiota through the administration 
of antibiotics 
The antibiotic-treated animal model was analysed in parallel to the germ-free animal 
model. This represented a different test system to the germ-free animal due to the 
conventional-type attributes of the animal, allowing the direct microfloral interactions 
with the host to be investigated. The impact of microbial re-establishment once 
antibiotic treatment had ceased was also investigated. 
The effectiveness of microbial suppression, and also microbial recolonisation, was 
evaluated through the culturing of cecal contents and through metabonomic analysis 
of the urine sampled from the antibiotic treated animals. Reductions in microbial- 
derived metabolites in the urine provided a good indication that the gut microbiota 
was perturbed by the antibiotic regimen. These microbial metabolites included 3- 
HPPA, 4-HPPA, hippurate and PAG. Hippurate is formed through the bacterial action 
upon plant phenolics and aromatic amino acids to form benzoic acid, which is 
subsequently conjugated with glycine to form hippurate174. The aromatic species, 3- 
HPPA and 4-HPPA arise through the bacterial hydrolysis of dietary derived 
chlorogenic acid and further bacterial reduction of caffeic acid175' 176 Anaerobic 
bacterial metabolism of phenylalanine and phenols leads to the formation of 
phenylacetate, which becomes conjugated with glycine in the liver to form PAG. 
TMAO was also observed to be reduced following antibiotic administration, although 
this can be dietary in origin the majority is obtained from bacterial degradation of 
precursors such as choline to trimethylamine (TMA) and subsequent oxidation in the 
177 liver to form TMAO' 178 
The cecal cultures suggested microfloral suppression had occurred in all animals of 
group III after eight days of antibiotic treatment. This was supported by the 
metabonomic data with the majority of urinary metabolic profiles being distinct from 
the control animals, with reduced microbial-derived metabolites. One animal from 
group III did appear to have a urinary metabolic profile resembling that of a control 
animal despite no bacteria being cultured from the animal's cecal contents. This may 
suggest microbial decontamination did not occur in all animals. As the antibiotic 
solution was supplied in the drinking water, sufficient intake was required for the 
antibiotics to be effective, and the ad libitum provision of the antibiotic solution could 
introduce variability into the degree of suppression, stressing the importance of 
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monitoring daily water intake in this animal model. Future studies could utilise 
fluorescence in situ hybridisation (FISH) techniques to obtain a more accurate 
quantitative assessment of the species present throughout the tract, although this 
approach is necessarily time-consuming. 
The urinary metabolic profiles of group II after four days of antibiotic treatment were 
of similar composition to group III, with lower concentrations of microbial related 
metabolites. These were clearly distinguished from the control urine and indicated 
bacterial suppression had occurred. By day eight, after antibiotic treatment had 
ceased, cecal cultures indicated that recolonisation, approaching a level comparable 
to the control group, had occurred. The metabolite profiles of the urine however, did 
not fully recover to resemble control animals, with microbial-derived metabolites still 
present at lower concentrations. This difference was presumably characteristic of 
recolonisation, indicating that after four days colonisation the gut microbiota had not 
yet diverged upon a climax community resembling that of the control animals. 
A summary of the transcript data for both group II and III animals is presented in 
table 3.18. In the transcript data the greatest disruption occurred in the group II rats, 
the bacterial recovery group, suggesting that bacterial restoration had a more 
prominent effect on gene expression than bacterial suppression. This possibly 
reflects re-exposure to bacterial ligands and an adjustment in the host to 
accommodate/utilise these bacteria. 
Table 3.18: Summary of the transcriptomic results for group II animals, and group III animals 
comparative to group I (control) animals. 
Tissue Group II (bacterial recovery) Group III (decontaminated) 
Liver T92 t66 
Ileum 14 14 T67 
Colon T 47 172 T 12 J 42 
Transcripts in the ileum were minimally perturbed by the antibiotic treatment in both 
group II and III animals. In the colon however, a larger perturbation occurred and this 
was greater in group II, this is understandable given that the colon harbours the 
greatest population of microbiota along the GI tract. In the re-colonising animals, the 
expression of three CYPs (CYP 2D9,2D22,4B1) was down-regulated compared to 
the controls, and interestingly these were expressed higher in the ileum of germ-free 
rats than the conventional rats. Down regulation of these CYPs may relate to 
increased LPS exposure in the re-colonising animals. As these animals become 
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recolonised and the bacteria establish communities, the concentration of intestinal 
LPS may be dynamic in comparison to the control animals and the expression of 
these CYPs may be modulated. This is supported by the increase in the transcripts 
relating to inflammation. This reinforces the potential for microfloral variations to 
affect drug metabolising enzyme expression within the host, even when the host has 
endured normal development. 
Further evidence of microfloral gene expression modulation was the up-regulation of 
squalene epoxidase in the liver of acclimatising animals compared to the control 
animals. This transcript is involved in cholesterol biosynthesis and was expressed 
lower in the liver of germ-free animals compared to the conventional animals. In the 
decontaminated animals (group III) transcripts for ABC G5, a cholesterol transporter, 
were up-regulated in the liver and were also expressed higher in the germ-free ileum 
in contrast to the conventional ileum. These transcription differences most likely 
correspond to subtle modulation of lipid metabolism after disturbance of the 
microbiota and a compensatory response by the host to maintain cholesterol 
homeostasis. This disruption to lipid metabolism was on a much smaller scale than 
witnessed in the germ-free animal and is corroborated by the lack of perturbation to 
the hepatic lipid profiles. Longer bacterial suppression may be required for the bile 
acid pool to increase to a level comparable to the germ-free animal, or it is possible 
that the increased bile acid and cholesterol pools result from a morphological or 
physiological characteristic typical of the germ-free animal, for example extended 
transit times. 
Overall, hepatic transcripts were not notably perturbed in either group II or group III 
animals, indicating antibiotic administration did not have a significant impact upon the 
hepatic transcriptome. A difference could be seen however, in the hepatic metabolite 
profile of both group II and group III animals compared to the control group. It is not 
possible to judge whether these differences are a direct effect of the antibiotics or the 
impact of bacterial suppression but the metabolite profiles of the antibiotic treated 
animals were not comparable to the germ-free animals. If the antibiotic dose does 
perturb the liver then, as a model for examining the effects of floral presence on 
hepatic function and drug metabolism, the antibiotic treated animal may not be ideal. 
Plasma chemistry data identified the activity of two aminotransferase enzymes, ALT 
and ALP, to be decreased during bacterial recolonisation, these were both lower in 
the germ-free plasma compared to the conventional animals suggesting microfloral 
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presence may influence the plasma activity or concentration of these 
aminotransferases. Plasma metabolites however, did not differ following antibiotic 
administration, yet in the plasma of germ-free animals a difference did exist to 
conventional animals. This indicated that the antibiotic treatment did not have an 
impact on systemic circulation, and reinforces the point that the germ-free animal 
model is notably different from the antibiotic-treated model. 
3.6 Conclusions 
The microflora have been demonstrated to exert a significant influence over the host 
biological system, specifically to host drug, lipid, and energy metabolism. These 
findings further emphasise the possibility that microfloral deviations could be an 
underlying factor in inter-individual variation in drug responses. It can be concluded 
that temporary suppression of the gut microflora did not evoke the same degree of 
disruption to the host transcriptome as an animal raised under germ-free conditions 
but short-term suppression and subsequent recolonisation was sufficient to modulate 
the expression of some drug metabolising enzymes; although without comprehensive 
knowledge of the extent of microbial suppression definitive conclusions are limited. 
To conclude, these are two very different test systems, the germ-free model is not a 
true reflection of a mammalian biological system as all mammals harbour gut 
microflora throughout life and therefore possess microfloral-associated 
characteristics. In this sense the antibiotic treated model would be a more 
appropriate model. However, the drawback of this test system is that the extent of 
floral suppression is difficult to ascertain and therefore definitive conclusions cannot 
be made. Inoculating germ-free animals with specific, known microbes (gnotobiotic 
animal model) is an alternative approach although this is still not representative of a 
conventional host, and requires greater laboratory expertise. The potential for the 
antibiotic dose to disrupt hepatic function prevents this model from being used to 
investigate microfloral influence over drug metabolism. 
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Chapter Four: Effect of methapyrilene toxicity on the 
mitochondrial protein carbamoyl phosphate synthetase I 
4.1 Aims and objectives 
As a model in animals with normal microflora, the mechanisms of methapyrilene 
toxicity were investigated. This work aimed to expand on the findings of previous 
work into methapyrilene induced hepatotoxicity, specifically to determine whether 
putative covalent binding of a methapyrilene related metabolite caused a change in 
carbamoyl phosphate synthetase (CPS I). The objectives were: 
" to employ Western blotting techniques to assess the carbamoyl 
phosphate synthetase protein following methapyrilene dosing 
9 to investigate the activity of carbamoyl phosphate synthetase following 
dosing using enzyme activity assays 
" to utilise 1H NMR spectroscopy based metabonomics to identify metabolic 
changes associated with altered CPS I activity and methapyrilene toxicity 
4.2 Introduction 
As discussed previously, methapyrilene (MP) is a model hepatotoxin whose 
mechanisms of toxicity are not yet fully characterised. The potential for protein 
modification to be a mechanism of toxicity is studied via assessment of the 
size/activity of CPS I protein in relation to the hepatic metabolite profile. 
4.2.1 Previous methapyrilene work and motivation for this study 
A recent study has applied integrated transcriptomic, proteomic and metabonomic 
analysis to MP induced hepatotoxicity in the rat19. In this study multiple doses of 
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both a sub-toxic (50 mg/kg/day) and toxic (150 mg/kg/day) dose of MP were 
administered to male Wistar rats. Whilst the sub-toxic dose did perturb all three levels 
of biomolecular organisation (transcriptomic, proteomic and metabolic profiles) in the 
rats it was considered this change was likely to reflect the pharmacological effects of 
the MP. The high dose however, was shown by histopathology to cause periportal 
hepatocyte degeneration and necrosis four hours after dosing with severity 
increasing through the study. Gene and protein fluctuations consistent with oxidative 
stress and global changes indicative of energy usage alterations were also noted in 
these animals. A summary of the changes induced by MP dosing is given in table 
4.1. 
Table 4.1: Common gene, protein, and metabolite changes associated with methapyrilene 
toXicity179. 
Pathway Gene Protein Metabolite 
Stress Heat shock protein 60 T Heat shock protein 60 1 
Glutathione s-transferase a1T Glutathione-S-transferase T 
DnaJ (hsp40) homolog, A2 T 
Heat shock 27kda protein 1T 
NAD(P)H quinine dehydrogenase T 
Thioredoxin reductase 1T 
Herne oxygenase T 
Metallothionein 
Stress-70 protein precursor T 
Protein disulfide isomerase A3 T 
Calreticulin T 
Glucose metabolism Fructose-1,6 bisphosphatase 1 Fructose 1,6 bisphosphatase 
Pyruvate carboxylase Pyruvate carboxylase l(I*) 
Pyruvate kinase 
Aldolase A/B 
Glucokinase 
Lipid metabolism Mitochondrial HMG-CoA synthase 
Short chain 3-hydroxyacyl-CoA 
dehydrogenase j 
3-Ketoacyl CoA dehydrogenase 
Mitochondrial Acyl-CoA thioesterase 1T 
Malic enzyme 1 
ATP citrate lyase ( 
Fatty acid CoA ligase 1/5 
Stearoyl-CoA desaturase 1j 
Urea cycle Ornithine carbamoyltransferase T Ornithine carbamoyltransferase 
Argininosuccinate lyase T Carbamoyl phosphate synthase ý(1*) 
Ornithine decarboxylase 1T 
Choline metabolism Dimethylglycine dehydrogenase Dimethylglycine dehydrogenase T 
Glycine methyltransferase 1 
Glucose I 
Glycogen 
Succinate (urine) T 
Triglycerides T 
[Adipate (urine)] T 
Dimethylglycine 
Sarcosine dehydrogenase T [TMAO (urine)] T 
Phenyl-alanine Phenylalanine 4-hydroxylase Phenylalanine 4-hydroxylase T 
metabolism 
Arrows indicate direction of change, (*) indicates mitochondrial proteins with apparently charged 
covalent modification. Metabolite changes were identified in the liver unless stated otherwise. 
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The oxidative stress shown in the gene and protein stress response is a frequent 
consequence of mitochondrial dysfunction. MP is known to cause mitochondrial 
proliferation in hepatocytes and it is noted that MP administration perturbs processes 
catalysed by mitochondrial-based enzymes180. Previous proteomic investigations in 
rat MP dosing have shown evidence of charge-modification occurring to 
mitochondrial matrix and inner membrane proteins. These are covalent modifications 
and were identified, via 2D electrophoresis, to occur in the mitochondrial F1 ATPase 
ß-subunit, heat shock protein 58, glucose regulated protein 75 and carbamoyl 
phosphate synthetase (CPS 1)181 
The focus of this chapter is to further investigate the role of the mitochondrial protein 
CPS I in methapyrilene toxicity. The decision to explore this protein change is due to 
the regulatory role of this enzyme in the urea cycle and the potential disruption MP 
causes to the urea cycle. Based upon transcriptomic work 182 on the aforementioned 
study, gene transcripts coding for enzymes connected to the urea cycle were 
perturbed after MP dosing (figure 4.1), although disruption was not observed in the 
transcripts for CPS I. The proteomic findings summarised in table 4.1 also indicate 
that in addition to CPS I alteration, the mitochondrial urea cycle enzyme ornithine 
carbamoyltransferase was down regulated following MP administration. 
Urea Cycle genes modified by 
150 mg/kg dosing of MP 
2000 
e 
N c d 
c 
100 
c 
C) 
Cl) 
Argininosuccinate lyase 
Argininosuccinate Arginine 
Ornithine decarboxylase 1 
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Ornithine transcarbamylase 
Ornithine P. Citrulline 
Figure 4.1: Impact of methapyrilene on the gene expression of urea cycle enzymes. Signal intensity 
values for gene transcripts relating to urea cycle enzymes after multiple doses of methapyºilene (0,24, 
48, and 72 hours). Reactions catalysed by the enzymes are shown on the right (adapted from A. Craig 
transcniptomic findings (unpublished)). 
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4.2.2 Carbamoyl Phosphate Synthetase I (CPS I) 
4.2.2.1 Role of CPS I 
The hepatic urea cycle (figure 4.2) is a major route for waste nitrogen disposal, 
converting toxic ammonia into the much less toxic urea. This cycle resides within the 
liver and comprises five enzymes, three which function in the cytosol; 
argininosuccinate synthetase, argininosuccinase and arginase, and two which 
function in the mitochondria; ornithine transcarbamoylase, and CPS I. Ammonia is 
transported into the mitochondria as glutamine, and then catabolised by glutaminase 
to ammonia and glutamate. The ammonia formed then enters the urea cycle via 
CPS 1183 
LMitochondrial 
matrix 
bicarbonate + ammonia 
(IK 
carbamoyl 
phosphate (2) 
++ citrulline 
omithine 
(1) carbamoyi phosphate synthetase (CPS I) 
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Figure 4.2: Simplified schematic representation of the urea cycle. Adapted from Badizadegan and 
Perez-Atayde lsa 
In ureagenic animals, CPS is synthesised predominantly in the liver with small 
amounts synthesised in the intestinal mucosa. Mammalian evolution has forced 
deviation from the CPS bacterial equivalent to the occurrence of two CPS forms, 
termed CPS I and CPS II. CPS I is located exclusively in the mitochondria and 
constitutes approximately 20% of the total matrix protein. It is responsible for 
catalysing the first reaction of the urea cycle, forming carbamoyl phosphate (CP) 
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from free ammonia and ATP (seen by reaction 4.1). CPS 11 is a cytosolic-based 
synthetase involved with pyrimidine biosynthesis. CPS I is covalently modified 
following MP dosing and so it is this form that is the focus of this chapter. 
Reaction 4.1: Reaction catalysed by CPS I, this reaction takes place via three steps 
(discussed in chapter two). 
NH4+ + HC03 + H2O +2 ATP -* carbamoyl phosphate + HP042- +2 ADP 
CPS I is absolutely dependent upon the allosteric activator, N-acetylglutamate, and is 
the only enzyme in the urea cycle known to have a regulatory cofactor. With CPS I 
located at the forefront of the urea cycle it is implicated as an important regulatory 
enzyme of the cycle 185 
4.2.2.2 CPS I structure 
Previous work performed by Thoden et al. determined the crystal structure of the 
E. coli CPS enzyme. This revealed the individual properties of the various domains 186 
E. coli CPS is an a, ß-heterodimeric protein possessing both a large and a small 
subunit; these are comprised of 1073 and 382 amino acid residues, respectively. The 
human equivalent, CPS I, is a 1500-residue polypeptide and the amino acid 
sequence closely resembles that of the E. coli CPS. The N and C-terminal regions of 
's7,188 CPS I equate to the large sub-unit of the E. coli counterpart 
Each terminal consists of both a 40 kDa and 20 kDa domain. These 40 kDa domains 
comprise a grasp-type ATP site. The 40 kDa domain of the N-terminal catalyses the 
phosphorylation of bicarbonate and the C-terminal equivalent phosphorylates 
carbamate. The 20 kDa domain of the C-terminal is the site where the N- 
acetylglutamate binds; this activates the enzyme by raising the affinity for ATP and 
initiates the step of activating the bicarbonate. An interesting aspect of this particular 
protein is the existence of a molecular tunnel within the protein linking the two 
phosphorylation sites. This provides numerous catalytic advantages, improving 
enzyme efficiency, controlling metabolic flux, and protecting the ammonia and 
carbamate from the external solvent188. 
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4.2.2.3 CPS I deficiency 
Inherited defects of the urea cycle enzymes are estimated to occur in 1 in every 
30,000 births, this is predominantly X-linked ornithine transcarbamylase deficiency. 
These defects halt the urea cycle resulting in an accumulation of ammonia. This 
hyperammonemic consequence, if untreated, can be fatal. Ammonia is an effective 
toxin to neurones within the cerebral cortex and brainstem. Mild hyperammonemia 
can cause vomiting, drowsiness, and a decreasing level of consciousness whilst 
severe cases can disrupt the central nervous system inducing brain damage and 
mental retardation. Approximately half of the newborn infants with urea cycle defects 
die with hyperammonemic coma189. 
CPS I deficiency in humans is a rare autosomal recessive condition190 characterised 
by the accumulation of plasma ammonia, glutamine and the reduction of citrulline. 
Research has been largely directed towards the neurological consequences of CPS I 
deficiency; however there are some reports of diffuse microvesicular steatosis and 
focal glycogenosis occurring in the hepatocytes184. Elevated ammonia has been 
demonstrated to affect intracellular pH and electrochemical gradients in 
hepatocytes191, disturb energy metabolism at the mitochondrial level 192, and reduce 
the in vitro growth of cells19' 
This work investigated the consequence of a charge modification to CPS I and 
whether potential impairment could serve as a mechanism of methapyrilene induced 
hepatotoxicity. Here, multiple 150 mg/kg doses of methapyrilene were administered 
to rats over 74 hours. To assess the impact of MP dosing on the CPS I enzyme, 
Western blotting methods were employed to study alterations to protein size, enzyme 
activity assays have been utilised to monitor enzyme activity, and NMR-based 
metabonomics has been used to observe the metabolite alterations occurring in the 
liver through time. 
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4.3 Materials and methods 
4.3.1 Methapyrilene study design 
Table 4.2: Overview of methapyrilene study 
Group Animal Number MP Dose (mg/kg) Time of Sacrifice after initial dosing/ hours (h) 
1 1to5 0 74h 
11 6 to 10 150 2h 
III 11to15 150 4h 
IV 16 to 20 150 6h 
V 21 to 25 150 8h 
VI 26 to 30 150 26 h (2 hours post 2n dose) 
VII 31 to 35 150 50 h (2 hours post 3r dose) 
VIII 36 to 40 150 74 h (2 hours post 4 dose) 
Male, Wistar derived AIpK: APfSD (AP) rats (n = 40) were obtained from the Rodent 
Breeding Unit at AstraZeneca, Alderley Park. Animals were selected with body 
weights falling within the range of 170-200 g. Groups I, II, and VIII were housed in 
metabolism cages whilst the remaining groups were housed in plastic bottomed 
cages. Food (standard rat and mouse diet No. 1 modified irradiated diet; Special Diet 
Services) and water were available ad libitum and all animals were subjected to 12- 
hour light, 12-hour dark artificial light cycle. Animals were acclimatised to these 
housing conditions for three days prior to the start of the dosing regime. 
The rats were separated into eight groups of five (I to VIII, see table 4.2). Group I, 
the control group, was dosed with the vehicle. Groups II to VIII were given a 150 mg 
kg-1 dose of MP. The MP dose was formulated in a solution of sterile water 10 ml kg-' 
and administered by oral gavage. Doses were administered at a time point 
designated as zero and then at 24,48, and 72 hours into the study unless animals 
were sacrificed prior to these time points (refer to table 4.2). Animals were 
euthanased by increasing CO2 gradient. 
The strategy for sample utilisation for investigating the effect of MP toxicity on CPS I 
protein is given in figure 4.3 
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Figure 4.3: Strategy for plasma and liver tissue utilisation. 
4.3.2 Collection of liver samples 
Plasma 
ALT activity 
assay 
The livers were excised immediately after sacrifice, weighed and then snap frozen in 
liquid N2, prior to storage at -80°C until required. 
4.3.3 Sample preparation for histopathological assessment 
All pathology and histological observations were made by the appointed study 
pathologist at AstraZeneca, Alderley Park. A histological section was prepared from 
the samples of the four major lobes (left and right lateral, left and right medial lobes) 
preserved in buffered formalin at necropsy. Each section was stained with 
Haematoxylin and Eosin. 
4.3.4 Alanine aminotransferase (ALT) activity assay 
The assay was performed on plasma samples taken at necropsy and carried out in 
the Clinical Chemistry laboratory at AstraZeneca, Alderley Park. This assay was 
performed following the laboratory's standard operating procedure using the Roche 
`ALT (ALAT/GPT) with/without pyridoxal phosphate activation kit'. Results are 
expressed as enzyme units per litre (U/L) 
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4.3.5 Western blotting 
Liver samples (1 g) were taken into 10 ml of homogenisation buffer (10 mM Tris HCI 
(pH 7.4) containing 0.25 M sucrose, 1 mM EDTA, 0.5 mg/ml BSA and a protease 
inhibitor cocktail) and stored until use at -80°C. When required, samples were thawed 
and centrifuged at 250 g for 10 minutes, the supernatant was then taken. 
The protein content of the sample homogenates was assayed in a background of 
diluted lysis buffer of the above composition except for the protease inhibitors. At this 
point the assay was performed for all samples using a Pierce BCA protein assay kit. 
Once assayed the samples were stored at -80°C. 
Prior to SDS-PAGE the samples were defrosted and a sufficient amount was taken to 
apply 10 µg of protein to the gel well. To this sample, 1 µl of NuPAGE (Invitrogen) 
sample reducing agent (10X) and 2.5 µl of NuPAGE LDS (loading buffer) was added 
and sufficient water was applied to make a final volume of 10 µl to apply to the well. 
The gels used were NuPAGE Novex Bis-Tris 4-12% gels. Prior to sample loading, 
the gels were rinsed with deionised water and the protective tape and comb were 
removed. Gels were locked into place in a Xcell Surelock mini cell. Into the lower 
(outer) buffer chamber, 800 ml of NuPAGE SDS running buffer (MOPS (3-[N- 
morpholino]propanesulfonic)) was poured and 500 µl of NuPAGE antioxidant was 
added to 200 ml of running buffer and used to fill the upper buffer chamber. The 
samples (10µI) were pipetted into individual wells, including the marker proteins 
(Rainbow Ladder, Amersham Biosciences) and the gels were run at 200 V constant 
for 50 minutes. 
The separated proteins were transferred onto a nitrocellulose membrane (0.45 µm 
pore size). This was carried out in the same Xcell Surelock mini cell using NuPAGE 
transfer buffer in the blot module and deionised water in the outer chamber. The 
samples were transferred overnight in the cold room at 15 V constant. 
To visualise the membrane, blocking was first carried out to block all unbound sites 
and prevent primary and secondary antibodies binding to the membranes. To block 
the membrane it was incubated in StartingBlock T20 (TBS) for 1 hour. A rabbit 
polyclonal antibody to CPS I (Abcam) was used for the primary antibody, this was 
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applied at a 1/5000 dilution (diluted with StartingBlock) and incubated with the 
membrane for 1 hour. Following three 20-minute wash steps with TBS-tween, the 
secondary antibody, a goat-anti-rabbit antibody (Pierce), at a dilution of 1/50000 was 
applied and left for 1 hour. 
Supersignal® West Dura (Pierce) was used to induce the fluorescence of the 
secondary antibody and was captured on film by a5 second exposure. A digital 
image was also acquired using a Syngene multi-genius bio-imaging system. 
4.3.6 CPS I activity assay 
This method was adapted from that used by Pierson 193 for assaying the activity of 
the enzyme CPS I. This method requires the conversion of carbamyl phosphate to 
hydroxyurea using hydroxylamine. This conversion has been shown to be >98%194 
and also converts a principle decomposition product of carbamyl phosphate 
(cyanate) into hydroxyurea. Hydroxyurea can be quantified by a sensitive colorimetric 
assay. 
Sample preparation requires the homogenisation of 100 mg of frozen liver in 2.0 ml 
of 50 mM triethanolamine HCI (pH 8.0), containing 10 mM ATP, 15 mM magnesium 
acetate and 1 mM dithiothreitol. Minute cell debris was removed via centrifugation 
(37 000 xg for 15 minutes). Small molecules were extracted by passing 690 µl of 
homogenate over a Pierce ZebaTM 2 ml desalting spin column. The desalted 
homogenate was assayed immediately. 
To run the reaction, the homogenate was combined with the necessary substrate and 
sufficient energy and permitted to run for a set time. An aliquot of 150 µl of reaction 
mixture was supplied to 50 µl of enzyme preparation. The reaction mixture supplied 
to the homogenate consisted of 1 µmol of ATP, 2 µmol of magnesium acetate, 1 
gmol N-acetyl-L-glutamate, 0.2 µmol of dithiothreitol, and 10 µmol of triethanolamine 
(pH 8.0). The substrate, ammonium bicarbonate, was also added here to the reaction 
mixture. The reaction was run at 37°C for 8 minutes, and then transferred to ice to 
halt the reaction. 
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The carbamoyl phosphate produced was converted to hydroxyurea by the addition of 
10 µI of 2.0 M hydroxylamine. This conversion was mediated by incubation at 95°C 
for 10 minutes. 
For hydroxyurea quantitation, 0.8 ml of chromogenic reagent was added to the 
stoppered reaction tubes. This was heated at 95°C for 15 minutes, and then cooled 
to room temperature. The chromogenic reagent was mixed from equal volumes of 
solutions A and B. Solution A consisted of 0.85 g of antipyrine dissolved in 100 ml of 
40% (v/v) sulphuric acid. Solution B comprised 0.625 g of diacetyl monoxime in 100 
ml of 5% (v/v) acetic acid. The sample mixtures were centrifuged at 37000 xg for 1 
minute to pellet out the denatured protein to prevent interference with the absorbance 
reading and finally transferred into 96 well plate (200 µl per well). 
The resultant yellow chromophore was measured at 450 nm on a Perkin Elmer 
Envision 2102 Multilabel reader spectrophotometer. A range of carbamoyl phosphate 
standards (0 - 300 µM) were included for the generation of a standard curve. Here 
the carbamoyl phosphate was converted to hydroxyurea and then the chromogenic 
reagent was applied and absorbance measured. A BCA protein assay was 
performed on the sample homogenate allowing the enzyme activity to be expressed 
as nmoles of CP produced per minute per milligram of protein at 37°C. 
To measure the kinetics of the CPS I enzyme this assay was performed with the 
concentration of ammonium bicarbonate adjusted to cover a range of 0- 160 mM. In 
this experiment two pooled groups, group I (control 74 hour) and VIII (150 mg/kg 
dosed 74 hour), were contrasted to investigate whether dosing induced any 
alterations to the Vmax (maximal velocity) of the enzyme. 
From the kinetic study of CPS I, it was determined that 100 mM of ammonium 
bicarbonate was required to achieve Vmax" The reaction was run for 8 minutes at 
37°C, and then transferred to ice to halt the reaction. A control for each sample was 
created, here 150 µl of reaction mix without ammonium bicarbonate was applied to 
the sample and left on ice. This control was then subjected to the same steps as the 
incubated sample, apart from heating at 37°C for 8 minutes. 
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The enzymatic rate was calculated by subtracting the no substrate/no incubation 
control CP measurement from the incubated sample measurement. Analysis of the 
data was performed using Graphpad Prism software. 
4.3.6.1 Method development for CPS I assay 
Initial method development was carried out to assess the validity of the method. 
Enzyme activity for a control animal was monitored over time using 60 µmol of 
ammonium bicarbonate, the amount applied by Pierson193. Also measured in this 
experiment was the CP produced over time in an enzyme preparation lacking the 
substrate, and an enzyme preparation that had been boiled prior to the addition of 
the reaction mixture. The results from this assay are shown in figure 4.4. 
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Figure 4.4: The effect that substrate presence and enzyme denaturing has upon the activity of CPS I. 
Experiments were run in triplicate, values are mean ± SD. 
These results show the activity of CPS I when substrate is available, is linear over 
time between 2 and 8 minutes. The linearity of the CP produced in this time frame 
under conventional enzyme conditions is essential for calculating enzyme activity as 
it proves enzyme activity is constant over this period. 
The enzyme solution with no ammonium bicarbonate is seen to contain a low level of 
CP but no further CP is produced over the time course. This baseline level of CP is 
most likely bound CP that dissociates once the experiment commences. It can be 
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considered not to interfere with the result because it does not increase and the 
conventional enzyme preparation produces greater quantities of CP. This establishes 
that it is the substrate that is being converted to CP and causing the colour changes 
not another uncontrolled factor. The boiled enzyme mixture is observed to contain a 
greater amount of CP at the 2 minute time point than the conventional solution. 
However, over the following time points there appears to be no further CP produced. 
The increased background concentration of CP comparative to the no substrate 
control is possibly a consequence of boiling the enzyme. As the temperature of the 
homogenate is being ramped up to 100°C a small degree of residual ammonium 
bicarbonate within the sample homogenate could be converted to CP. The lack of 
subsequent activity suggests that denaturing the enzyme inhibits the activity and 
provides confidence that it is the activity of CPS I that is generating the colour 
change. 
4.3.7 Metabonomic analysis of liver aqueous extracts 
4.3.7.1 Aqueous extraction of liver tissue 
To acquire the aqueous extracts of the liver samples, 100 mg of frozen liver tissue 
was weighed out and homogenised in 1 ml of acetonitrile: water (1: 1) in a glass vial. 
The tissue was homogenised using a mechanical homogeniser set at full speed and 
the homogenate was then centrifuged for 6 minutes at 10,000 rpm. The supernatant 
was transferred to an eppendorf and the acetonitrile was allowed to evaporate off. 
Once the organic solvent was removed the water was removed by Iyophilisation prior 
to storage at -80°C. 
4.3.7.2 Preparation of liver aqueous extracts for 1H NMR 
spectroscopy 
For 1H NMR spectroscopic analysis, the lyophilized sample was reconstituted in 700 
pl of D20: H2O (9: 1) containing 1mM of TSP. The sample was vortexed to ensure 
reconstitution and then spun at 8,000 rpm for 10 minutes to pellet out any debris. 
Once free of particulate matter, 600 pl of the supernatant was transferred to a5 mm 
outer diameter NMR tube. 
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4.3.7.3 One-dimensional 1H NMR spectroscopy of liver aqueous 
extracts 
All samples were analysed using the same parameters that were applied in chapter 
three (section 3.3.4.5) Briefly, a standard one-dimensional NMR spectrum using 
water peak suppression was acquired using a standard pulse sequence using 8 
dummy scans, followed by 64 scans and collected into 64 K data points. Spectral 
width of 20 ppm, mixing time (tm) was set at 100 ms and the recycle delay at 2 s. 
4.3.7.4 Data reduction and analysis 
The spectral data were phased and corrected for baseline distortions, and calibrated 
to the internal standard (TSP) using the tools available in the XWINNMR program. 
The spectra were then digitised into consecutive integrated spectral regions 
(buckets) of equal width (0.04 ppm). The area of each segmented region was 
expressed as an integral value. The area corresponding to the suppressed water 
peak (b 4.50 - 5.98) was removed from the analysis and then each spectrum was 
normalised to unit area and mean centred. SIMCA-P10.5 (Umetrics) was used to 
perform PCA. 
Metabolites of interest were quantified using proprietary integration software 
(Crockford) running on a Matlab platform. Briefly, in the un-bucketed spectrum an 
integral was taken for a peak that related to the metabolite of interest (one with no 
other overlapping peaks), this was divided by the integral of the peak generated from 
the internal standard (TSP) of known concentration. The number of protons relating 
to the TSP peak (9) was then divided by the number of protons relating to the peak of 
interest. These two values were multiplied together and lastly multiplied by the known 
concentration of the internal standard. These data were used to generate the 
summary table (table 4.3). 
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4.4 Results 
4.4.1 Histopathology 
Periportal hepatocyte degeneration and necrosis was seen to occur in animals 
receiving methapyrilene from four hours post-dosing, with increased severity at the 
74 hour sampling point (post fourth dose). No members of the control group 
displayed any sign of periportal hepatocyte degeneration or necrosis. Periportal 
acute inflammatory cell infiltration occurred at 26 hours post dosing (two hours after 
second dose) and increased in severity and frequency with time. Reduced 
hepatocyte glycogen vacuolation was also observed in the dosed animals at 26 
hours. Additionally, mild (two animals) and moderate (one animal) bile duct 
proliferation was observed in members of the dosed group at the 76 hour time point. 
No similar observations were made in the control animals. 
4.4.2 Alanine aminotransferase activity assay 
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Figure 4.5: ALT activity of plasma sampled over the study following multiple (150 mg/kg) 
doses of methapyrilene (n = 5). C is control group, 0 mg/kg dose at 74 hours. Values are 
mean + SD. Significant difference from control by ANOVA with Dunnett post test, p=*<0.05, 
** < 0.01. 
Plasma ALT measurements (figure 4.5) indicated that ALT activity steadily increased 
after the first dose. A significant increase was first witnessed eight hours post dosing. 
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The second dose did not appear to increase the plasma ALT activity any further from 
the values at the eight hour time point, but the subsequent third and fourth doses did 
cause a large increase in activity. Increased plasma ALT activity reflects leakage of 
the enzyme from the liver into the plasma indicative of liver damage. 
4.4.3 Western Blot 
Dose 0 150 10 
Time (h) 74 2468 26 50 74 
(165 kDa) CPS I- ýr vim "ý ý1 
Figure 4.6: Immunoblot analysis of CPS I (-165 kDa). Size modified CPS I proteins can be 
observed above the CPS I band following a toxic dose of methapyrilene 
The dark bands seen at 165 kDa correspond to the CPS I enzyme (figure 4.6). The 
fainter higher molecular weight bands (size range of >165 kDa), not seen in the 
control group, may indicate a modification had occurred increasing the size of the 
CPS I enzyme following MP dosing. The abundance of the higher molecular weight 
bands increased through time with the greatest at the 74-hour time point. The higher 
molecular weight bands could be observed as early as two hours post dosing. 
4.4.4 CPS I Activity Assay 
The enzyme kinetic analysis carried out on the pooled samples from group I (control 
74 hours) and VIII (150 mg/kg MP 74 hours) is displayed in figure 4.7. For the CPS I 
enzyme, Vmax was seen to occur at a substrate (ammonium bicarbonate) 
concentration close to 100 mM and following multiple toxic doses of MP a clear 
decrease in the Vmax of CPS I was observed. At 100 mM ammonium bicarbonate, the 
reaction velocity of group I was 34.34 CP (nmol)/protein (mg)/min and for group VIII it 
was 10.69 CP (nmol)/protein (mg)/min, (p = 2.16 x 10-6). 
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Figure 4.7: A plot of the reaction velocity, V, as a function of the substrate concentration for 
the enzyme CPS I. Pooled samples from groups I (control - 74 hours) and Vlll (150 mg/kg - 
74 hours) are compared. 
The maximal activity of the CPS I enzyme was measured for all time points and the 
averaged data is presented below in figure 4.8. Assuming normal distribution a one- 
way ANOVA using the Dunnett post test, to compare all time points with the control 
group, was used to establish significance. 
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Figure 4.8: Maximal enzymatic activity (Vmax) of CPS / over time following multiple doses (150 
mg/kg) of methapyrilene (n = 3). Values are mean + SD. Significant difference from control by 
ANOVA with Dunnett post test, p=*<0.05, ** < 0.01. 
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The activity of CPS I decreased over time following MP dosing. This decrease follows 
a trend with a drop clearly occurring as early as four hours post dosing. At eight 
hours there appears to be a recovery in CPS I activity which then re-adjusts to 
comply with the trend by 26 hours. By 74 hours the activity can be seen to be greatly 
reduced comparative to the control. 
4.4.5 Metabonomics 
Typical 1H NMR spectra from the liver extracts of a control (74 hours) and dosed 
animals (2 - 74 hours) are shown in figure 4.9a and b. It can be observed that over 
the course of the study and in response to the doses of methapyrilene, the hepatic 
metabolic profiles undergo dynamic fluctuations. Metabolites of MP were not 
observed in the spectra of the hepatic aqueous extracts from the dosed animals. 
PCA trajectory scores plots were constructed to display how the metabolites present 
in the liver fluctuated through time, and in response to the multiple doses of 
methapyrilene (figure 4.10). From these plots it can be seen that the first dose 
caused a steady deviation from the control profile over the first eight hours. Following 
the second dose of methapyrilene the metabolite changes that occurred differ from 
those at eight hours and deviate further from the control profiles. The third dose 
shifted the metabolite alterations away from those witnessed at 26 hours and the 
fourth dose pressed this digression further, this is observed as a northward 
movement in principal component 2. At no point over the course of the study do the 
metabolic profiles reflect recovery occurring back to the control profile. Methapyrilene 
metabolites were also not visible in the metabolite profiles of any dosed animals. 
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Figure 4.9: 'H NMR spectra obtained from the aqueous extracts of the liver from control (74 
hours) and dosed animals (2 - 74 hours). (A) Control and dosed (2-6 hours) hepatic aqueous 
extracts (B) dosed (8 - 74 hours) hepatic aqueous extracts. 
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Figure 4.10: Trajectory PCA scores plots of the liver metabolite profiles from the control and 
dosed animals over the course of the study. (A) Two-dimensional (PCI V PC2) (Q2 = 0.278) 
and (B) three-dimensional (PC1 v PC2 v PC3) (Q2 = 0.28). Control animals at 74 hours (black 
triangle), dosed at two hours (yellow open triangles), four hours (orange open triangle), six 
hours (green open triangle), eight hours (dark green open triangle), 26 hours (blue open 
triangle), 50 hours (purple open triangle), 74 hours (red open triangle). 
To determine the metabolites responsible for the movement in figure 4.10, PCA 
scores plots were constructed to explain how the metabolite concentrations altered at 
the specific time points. The metabolite differences incurred from the first dose after 
two hours are highlighted by figure 4.11. The control profiles separate from those 
two hours post dosing explained by raised relative concentrations of phosphocholine, 
glutamine and betaine and decreased glucose and glycogen concentrations. 
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Figure 4.11: Metabonomic analysis comparing the hepatic metabolic profiles of control and dosed (two 
hours) animals. (A) PCA scores plot constructed from the integrated standard 1H NMR spectra from 
control (black triangles) and two hours post dosing (yellow open triangles) rat liver extracts (Q2 = 0.788). 
(B) Metabolite differences responsible for separation observed in A. 
Differences were exposed in the metabolite profiles of the liver sampled two hours 
and eight hours post dosing by PCA (figure 4.12). This separation was due to further 
deviation from the control profiles at eight hours, shown by further increased 
concentrations of phosphocholine and reduced concentrations of glucose and 
glycogen. Glutamine remained elevated at the same concentration as seen at two 
hours post dosing. Phosphocholine appeared at its highest concentration eight hours 
post dosing. An outlier (animal 22, group V) was removed from the analysis due to 
broad peaks in the 'H NMR spectrum due to contamination by lipid species, most 
likely a result of incomplete extraction in the sample preparation step. 
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Figure 4.12: Metabonomic analysis comparing the hepatic metabolic profiles of dosed animals at two 
and eight hours. (A) PCA scores plot (PC1 versus PC2) comparing the hepatic metabolic profiles of rats 
two hours (yellow open triangles) and eight hours (dark green open triangles) after the first 
methapynilene dose (Q2 = 0.664). (B) Metabolites responsible for the separation seen in A. 
The second dose was shown in figure 4.10 to draw the metabolite profile further 
away from the control group with different metabolite alterations occurring than those 
witnessed after eight hours. The liver profiles from the 26 hour time point (two hours 
after second dose) were contrasted against those from the eight hour time point 
(figure 4.13). Clear separation can be seen in the scores plot related to elevated 
betaine, and glutamine in response to the second dose with glucose decreased 
further. The amino acids, alanine, isoleucine, leucine and valine were also decreased 
following the second dose. Betaine appeared at peak concentration at this time point. 
Phosphocholine, still greater than in the control liver, was decreased from the 
concentration observed at eight hours. Lactic acid was observed to increase slightly 
at 26 hours, yet remained at a lower concentration than the control livers. 
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Figure 4.13: Metabonomic analysis comparing the hepatic metabolic profiles of dosed animals at eight 
and 26 hours. (A) PCA scores plot (PC1 versus PC2) contrasting the hepatic metabolic profiles of the 
dosed animals sampled at eight hours (dark green open triangles) and 26 hours (blue open triangles) 
into the study (Q2 = 0.717). (B) The metabolites that contribute to separation. 
A PCA scores plot was constructed to show the effects of the third and fourth doses 
of MP on the liver metabolic profiles (figure 4.14). From this plot it can be observed 
that both the third and fourth dose induced a similar effect on the metabolic profiles 
with the fourth dose exaggerating the effect seen after the third. This effect was a 
further increase in the concentration of glutamine, an increase in lysine, and to a 
lesser extent isoleucine, leucine and valine following the successive doses. The 
concentration of betaine decreased from the level seen at 26 hours, and lactate was 
observed to decrease back to the concentration seen eight hours post dosing. 
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Figure 4.14: Metabonomic analysis comparing the hepatic metabolic profiles of dosed 
animals at 26,50 and 74 hours. (A) PCA scores plot (PCI versus PC2) for the hepatic 
metabolic profiles taken 26 hours (blue open triangles), 50 hours (purple open triangles), and 
74 hours (red open triangles) (Q2 = 0.633). (B) Metabolite differences in profiles from 50 and 
74 hours compared to those at 26 hours. 
Overall there appears a time-dependent increase in Blutamine and decrease in 
glucose and glycogen. Phosphocholine concentration peaked at eight hours then 
slowly decreased but remained higher than in controls throughout. Betaine 
concentrations peaked at 26 hours and lysine concentrations increased by the fourth 
dose of methapyrilene. The fold change difference of the main discriminatory 
metabolites in the dosed animals relative to the control animals is given with 
statistical significance in table 4.3. 
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Table 4.3: Fold change difference of the major discriminatory metabolites in dosed animals 
with respect to control animals over the study. Significant difference from the controls by 
Student's t test, p=*<0.05, ** < 0.01, *** < 0.001. 
Metabolite 2 hours 8 hours 26 hours 50 hours 74 hours 
Glutamine 1.5** 1.5** 1.6*** 1.5* 1.6* 
Betaine 1.1 1.5* 1.5** -1.4 -2.4'"' 
Phosphocholine 1.2 3.0*** 1.7** 1.2 1.1 
Lactate -1.7*** -1.5* -1.3 -1.8*** -2.0** 
Glycogen -2.8*** -3.0** -5.2*** -13.7*** -25.0'`** 
Glucose -1.2** -1.3 -1.6*** -2.3*** -3.7*** 
4.5 Discussion 
The aim of this chapter was to investigate the impact of MP dosing on the CPS 
enzyme and to determine whether alterations to this protein have a causative role in 
the observed cell necrosis. Liver damage was shown by histopathology to occur four 
hours post dosing, and by plasma ALT activity to occur eight hours after the first dose 
with subsequent doses increasing this damage. 
It has previously been shown that MP induced a negative charge modification to CPS 
1179,195 In the current study there was an increase in the size of CPS I, this was seen 
two hours after the first dose indicating that this change was consistent with the 
relatively quick covalent modification of the protein and precedes the observed liver 
damage. The amount of modified CPS I enzyme increased over the course of the 
study. 
As the frequency of modified CPS I enzyme increased, the activity of CPS I 
decreased, suggesting that the covalent modification of CPS I may reduce the 
activity of the enzyme. The high abundance of CPS I in the mitochondrial matrix may 
explain why, even though size alterations were noted two hours after the first dose, it 
was not until four hours after that the activity was notably decreased. This could 
explain why multiple doses of MP are required to elicit hepatotoxicity. Given the lack 
of gene expression changes regarding CPS I in the previous study, this illustrates the 
value of applying a multi-omic approach, where events undetected by one technique 
may be exposed by another. 
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Raised plasma levels of CPS I have been proposed as a good biomarker of liver 
damage in sepsis196 and hepatitis' 97. In these studies, CPS I was observed to leak 
into the circulation following damage to the liver in the same manner as ALT. In this 
study however, the Western blot does not indicate any major decrease in CPS I 
abundance throughout the study, and when investigating CPS I activity the samples 
all contained the same total protein content, and therefore CPS I leakage would not 
explain the decreased activity in this study. For confidence that CPS I abundance 
remained stable within the mitochondria throughout the study, mitochondrial extracts 
could be investigated via Western blotting. 
Inhibition of CPS I activity is likely to perturb the urea cycle, as suggested in the gene 
transcription data presented in figure 4.2 and in the proteomic work summarised in 
table 4.1. Urea cycle disruption may be further implied by the accumulation of 
hepatic glutamine in the metabonomic data. Glutamine is considered a carrier of 
ammonia and raised plasma glutamine is characteristic of CPS I inhibition'so 
Glutamine is transported into the mitochondria and then catabolised by glutaminase 
to ammonia and glutamate, the ammonia formed then enters the urea cycle via CPS 
1. These urea cycle enzymes and glutaminase are predominantly expressed in the 
periportal hepatocytes. Ammonia that escapes the urea cycle is taken up by the 
perivenous hepatocytes where glutamine synthetase converts the ammonia to 
glutamine (figure 4.15). By this arrangement net glutamine catabolism is observed in 
the periportal region and net glutamine synthesis occurs in the perivenous region. It 
is estimated that approximately two thirds of ammonia is removed via the urea cycle 
whilst the remaining ammonia is converted to glutamine 183,198 The periportal specific 
toxicity of methapyrilene may explain the accumulation of glutamine due to damage 
to the periportal hepatocytes, leading to impaired glutamine catabolism. Conversely, 
the periportal specific toxicity could be caused by the localisation of glutaminase and 
urea cycle enzymes, including CPS I, to this region. Inhibition of the urea cycle has 
the potential to cause elevated ammonia in the periportal hepatocytes and a shift in 
this `intercellular glutamine cycle' towards the synthesis of glutamine. Increased 
glutamine two hours post dosing, the same time protein modifications were initially 
witnessed and prior to the occurrence of liver damage provides evidence for the latter 
hypothesis. 
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Figure 4.15: Intercellular glutamine cycle. 
Periportal Hepatocyte 
Studies have shown that in vitro, glutamine can have direct toxic effects. Glutamine 
exposure to isolated rat cerebral mitochondria induced mitochondrial swelling and 
activation of the mitochondrial permeability transition (MPT) leading to mitochondrial 
dysfunction199. Unfortunately there was insufficient sample to measure ammonia 
directly in this study, however, raised glutamine and inhibited CPS I suggest an 
increase may have occurred. Hyperammonemia can be excluded as there was no 
observed neurotoxicity, but a subtle increase in the hepatocytes may have arisen 
from glutamine catabolism and urea cycle inhibition, this can be sufficient to lower the 
pH of the mitochondrial matrix and disrupt the function of the organelle. Lack of 
evidence limits definitive conclusions19' 
Previous work identified MP to cause an early loss in mitochondrial function and 
implicated mitochondrial dysfunction as a mechanism in cell necrosis 200. The 
majority of the hepatocyte's ATP requirements are provided by the mitochondria 
through oxidative phosphorylation. Mitochondrial dysfunction reduces the ATP 
synthesis capacity of the organelle, and without adequate ATP the cell is unable to 
function correctly 201. In the event of cell injury the hepatocyte preferentially 
undergoes controlled apoptosis; however a lack of cellular energy forces cell death to 
occur by cell necrosis instead. The decreased glucose and glycogen indicated an 
early shift in energy metabolism consistent with mitochondrial dysfunction, this 
complies with literature that found a loss in mitochondrial function within two hours of 
dosing 180, like the CPS I changes these appear prior to the observed hepatotoxicity. 
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The steady decrease in glucose and glycogen reflects an up-regulation of hepatic 
glycolysis and glycogenolysis. These two pathways occur in the cytosol, with 
glycogenolysis converting glycogen to glucose and glycolysis converting glucose to 
pyruvate. Mitochondrial oxidative phosphorylation impairment would result in a loss 
of cellular energy and increased glycolysis reflects the cells attempts to compensate 
for this loss. Interestingly ammonia has been reported to activate 
phosphofructokinase, a key enzyme in glycolysis191. 
Up to eight hours into the study the concentration of phosphocholine was witnessed 
to peak and then gradually decrease. Phosphocholine is a product of phospholipid 
degradation, a process which may occur if the ß-oxidation activity of the peroxisomes 
was increased to counteract loss in cellular energy. A similar metabolite pattern was 
observed in paracetamol toxicity, with increased phosphocholine, decreased glucose 
and glycogen, and a depletion of phospholipid species, these changes are 
considered a consequence of disrupted energy metabolism202. The observed 
decrease in the glucogenic amino acids, isoleucine and valine, at 26 hours, and the 
later decrease in lactate may reflect a shift in energy metabolism from glycolysis to 
gluconeogenesis. This shift may relate to glucose and glycogen stores being 
exhausted in the latter stages of the study. 
Elevated lysine witnessed at 74 hours may also relate to mitochondrial impairment, 
where the enzymes responsible for the initial catabolism of lysine are housed in the 
mitochondrial matrix. Adequate movement of lysine into the matrix is required for 
oxidation and in the event of mitochondrial injury such movement may be 
203 restricted 
These global findings are consistent with mitochondrial dysfunction, and the early 
onset appears to compliment the early modification of CPS I, reduced activity, and 
increased glutamine. Inhibition of CPS I may induce mitochondrial impairment 
through the increase in glutamine and potentially ammonia. A `Trojan horse' 
hypothesis has been suggested as the mechanism by which glutamine exerts toxicity 
in astrocytes. This theory proposes that glutamine enters the mitochondria and is 
catabolised in the relatively small inner mitochondrial membrane by glutaminase to 
ammonia. Excessive generation of ammonia in this small compartment can induce 
MPT199, resulting in a loss of the transmembrane potential required for the electron 
transport chain and this leads to mitochondrial dysfunction. Ratra et al. have 
demonstrated that MPT may have a role in MP toxicity after it was shown that toxicity 
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was abated when mitochondrial transition permeability pore opening was inhibited, 
and intracellular Ca2+ movement was restricted 180 
There was an observed peak in betaine 26 hours into the study. Betaine is an 
oxidative metabolite of choline and this peak may relate to the metabolism of 
phosphocholine, observed to peak at eight hours204. Alternatively, betaine does 
possess cytoprotective properties and an increase may reflect a protective response 
by stressed cells. Betaine is an organic osmolyte and in the event of osmotic stress 
intracellular accumulation of osmolytes equilibrates the osmotic pressure of the cell. 
Betaine can also protect proteins from denaturation in adverse conditions by 
functioning as a chemical chaperone, increasing the thermodynamic stability of 
folded proteins205 
The enzyme CPS I undergoes a rapid size alteration following MP dosing and this 
reduced the functional ability of the enzyme. In addition hepatic glutamine was 
observed to increase and may be related to the reduction of CPS I activity. Taken 
collectively with previous transcriptomic and proteomic findings it is possible that MP 
administration may disturb the urea cycle. There is strong evidence, as previously 
reported, that mitochondrial dysfunction has occurred and that cellular energy 
metabolism was perturbed. Both mitochondrial dysfunction and CPS I inhibition 
appear at approximately the same time as the observed hepatotoxicity (based upon 
histopathology) suggesting that these may be the cause rather than consequences of 
the toxicity. Mitochondrial dysfunction is proposed as a mechanism of MP 
hepatotoxicity and the inhibition of CPS I and subsequent increase in glutamine may 
be connected to the impairment of this organelle. 
Future work needs to ascertain whether reduced CPS I activity does significantly 
inhibit the urea cycle, this could involve a metabonomic study on the plasma samples 
of MP dosed animals, focusing on urea cycle intermediates (citrulline, 
argininosuccinate, Na-acetyl-citrulline). Plasma and hepatic ammonia concentrations 
need to be measured to observe if CPS I inhibition does lead to increased ammonia. 
The effect of subtle increases in hepatic ammonia and glutamine on mitochondrial 
function could also be studied and the effects of MP toxicity if excess glutamine and 
ammonia were removed could be explored. 
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4.6 Conclusions 
" Western blotting data suggested a modification may have occurred to the 
CPS I protein following methapyrilene dosing. This alteration was first 
observed two hours after the first dose. 
" The functionality of CPS I was notably reduced four hours after dosing. 
" 1H NMR spectroscopy identified hepatic glutamine concentrations to increase 
two hours post dosing and may be a consequence of CPS I inhibition 
" 1H NMR spectroscopy indicated mitochondrial impairment occurred two hours 
post dosing; a factor previously implicated in the mechanism of MP toxicity 
" Covalent bindin 
"g of a methapyrilene related metabolite may have caused a change in CPS I 
protein resulting in a reduction in the activity of the enzyme, this could 
potentially lead to the accumulation of glutamine which may be induce to 
mitochondrial dysfunction. 
" This investigation demonstrated the use of applying a systems biology 
approach to a toxicological study. A hypothesis was first generated via multi- 
omic techniques, and this was then explored using a combination of 
biochemical assays and metabonomics. 
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Chapter Five: Role of the gut microflora on the metabolism 
and toxicity of hydrazine 
5.1 Aims and objectives 
The influence of the microbiome on the metabolism and toxicity of hydrazine was 
investigated. To examine this influence the response of germ-free and `conventional' 
rats to hydrazine administration was compared. Due to experimental limitations it was 
not possible to maintain the germ-free rats under sterile conditions and so this was 
carried out in acclimatising germ-free rats. Aminotransferase enzymes and their 
essential co-factor, pyridoxal 5-phosphate were also investigated in these animals. 
These factors have been implicated in the mechanism of hydrazine toxicity and early 
findings identified basal differences in aminotransferase gene expression and activity 
between the two animal strains. The objectives were: 
" To characterise the acclimatising germ-free rat model using both 
transcriptomic and metabonomic approaches. 
" To investigate and compare the response of conventional and germ-free rats 
to hydrazine (60 mg/kg) using transcriptomic and metabonomic approaches. 
" To investigate aminotransferase function and pyridoxal 5-phosphate 
concentration in germ-free and conventional rats, and explore the potential for 
such differences to modulate the toxicity of hydrazine. 
5.2 Introduction 
Microfloral metabolism is a major component of mammalian biocomplexity. The 
microbiome plays a significant role in the metabolism of many endogenous, dietary 
and xenobiotic molecules, and it is proposed to be responsible for some idiosyncratic 
drug responses. As previously shown in chapter three, in addition to findings from 
others135' 206 , the microbiota are capable of modulating 
host gene and enzyme 
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regulation of several drug metabolising enzymes and transporters in the GI tract. 
With inter-individual variation in metabolism impacting upon drug efficacy and 
toxicity, the requirement for sufficient understanding into the microfloral contribution 
to host metabolism is evident74 
Due to experimental constraints the germ-free animals were unable to be maintained 
under sterile conditions; consequently the germ-free animals were subject to 
bacterial colonisation throughout the study. Therefore, prior to studying the response 
of these animals to hydrazine, the effect of bacterial colonisation on the germ-free 
model was first investigated. Hydrazine was administered to both conventional and 
germ-free rats at a dose level known to induce mild toxicity in the conventional rat. 
Whilst the hydrazine dose did induce mild toxicity in the conventional animals, the 
toxic response was markedly more severe in two out of three of the germ-free dosed 
animals with neurotoxicity suspected. These findings further suggest that microfloral 
variations between individuals may be responsible for some idiosyncratic drug 
responses. 
5.2.1 Implication of the microbiome in idiosyncratic drug reactions 
Idiosyncratic toxicity is defined as `an adverse reaction that cannot be predicted 
based on dose, duration of exposure or mechanism of action'207. Such reactions only 
occur in a small fraction of the population (<5%) and as such are often undetected 
until the drug reaches phase II clinical trials, or in some cases, even when the drug is 
on the market208 
significant risk to 
In this instance idiosyncratic drug reactions (IDRs) pose a 
public health and undermine public confidence in the 
pharmaceutical industry. Additionally, the economic cost of IDRs and the removal of 
a drug from the market pose another significant threat to the pharmaceutical industry. 
Several hypotheses have been presented to account for the occurrence of IDRs. It is 
recognised that in most cases there may not be a single mechanism responsible but 
more likely an overlap of two or more. One hypothesis is genetic polymorphism, 
whereby subtle differences in key genes involved in xenobiotic metabolism produce 
different metabolic outcomes. These differences could include toxic intermediates or 
differential drug exposure209. In a similar context, subtle differences in microfloral 
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composition could alter biotransformation outcomes and may lead to the generation 
of reactive intermediates or altered bioavailability thus having a direct role in IDRs. 
Components of the microbiota can also have an indirect role in IDRs by increasing 
the susceptibility of the biological system to the effects of a compound. It was 
proposed by Zimmerman that host vulnerability might play a role in some 
idiosyncratic toxicities210. This concept has since been furthered through the work of 
Roth et al. whereby an episode of modest inflammation during drug treatment can 
predispose an animal to tissue injury 208' 211 Products of indigenous microorganisms 
have been demonstrated to precipitate an inflammatory episode, these 
environmental inflammagens, endotoxin or the Iipopolysaccharide (LPS) component, 
are released from Gram negative bacteria and translocate across the intestinal 
mucosa into the circulation. This translocation can be influenced by a variety of 
factors including disturbance of the GI tract, diet, and alcohol consumption, and can 
evoke a mild inflammatory response 212. According to this theory periods of mild 
inflammation can sensitise the liver to the toxic effects of drugs lowering the 
threshold of toxicity, or conversely drug exposure can sensitise the liver to the 
inflammatory response. Under these conditions a commonly non-toxic drug dose can 
result in an adverse reaction209. This concept is illustrated by figure 5.1208. 
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Figure 5.1: Exposure to LPS as a determinant of drug idiosyncrasy 208. (A) Various factors enhancing 
the LPS translocation from the intestine into the portal circulation. (B) Hypothetical threshold for toxicity, 
inversely proportional to plasma LPS concentration. 
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Sufficient understanding of microbiome-mammalian interactions in xenobiotic 
metabolism is necessary to account for this variable when modelling mammalian 
metabolism, investigating idiosyncratic drug toxicity and for future drug development. 
5.2.2 Hydrazine 
The toxic effects of hydrazine (previously discussed in chapter one) have been well 
characterised and include perturbation of lipid, protein, and carbohydrate 
metabolism. High doses of hydrazine are acutely toxic, causing liver damage with a 
dose-dependent accumulation of fat (steatosis)114,213 A number of metabonomic 
investigations on the biochemical effect in normal rats have been reported and the 
115,214,215 biomarker biochemistry is relatively well understood"', 
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Figure 5.2: Metabolism of hydrazine. Adapted from Delaney and Timbrell 216 
The metabolism of hydrazine has been extensively studied and several metabolites 
have been found (figure 5.2). In the urine, unchanged hydrazine 217 , acetyl- and 
diacetyl-hydrazine, pyruvate-hydrazone and 2-oxoglutarate hydrazone have been 
identified. Additionally the excretion of 1,4,5,6-tetrahydro-6-oxo-3-pyridazine 
carboxylic acid (THOPC), a cyclic condensation product of the reaction of hydrazine 
with 2-oxoglutarate has also been observed215. Approximately 25% of hydrazine is 
known to be degraded to nitrogen detected in expired air and has also been shown to 
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be incorporated into ammonia and urea. The metabolic fate of approximately 25% of 
the dose remains unknown 216 
High doses of hydrazine have been shown to have neurotoxic effects, leading to 
disturbances in the central nervous system and the induction of seizures shortly after 
dosing. To assess the neurotoxic consequences of hydrazine dosing the metabolic 
profiles of sections taken from the brain were also investigated in this study. 
Elevation in the cerebral concentrations of the excitatory amino acid, y-aminobutyric 
acid (GABA) and the amino acid 2-aminoadipate (2-AA) have been associated with 
this neurotoxicity. 2-AA is a glial toxin known to elicit limbic seizures and convulsions 
in animal models. These amino acids are considered to increase due to the inhibition 
of their respective aminotransferases. Aminotransferases are involved in the 
transamination of amino acids into their respective oxoacid, transferring the amino 
group to another oxoacid. Hydrazine is suggested to inhibit these enzymes through 
the sequestration of their essential co-factor, pyridoxal 5-phosphate (PLP). Hydrazine 
can react directly with PLP to form a Schiff base (pyridoxal phosphate-hydrazone) 
preventing the formation an enzyme-PLP Schiff base required for transaminations218' 
219 or as found by Lightcap and Silverman, hydrazine can cause slow-binding 
inhibition of the enzyme through the formation of an enzyme-inhibitor complex220. 
Initial investigations characterising the acclimatising germ-free animals found 
transcripts for two aminotransferases (alanine aminotransferase and serine 
dehydratase) to be significantly lower in the germ-free animals compared to the 
conventional animals. As a potential cause for lower aminotransferase expression, 
PLP concentrations were investigated in all study animals. PLP is the biologically 
active form of vitamin B6, and whilst the majority is obtained from the diet it can also 
be synthesised by the micro-organisms of the large gut. Gut microfloral enzymes are 
involved in the methylerythritol 4-phosphate pathway, which synthesises 
deoxyxylulose 5-phosphate, the precursor in the biosynthesis of PLP4.221. It was 
hypothesised that lower basal aminotransferase expression/activity in the 
acclimatising germ-free animals would render these animals more susceptible 
to 
aminotransferase inhibition following hydrazine administration and therefore more 
susceptible to hydrazine toxicity. 
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5.3 Materials and Methods 
5.3.1 Study Design 
Animal work was carried out by the In-life phase section at AstraZeneca, Alderley 
Park. Male Sprague-Dawley conventional rats (n = 6) and germ-free (OFA) Sprague- 
Dawley rats (n = 6) were purchased from Charles River and housed in individual 
metabolism cages. Three rats from each strain were assigned as controls and 
treated with a single oral dose, by gavage, of physiological saline. The remaining 
animals were administered a 60 mg/kg oral gavage of hydrazine hydrochloride 
dissolved in physiological saline (table 5.1). 
Animals were maintained in metabolism cages, in a standard laboratory environment. 
It was not experimentally possible to restrict bacterial colonisation in the germ-free 
animals throughout the study. Cages were maintained at room temperature and 
subjected to 12 hour light/12 hour dark cycle. Food (Rat and Mouse No. 1 Modified 
Irradiated Diet, Special Diet Services) and water were provided ad libitum throughout 
the study. 
Table 5.1 Overview of the hydrazine study. 
Rat number Animal type Sacrifice time (hours) Dose level (mg kg) 
1 Conventional 96 0 
2 Conventional 96 0 
3 Conventional 96 0 
4 Conventional 96 60 
5 Conventional 96 60 
6 Conventional 96 60 
7 Germ-Free 96 0 
8 Germ-Free 96 0 
9 Germ-Free 96 0 
10 Germ-Free 96 60 
11* Germ-Free 24 60 
12* Germ-Free 24 60 
* Animals 11 and 12 were prematurely sacrmcea for numane reasons as iney naa become monDuna. 
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5.3.2 Sample Collection 
Urine samples were collected pre dose, and for the periods 0-8,8-24,24-48,48-72, 
and 72-96 hours after dosing. Whole blood was taken 8 and 24 hours post dosing 
into heparinized sample tubes. Plasma was prepared by centrifugation of whole 
blood (1500 g for 10 minutes). Animals were sacrificed 96 hours post dose by 
halothane inhalation except animals 11 and 12 who were sacrificed 24 hours post 
dose. All biofluid samples were frozen on dry ice and stored at -80°C. Immediately 
after sacrifice the brain was removed followed by the liver. All tissue samples were 
snap frozen in liquid nitrogen and then stored at -80°C until required. 
5.3.3 Sample preparation for histopathological assessment 
At necropsy, liver and kidneys were excised quickly and immersed into 10% neutral 
buffered formalin and fixed for 24-48 hours followed by conventional histological 
tissue processing and the generation of tissue sections stained with haematoxylin 
and eosin. These sections were examined using light microscopy. 
5.3.4 Transcriptomics 
5.3.4.1 Affymetrix gene expression profiling 
Transcriptomic analysis was performed on RNA isolated from frozen liver samples 
from all animals. The `Rat Genome 230 2.0' gene chip (Affymetrix) was used to 
generate the data following the same protocol used in chapter three (section 3.3.3). 
The microarray data were normalised using robust regression. Control germ-free 
transcripts were analysed in comparison to the control conventional transcripts. The 
dosed animals were compared to their respective controls. The mean intensity value 
was calculated for each transcript across the individual animal groups, with only 
values of equal or greater than 50 being considered significant. If a transcript was 
regulated equal or more than two fold (up or down) and a two-tailed t-test assuming 
unequal variance returned ap value of less than or equal to 0.05 then the gene was 
considered differentially regulated. For up-regulated transcripts there had to 
be a 
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`present' call by the Affymetrix `absolute call' metric in all samples of the dosed 
groups, and in down-regulated transcripts there had to be a `present' call in all 
samples of the control groups. In the germ-free control versus conventional control 
comparison, up-regulated transcripts had to have `present' calls in all transcripts of 
the germ-free control group and in the down-regulated transcripts `present' calls had 
to be in all transcripts of the conventional control group. The probe sets were 
matched to the corresponding gene using the NetAffx database (Affymetrix) and 
were assigned where possible to particular metabolic and functional pathways using 
associated Gene Ontology information. 
5.3.4.2 Q-PCR protocol 
Genes to be analysed by Q-PCR were selected based upon microarray 
measurements, these were alanine aminotransferase (ALT) 1 (Applied Biosystems 
Assay ID Rn00578989_gl) and lipocalin 2 (Applied Biosystems Assay ID 
Rn00590612_m 1). The same protocol followed in chapter three (section 3.3.3.3) was 
applied, using Taq-man probes purchased from Applied Biosystems. The relative 
level of expression of ALT and lipocalin 2 mRNA is related to the amount of 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA which serves as a 
normalising gene. 
5.3.5 Metabonomics 
5.3.5.1 One-dimensional 1H NMR spectroscopy of biofluids 
Urine and plasma samples were prepared and analysed following the same protocol 
used in chapter three. All samples were analysed on a Bruker DRX-600 NMR 
Spectrometer at 300 K operating at 600.13 MHz for 1H observation. 
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5.3.5.2 Magic Angle Spinning (MAS) NMR spectroscopy of intact 
liver tissue 
Liver tissue was analysed using magic angle spinning (MAS) NMR spectroscopy. 
Here, a small piece of liver tissue (approximately 15 mg) was whetted with D20 and 
packed into a4 mm outer diameter zirconium oxide rotor and loaded into the a 
Bruker DRX600 spectrometer with an MAS probe at room temperature. Samples 
were spun at 6 KHz. For one-dimensional NMR spectra, 128 transients were 
collected into 64 K data points for each spectrum. A spectral width of 20 ppm was 
employed and an acquisition time of 1.36 s per scan. Three different 1H NMR spectra 
were acquired for each tissue sample. A standard one-dimensional water 
presaturation pulse sequence, noesypr1 d, was employed to suppress the water 
peak. The second was a Carr-Purcell-Meiboom-Gill (CPMG) 1H NMR spin echo 
spectrum for observing changes in the low molecular weight metabolite profile by 
suppression of the contribution of the larger metabolites such as lipids and proteins. 
The third spectrum was a water-suppressed diffusion-edited 1H NMR spectrum. 
5.3.5.3 One-dimensional 1H NMR spectroscopy of aqueous brain 
extracts 
Brains were removed and bilaterally divided. From one half of the brain, targeted 
brain regions (brain stem, cerebellum, cortex and hippocampus) were dissected from 
the surrounding tissue using a scalpel. An aqueous extract was then taken of the 
excised tissue using the method employed for the aqueous extraction of liver tissue 
in chapter three using acetonitrile: water. For 'H NMR analysis, samples were 
reconstituted in D20 containing 1mM TSP, and the noesypr1 d pulse sequence was 
employed to acquire the spectrum. In this pulse sequence 8 dummy scans were 
followed by 64 scans collected into 64 K data points, with a spectral width of 20 ppm. 
5.3.5.4 Solid phase extraction of aqueous extracts taken from liver 
tissue 
Aqueous extracts were obtained from liver tissue using the method outlined in 
section 3.3.4.3. Solid phase extraction was performed on these aqueous extracts to 
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enable spectral simplification and to permit inspection of the bile acids. Here, Varian 
Bond Elut C18 columns were used containing particles 3-60 pm in diameter. 
Columns were first conditioned by pre-treating the stationary phase with three passes 
of 100% methanol, followed by one pass of 20% methanol and finally acidified water 
(pH 2). The sample (2 ml) was applied to the conditioned column and left for one 
minute before the column was washed with 2 ml of acidified water. Metabolites were 
then eluted step-wise from the column based upon their polarity. The first fraction 
was 5% methanol (2 ml) with subsequent fractions of 10%, 20%, 40%, 60%, 80%, 
and 100%. More polar metabolites eluted in the early fractions with bile acids eluting 
in the 60% fraction. Methanol was evaporated off the eluate and the water was 
removed by lyophilisation. For 1H NMR analysis, samples were reconstituted in 500 
pl deuterated methanol containing 1mM TSP, and the noesypr1 d pulse sequence 
was employed to acquire the spectrum using 8 dummy scans followed by 64 scans 
collected into 64 K data points, with a spectral width of 20 ppm. 
5.3.5.5 Data reduction and analysis 
Data was analysed in the same manner as in chapter three. Spectra were phased 
and baseline corrected using in-house software and digitised into consecutive 
integrated spectral regions of equal width (0.04 ppm). Each spectrum was then 
normalised to unit area and SIMCA-P10.5 software was utilised to perform PCA. 
Here PCA was used for the sole purpose of visualisation of metabolic patterns within 
the data. 
5.3.6 Alanine aminotransferase (ALT) activity 
Liver samples (200 mg) were placed into 2 ml of homogenisation buffer containing 50 
mM Tris base and 150 mM KCI (pH 7.4) and homogenised. Homogenates were 
centrifuged at 250 g for 15 minutes and the supernatant was taken. The protein 
content of the sample homogenates was assayed using a Pierce BCATM protein 
assay kit. All samples were adjusted to give a protein concentration of 1 mg/ml. 
The assay was carried out in the Clinical Chemistry laboratory at 
AstraZeneca, 
Alderley Park. This assay was performed following the laboratory's standard 
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operating procedure using the Roche ALT (ALAT/GPT) with/without pyridoxal 
phosphate activation kit. Results are expressed as enzyme units per litre (U/L) 
5.3.7 PLP Assay 
PLP concentration was measured using a reverse phase HPLC method utilising pre- 
column derivatisation. This assay was carried out using the Chromsystems `Vitamin 
B6 in plasma/serum/whole blood' kit. 
PLP concentration was measured in the aqueous extracts taken from the liver and 
brain cortex (using the acetonitrile: water method previously described in section 
3.3.4.3). Where possible the samples were protected from light exposure. The 
Chromsystem standard (59 nmol/L) and quality controls I and II (34 and 94 nmol/L 
respectively) were reconstituted with distilled water according to the manufacturers 
instructions. 
Liver and brain extracts, and standards were hereafter prepared via the same 
protocol. In a light protected vial, 200 µI of sample was combined with 300 µl of 
precipitation reagent to deproteinise the sample. After centrifuging at 16,000 xg for 
five minutes the supernatant was taken (250 µl) and neutralised by the addition of 
250 µl of neutralisation reagent. This was briefly mixed and 100 µl of derivatisation 
reagent was applied followed by incubation at 60°C for 20 minutes. After cooling, the 
preparation was incubated at 4°C for 10 minutes and centrifuged for two minutes at 
16,000 x g. The supernatant (50 µl) was transferred into a light protected 
autosampler vial, and 40 µl of sample was injected into the HPLC system. 
The HPLC system comprised a Perkin-Elmer Series 200 autosampler, Perkin-Elmer 
series 200 LC pump, a Jasco FP-920 fluorescence detector and NLG analytical 
degasser. The isocratic mobile phase was supplied with the Chromsystems kit and 
the reverse-phase column was purchased separately from Chromsystems and was 
received already equilibrated. The sample was pumped through at a flow rate of 1 
ml/min for 10 minutes. These parameters were optimised using the standard. 
PLP fluorescence was measured. The excitation (Ex) wavelength was 320 nm, and 
emission (Em) wavelength, 415 nm. PLP concentration (nmol/L) was calculated 
by 
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multiplying the peak area ratio of analyte (PLP) in sample and in the standard with 
the concentration of analyte in the standard (59 nmol/L). The quality control peak 
area ratios were also compared to the standard to validate the method. 
5.3.7.1 Method validation for PLP assay 
To ensure that only unbound PLP was detected via the HPLC method and that PLP 
was not cleaved from the PLP-hydrazone complex during the derivatisation step, the 
validity of the assay was investigated. Here, 10 pM of PLP and 100 pM of hydrazine 
HCI were combined (500 pl of each) and heated for 10 minutes at 37°C to form the 
PLP-hydrazone complex. The following samples were prepared using the sample 
preparation steps listed above and analysed via the HPLC technique, the peak areas 
are given in table 5.2. 
" Solution A- 10 NM PLP solution. 
" Solution B- 100 pM hydrazine HCI solution. 
" Solution C- 10 pM PLP solution heated at 37°C for 10 minutes. 
9 Solution D- PLP-hydrazone (PLP (10 pM) + hydrazine HCI (100 NM)) heated 
at 37°C for 10 minutes. 
Table 5.2: Method validation results for PLP-hydrazone investigation. 
Solution Peak area (mV) 
A. PLP (10 NM) 1615.6 
B. Hydrazine HCI (100 pM) -165.9 
C. PLP (10 NM) heated 1622.6 
D. PLP (10 NM) + hydrazine HCI (100 pM) heated 115.4 
These results indicate that heating PLP at 37°C for 10 minutes prior to sample 
preparation does not affect the rate of detection in this assay. This confirms that 
hydrazine HCI and PLP-hydrazone are not detected and that the derivatisation step 
does not cleave bound PLP from the PLP-hydrazone complex. Therefore confidence 
can be taken that the PLP measurement reflects only free PLP. 
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5.4 Results 
5.4.1 Observations 
The control (undosed) animals from both strains appeared behaviourally normal 
throughout the course of the study, as did the conventional animals dosed with 
hydrazine. This was in sharp contrast to the germ-free group dosed with hydrazine, 
where 24 hours post dosing two out of three members (animals 11 and 12) had to be 
prematurely sacrificed as they had become moribund. The third member of the group 
(animal 10) appeared unaffected. 
5.4.2 Liver and kidney histopathology 
Histopathology identified that one of the germ-free animals given hydrazine (animal 
11) showed mild multifocal cortical tubular necrosis whilst another (animal 12) 
showed severe focal cystic tubules. No other histopathological changes were 
observed in these, or the other animals in either the conventional or germ-free 
groups. 
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5.4.3 Transcriptomic results 
5.4.3.1 Transcriptomic comparison of the livers from germ-free and 
conventional control rats 
There were 280 transcripts expressed at higher levels in the germ-free animals than 
in the conventional animals and 55 transcripts that manifested lower expression. The 
major transcripts and their respective functions and pathways are summarised in 
figure 5.3. 
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Figure 5.3: Summary of the number of major hepatic gene transcript alterations in the germ-free (GF) 
animals compared to the conventional (CV) animals (n = 3). Blue indicates the number of transcripts 
higher expressed in the GF rats compared to the CV rats and purple indicates the number of transcripts 
expressed lower in the GF compared to the CV. 
Signalling appeared to be the function with the greatest difference in transcripts 
between the two animal strains. This group of genes covered a range of signalling 
pathways and reflected small differences in a number of signalling pathways with no 
single pathway emerging as substantially different. As such this will not be discussed 
further. 
Gene transcripts related to immune function were differentially expressed between 
the conventional and the acclimatising germ-free rats. There were in total 37 
transcripts higher and 13 lower in the germ-free animals, of these 10 were involved in 
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antigen presentation (five up, five down) and three were related to inflammatory 
response. Interestingly the transcript for lipocalin 2, an iron-sequestering protein in 
the antibacterial innate immune response was 298 fold greater in germ-free control 
animals compared to the conventional control animals. A gene transcript coding an 
LPS-binding protein was also observed to be five fold higher in the germ-free 
animals. 
The germ-free group had 12 transcripts involved in lipid metabolism higher than the 
conventional group and 26 transcripts expressed lower. The major transcripts are 
listed with their function in table 5.3. Several genes were involved in the arachidonic 
acid pathway, and steroid and bile acid biosynthesis. 
Table 5.3: Major hepatic transcripts involved in lipid metabolism that differed in expression in 
acclimatising germ-free animals compared to the conventional animals. 
Gene name Fold change Function 
Annexin 1 2.1 Arachidonic acid metabolism 
Stearoyl-coenzyme A- desaturase 2 2.9 Arachidonic acid metabolism 
Arachidonate 12-lipoxygenase 8.7 Arachidonic acid metabolism 
Prostaglandin D2 synthase 2 2.1 Arachidonic acid metabolism 
CYP 4A12 -8.6 Arachidonic acid metabolism 
Epoxide hydrolase 2 -11.1 Arachidonic acid metabolism 
Squalene epoxidase 2.1 Cholesterol biosynthesis 
Lanosterol synthase 2.2 Cholesterol biosynthesis 
Sterol-C4-methyl-oxidase 2.6 Bile acid biosynthesis 
Aldo keto reductase 1 C6 -6.1 Bile acid biosynthesis 
CYP 17A1 4.4 Steroid hormone metabolism 
ABC A8B 4.0 Lipid transport 
ABC G5 -3.3 Lipid transport 
Low density lipoprotein receptor-related 2.0 Lipoprotein transport 
protein 11 
Apolipoprotein A-IV -2.3 Lipoprotein transport 
SREBP 1 -2.3 Transcription regulation 
SREBP 2 2.0 Transcription regulation 
There were four transcripts involved in amino acid metabolism expressed in higher 
levels in germ-free animals and three at lower levels than the conventional animals. 
These included lower transcripts for aminotransferases, alanine aminotransferase 
(ALT) 1 and serine dehydratase, with phosphoserine aminotransferase higher. 
Transcripts for glutathione peroxidise 7 and glutathione S-transferase Yc2 subunit 
were expressed at lower levels in the germ-free liver compared to the conventional 
liver, in addition to lower expression of CYP2D13 (-2.38 fold) and CYP2D22 
(-4.17 
fold). 
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5.4.3.2 Transcriptomic comparison of the livers from control and 
dosed conventional animals 
In the conventional rats administered a single 60 mg/kg oral dose of hydrazine, 13 
transcripts were induced and 45 were reduced at least two fold in the liver at 96 
hours from the control rats. Of these, major transcripts were assigned to functional 
classes and the data are summarised in table 5.4. Regulation of mRNA levels 
involved in lipid, drug, and amino acid metabolism and also oxygen transport were 
disrupted by the hydrazine dose. 
Table 5.4: Major hepatic gene transcript alterations induced by hydrazine dosing in 
conventional rats. 
Gene name Fold change Function 
20 a-hydroxysteroid dehydrogenase 2.1 Lipid metabolism 
Carboxylesterase 2 2.6 Lipid metabolism 
Nuclear receptor 0B2 4.5 Lipid metabolism 
Apolipoprotein A-IV -2.1 Lipid metabolism 
CYP4A10 -2.8 Lipid metabolism 
Isopentenyl-diphosphate b isomerase -2.2 Lipid metabolism 
Alcohol dehydrogenase 1 -2.2 Lipid metabolism 
CYP2T1 -2.2 Lipid/Drug metabolism 
N-acetyltransferase 8 -3.0 Drug metabolism 
Aminolevulinic acid synthase -5.5 Amino acid metabolism 
Glucose 6-phosphatase -2.5 Glycogenolysis/gluconeogenesis 
Hemoglobin ß-chain complex -7.9 Oxygen transport 
Hemoglobin a-2 chain -5.4 Oxygen transport 
Hemoglobin a-1 chain -4.9 Oxygen transport 
Hemoglobin ß-2 subunit -14.9 Oxygen transport 
Globin, a -9.5 Oxygen transport 
5.4.3.3 Transcriptomic comparison of the livers from control and 
dosed germ-free animals 
Caution must be taken when analysing the transcriptomic data, as this represents a 
snapshot of the liver transcripts at the time of sampling, 24 hours for those animals 
removed from the study prematurely (animals 11 and 12) and 96 hours 
for animal 10 
and the other study animals. Whilst the transcription differences at 
24 hours may be 
of interest and may relate to a response to hydrazine 
dosing, comparisons to the 
other animal groups must not be over-interpreted, as 
it is not possible to determine 
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the regulation of the transcripts in the other animals 24 hours into the study. PCA 
analysis was performed on the transcriptomic data from the germ-free animals 
(figure 5.4); it is evident that animals 11 and 12 had clearly different transcript 
profiles from the control group and also from animal 10. As such a decision was 
made to combine these two animals without the remaining group member (animal 
10). In this manner information may be gleaned to provide an explanation for the 
enhanced response to hydrazine in these animals. 
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Figure 5.4: PCA scores plot of gene transcripts from germ-free control (black open triangles) and dosed 
(red open triangles) rats (Q2 = 0.51). 
Previous statistical criteria could not be applied to an n of 2, in this case for each 
transcript, the standard deviation of the two intensity values was divided by their 
mean, and then a cut-off of less than or equal to 0.2 was applied. The same was 
applied to the control group (n = 3), this ensured the variation between the group 
transcript intensity values was kept low. A greater than or equal to two fold change 
(up or down) comparative to the control germ-free group was required for a transcript 
to be considered differentially regulated. 
There were 658 transcripts induced and 175 reduced in the germ-free hydrazine 
treated group at 24 hours compared to the germ-free control animals at 96 hours. 
These were predominantly linked to lipid metabolism and transport, immune 
response, apoptosis, energy metabolism, and stress. A selection of transcripts is 
listed in table 5.5. 
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Table 5.5: A selection of hepatic transcripts that are up or down regulated in the germ-free 
animals (animals 11 and 12) 24 hours after hydrazine dosing compared to the control germ- 
free animals. 
Gene name Fold change Function 
Glutamic pyruvic transaminase 1 (2) 6.2 (2.7) Aminotransferase 
Tyrosine aminotransferase 2.8 Am i notransfe rase 
Succinate semialdehyde dehydrogenase -2.7 GABA metabolism 
Solute carrier family 6 member 13 -4.8 GABA transport 
Aminoadipate-semialdehyde synthase 2.1 Lysine catabolism 
Glutathione synthetase 2.1 Glutathione 
Glutathione S-transferase a-type 2 -4.0 Glutathione 
Carbonyl reductase 2.3 Arachidonic acid metabolism 
Prostaglandin E synthetase 2 2.9 Prostaglandin 
Phosphatidylcholine: ceramide 2.1 Inflammatory response 
cholinephosphotransferase 1 
Aconitase 2 3.3 TCA cycle 
Isocitrate dehydrogenase 3 (NAD+) ß 2.3 TCA cycle 
Dihydrolipoamide S-succinyltransferase 2.6 TCA cycle 
Amylo-1,6-glucosidase, 4-a-glucanotransferase -2.0 Carbohydrate metabolism 
Triosephosphate isomerase 2.1 Gluconeogenesis 
Xanthine dehydrogenase -2.3 Oxidative stress 
Hydroxyacid oxidase 1 -2.2 Oxidative stress 
stress-induced-phosphoprotein 1 2.1 Stress 
Lipocalin 2 -59.4 Response to bacteria 
Lysozyme -3.1 Response to bacteria 
Cathepsin C -3.8 Immune 
Chemokine (C-C motif) ligand 6 -2.4 Immune 
Transcripts related to lipid metabolism and transport were disturbed 24 hours after 
the hydrazine dose (four up and 12 down regulated transcripts) compared to the 
control animals and these are presented in table 5.6. 
Lipocalin 2 transcripts which were identified in the germ-free control group to be 
greatly up regulated were expressed to a lesser extent in these animals at 24 hours. 
It can also be observed that transcripts relating to immune function were also 
expressed lower at 24 hours than at 96 hours. Specifically, the transcripts for 
lysozyme, a protein that destroys bacterial cell walls and prevents bacteria becoming 
pathogenic, were lower at 24 hours. 
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Table 5.6: Hepatic transcripts associated with lipid metabolism and transport perturbed 24 
hours after hydrazine treatment in the germ-free animals (animals 11 and 12) compared to 
the control germ-free animals. 
Gene name Fold change Function 
Platelet-activating factor acetylhydrolase alpha 2 subunit 2.5 Lipid catabolism 
DDHD domain containing 1 -2.3 Lipid catabolism 
Glyceronephosphate 0-acyltransferase 3.3 Lipid metabolism 
mitochondrial acyl-CoA thioesterase 1 5.7 Lipid metabolism 
Acyl-CoA hydrolase 2.2 Lipid metabolism 
Annexin III -2.6 Lipid metabolism 
Copine III -2.9 Lipid metabolism 
20 a-hydroxysteroid dehydrogenase -8.1 Lipid metabolism 
Testis-specific farnesyl pyrophosphate synthetase -2.4 Cholesterol and steroid 
biosynthesis 
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 -5.7 Cholesterol biosynthesis 
Cytochrome P450 51 -6.1 Cholesterol and steroid 
biosynthesis 
Mevalonate kinase -2.5 Cholesterol biosynthesis 
Apolipoprotein AN -2.3 Lipid transport 
Fatty acid binding protein 1 -2.6 Lipid transport 
ABC Al -2.3 Phospholipid transport/ 
cholesterol transport 
Hydroxysteroid (17-beta) dehydrogenase 4 -2.0 Fatty acid metabolism 
Transcriptomic analysis comparing animal 10 to the germ free control group exposed 
just one transcript to be induced 96 hours after the hydrazine dose and 34 transcripts 
to be reduced. Criteria were greater than or equal to 2 fold up- or down-regulation, 
less than or equal to 0.2 standard deviation divided by the mean in the germ free 
control group and intensity values of greater than 50 in both the control group and 
animal 10. The transcripts of note are listed in table 5.7. 
Table 5.7: Hepatic transcripts differentially regulated in animal 10 at 96 hours post hydrazine 
dosing compared to the control germ-free animals. 
Gene name Fold change Function 
Transferrin 2.0 Iron ion delivery 
bacteriocidal properties 
Hydroxyl-6-5-steroid dehydrogenase, 
3ß and steroid S-isomerase 
Myo-inositol 1-phosphate synthase 
Al 
Lipopolysaccharide binding protein 
Lipocalin 2 
-5.5 Steroid biosynthesis 
-2.3 Phospholipid 
biosynthesis 
-2.2 Response to bacteria 
-5.4 Response to bacteria 
Interleukin 1a -3.1 
Inflammatory response 
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5.4.3.4 Q-PCR analysis results 
5.4.3.4.1 Q-PCR analysis of lipocalin 2 
The expression of transcripts for lipocalin 2 was assessed using Q-PCR and the 
data, which correlated with the microarray data, is presented in figure 5.5. These 
transcripts were expressed significantly higher in the germ-free control group than in 
the conventional animals. In the germ-free dosed animal at 96 hours (animal 10), the 
lipocalin 2 transcripts were not expressed to the same extent as in the germ-free 
control animals, but was higher than in the other two group members at 24 hours. 
This result provides confidence in the transcriptomic data as the results of two 
independent techniques yield the same result. 
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Figure 5.5: Q-PCR analysis of the lipocalin 2 transcript in liver of all study animals. Conventional (CVC) 
and germ-free (GFC) control animals and conventional dosed (CVD) animals (n = 3). Values are mean + 
SD. Also shown are the individual animals from the germ-free dosed group. Significant difference from 
conventional control by Student's t test, p=*: 5 0.05. 
5.4.3.4.2 Q-PCR analysis of alanine aminotransferase 
Initial transcriptomic work characterising the acclimatising germ-free model identified 
transcripts coding for two aminotransferases, ALT and serine dehydratase, to be 
significantly lower in these animals compared to the conventional animals. These 
findings were validated for ALT using Q-PCR (figure 5.6). Due to the variable 
response across the germ-free dosed group, ALT data are shown for the individual 
animals. Transcripts for ALT were unperturbed in animal 10, whilst at 24 hours the 
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ALT transcripts of animals 11 and 12 were markedly elevated compared to the germ- 
free controls. 
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Figure 5.6: Q-PCR analysis of transcripts coding for alanine aminotransferase 1 (also shown are results 
obtained via microarray technique) in conventional (CVC) and germ-free (GFC) control animals and 
conventional dosed (CVD) animals (n = 3). Values are mean + SD. Also shown are the individual 
animals from the germ-free dosed group. Significant difference from conventional control by Student's t 
test, p= *<_0.05, **<_0.01. 
5.4.4 Investigation into alanine aminotransferase activity 
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Figure 5.7: ALT activity measured in liver tissue homogenate of conventional (CVC) and germ-free 
(GFC) control animals and conventional dosed (CVD) animals (n = 3). Values are mean + SD. Also 
shown are the individual animals from the germ-free dosed group. Significant difference from 
conventional control by Student's t test, p=*: 5 0.05, **: 5 0.01. 
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Hepatic ALT activity was significantly lower in the germ-free control animals 
compared to the conventional animals (figure 5.7). This indicates the difference in 
the ALT transcripts affected the abundance of the ALT enzyme. In the conventional 
animals, hydrazine dosing reduced the transcripts for ALT, yet the activity of ALT was 
not significantly affected. In the germ-free dosed animals the activity of ALT did not 
appear to follow the same trend as the transcripts, being similar in all germ-free 
animals. 
5.4.5 Metabonomic analysis 
5.4.5.1 Metabonomic analysis comparing acclimatising germ-free 
animals and conventional animals 
5.4.5.1.1 Metabonomic analysis comparing the urine of germ-free and 
conventional control animals 
There were clear differences in the pre-dose urinary metabolite profiles of germ-free 
and conventional animals (figure 5.8a, b, c, and d). These samples were obtained at 
the beginning of the study prior to any colonisation occurring. The separation 
witnessed in the principal components analysis (PCA) scores plot (figure 5.8d) is 
explained by higher concentrations of formate, 2-oxoglutarate, and creatine in the 
germ-free animals and relatively higher concentrations of microbially derived 
metabolites in the conventional animals (figure 5.8c). These microbial metabolites 
included 3-hydroxyphenylpropionic acid (3-HPPA), 4-hydroxyphenylpropionic acid (4- 
HPPA), and hippurate. Trimethylamine-N-oxide (TMAO), can be both a mammalian 
and bacterial metabolite and can be obtained from the diet, this was found in 
miniscule amounts in germ-free animals. Dimethylglycine (DMG), creatinine, and 
succinate were present in greater amounts in the conventional urine. 
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Figure 5.8: Metabonomic analysis comparing the urinary metabolic profiles from germ-free and 
conventional animals. 'H NMR spectra of urine from germ-free (A) and conventional (B) animals. PCA 
scores plot (D) comparing pre-dose urine from germ-free (open triangles) and conventional (closed 
triangles) animals (Q2 = 0.56) and the corresponding loadings plot (C). A trajectory scores plot (E) of the 
urine from the germ-free (open triangles) and conventional (closed triangles) rats over the course of the 
study (Q2 = 0.56). Times indicate the average metabolite profile of the germ-free animals at a given 
sampling point. 
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A trajectory PCA scores plot of urine spectra (figure 5.8e) illustrates the temporal 
variation in the urine of the germ-free animals over the 96 hour study, compared to 
the relative stability of the conventional urine. A similar study by Nicholls et al. 
characterised the metabolic effect of colonisation of germ free animals over a 21 day 
period, showing that the acclimatising profile matched that of a conventional animal 
21 days after exposure to conventional conditions. Results obtained from this study 
appear to comply with the findings of that work 133 
Urinary phenylacetyiglycine (PAG), hippurate, 2-oxoglutarate, 3-HPPA, and 4-HPPA 
increased throughout the study whilst creatine, citrate, and formate decreased. It is 
evident that whilst colonisation had occurred the metabolite profiles of the germ-free 
animals did not stabilise within the 96 hours, and were still clearly differentiated from 
the conventional urinary profiles in the first principal component (PC) at the 96 hour 
time point. 
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5.4.5.1.2 Metabonomic analysis comparing plasma from germ-free and 
conventional control animals 
Differences were observed in the CPMG (spin-echo) NMR spectra of germ-free and 
conventional plasma eight hours into the study (figure 5.9). The metabolites that 
differed between the two strains are tabulated in figure 5.9d. No differences were 
observed in the lipoprotein concentrations between the two animal strains. 
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Figure 5.9: Metabonomic analysis comparing the plasma metabolic profiles of germ-free and 
conventional rats sampled at eight hours. 'H NMR spin-echo spectra of plasma from germ-free (GF) (A) 
and conventional (B) rats. PCA scores plot (C) from plasma spectra of germ free (open triangles) and 
conventional (closed triangles) animals (Q2 = 0.62) and the metabolites that contribute to the separation 
are tabulated in (D). 
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5.4.5.1.3 Metabonomic analysis of the liver tissue from germ-free and 
conventional animals 
Spin-echo spectral data of the liver revealed metabolite differences between germ- 
free and conventional rats. PCA analysis identified germ-free hepatic profiles to have 
relatively greater concentrations of betaine and phosphocholine with respect to the 
total normalised tissue metabolite profile, whilst conventional livers possessed higher 
glucose and glycogen, and greater taurine (figure 5.10d and e). Visual inspection of 
the spectra revealed the conventional rats to have increased tyrosine, leucine, valine, 
and isoleucine (figure 5.10a and b). There were no identifiable differences in the 
lipid profiles of germ-free livers compared to conventional. 
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Figure 5.10: Metabonomic analysis of the hepatic metabolic profiles from germ-free and conventional 
animals. 'H MAS NMR spin-echo spectra of liver tissue from germ-free (A) and conventional (B) 
animals, with the region 0.85-1.1 ppm enlarged (C) to display the difference in concentration of valine, 
isoleucine, and leucine in germ-free (red) and conventional (black) rats. PCA scores plot (D) from spin- 
echo spectra of liver tissue from germ-free (open triangle) and conventional (closed triangle) animals 
(Q2 = 0.74) and corresponding loadings plot (E). 
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5.4.5.1.4 Metabonomic analysis comparing solid phase extraction 
fractions taken from the aqueous liver extracts of germ-free and 
conventional control animals 
Bile acids eluted in the 60% methanol fraction obtained from the solid phase 
extraction of the aqueous liver extracts. Figure 5.11 c is a PC scores plot constructed 
from the spectra of these fractions and reveals clear separation between the animal 
strains. Figure 5.11a and b, show that the conventional animals conjugated their bile 
acids preferentially with taurine whereas the bile acids from germ-free animals were 
predominantly conjugated with glycine. 
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Figure 5.11: Metabonomic analysis of solid-phase extracts taken from the livers of germ-free and 
conventional control animals. 'H NMR spectra (0.5-1.5 ppm and 3-4 ppm regions) of the 60% methanol 
fraction obtained from the aqueous extracts of conventional (A) and acclimatising germ-free (B) liver. PC 
scores plot comparing the differences between conventional (closed triangles) and acclimatising germ- 
free (open triangles) liver fractions (Q2 = 0.99). 
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5.4.5.1.5 Metabonomic analysis of brain aqueous extracts from germ-free 
and conventional control animals 
Metabonomic analysis of all the brain regions (cortex, cerebellum, hippocampus, 
brain stem) identified that the metabolite profiles of the hippocampus section differed 
between germ-free and conventional animals. No differences could be observed in 
the other brain regions between the two animal strains. Hippocampus metabolite 
profiles from germ-free animals contained higher relative concentrations of taurine, 
myo-inositol, and creatine. Glutamate and glutamine were marginally higher in the 
germ-free hippocampus. Conventional animals had greater N-acetyl-aspartate 
(NAA), choline, and y-aminobutyric acid (GABA) (Figure 5.12). 
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Figure 5.12: Metabonomic analysis of the germ-free and conventional hippocampus. Typical 'H NMR 
spectra of the aqueous extracts taken from germ-free (A) and conventional (B) rat hippocampus. PCA 
scores (C) (Q2 = 0.62) and loadings (D) plots comparing the hippocampus metabolic profiles of germ- 
free (open triangles) and conventional (closed triangles) animals. GABA, y-aminobutyric acid, gin, 
glutamine, glu, glutamate, myo, myo-inositol, NAA, N-acetyl-aspartate. 
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5.4.5.2 Metabonomic analysis of conventional rats administered 
hydrazine 
5.4.5.2.1 Metabonomic analysis of the effect of hydrazine dosing on the 
urinary metabolic profile of conventional animals 
The 60 mg/kg hydrazine dose was estimated to produce mild toxicity and the 
response of the conventional rats to this dose level complied with the literature. 
Figure 5.13c shows a trajectory scores plot of the urinary metabolite profile of the 
conventional dosed rats over the course of the study. Here a maximum metabolic 
response could be observed at the 48 hour sampling point with subsequent sampling 
points indicating recovery back to the pre-dose profiles. The metabolites altered at 48 
hours are given in figure 5.13d. 
Investigation into the hydrazine metabolites, acetyl-hydrazine, diacetyl-hydrazine, 
and THOPC revealed that their excretion occurred primarily by the eight hour time 
point with smaller quantities excreted at later time points. All conventional dosed 
animals behaved in a similar manner throughout the study. 
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Figure 5.13: Metabonomic analysis of the effect of hydrazine dosing upon the conventional urinary 
metabolic profile. 1H NMR spectra of urine from control (A) and dosed (B) conventional animals 48 
hours into the study. Trajectory scores plot (C) of the urine sampled over the course of the study from 
control (black closed triangles) and dosed (red closed triangles) conventional rats (Q2 = 0.58). 
Metabolite differences 48 hours post dosing (D). 2-AA, 2-aminoadipate, 2-OG, 2-oxoglutarate, DMG, 
dimethylglycine, DMA, dimethylamine, TMAO, tºimethylamine-N-oxide. 
5.4.5.2.2 Metabonomic analysis of the effect of hydrazine dosing on the 
plasma metabolic profile of conventional animals 
Both standard and CPMG NMR spectra of plasma sampled 24 hours post dosing 
showed the hydrazine dose caused an increase in 2-AA, alanine, creatine, citrulline, 
D-3-hydroxybutyrate, tyrosine, and valine and a decrease in lipoproteins. This is 
shown in figure 5.14. 
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Figure 5.14: Metabonomic analysis of the effect of hydrazine dosing on the conventional plasma 
metabolic profile. Spin-echo 'H NMR spectra from control (A) and dosed (B) conventional plasma 
sampled at 24 hours. Scores (C) (Q2 = 0.62) and loadings (D) plots of the spin-echo spectra from 
control (black closed triangles) and dosed (red closed triangles) plasma 24 hours post dosing. LDL, low 
density lipoproteins, VLDL, very low density lipoproteins. 
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5.4.5.2.3 Metabonomic analysis of the effect of hydrazine dosing on the 
hepatic metabolic profile of conventional animals 
From the CPMG NMR spectra shown in figure 5.15a and b it is evident that 
hydrazine dosing caused an increase in lipids in the liver, illustrated by the 
broadening of the peaks and increased intensity of resonances corresponding to 
lipids. Visual inspection of the spectra showed hydrazine dosing had reduced 
glucose, glycogen, taurine, TMAO, choline and phosphocholine. There were also 
decreases in valine, isoleucine, and leucine. This is further corroborated by the PCA 
analysis, although whilst separation is observable the dosed animals did not migrate 
far from the control animals suggesting that they were not dramatically disparate from 
the controls. These liver tissues reflect the hepatic metabolite profile at 96 hours, 
after urinary metabolic recovery had occurred and therefore marked differences from 
the control profiles were not likely. The main observation is the accumulation of lipids, 
clearly visible in the diffusion edited spectra (figure 5.15c and d, scores plot 5.15f). 
This complies with the disturbance witnessed to the gene transcripts in lipid 
metabolism and transport and is a known effect of hydrazine. 
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Figure 5.15: Metabonomic analysis of the impact of hydrazine upon the conventional hepatic metabolic 
profile. 'H MAS NMR spin-echo spectra of liver tissue from control (A) and dosed (B) conventional 
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5.4.5.2.4 Metabonomic analysis of the effect of hydrazine dosing on the 
brain metabolic profiles of conventional animals 
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Figure 5.16: Metabonomic analysis of the impact of hydrazine upon the brain metabolic profiles of conventional 
animals. 1H NMR spectra of aqueous extracts from the hippocampus region of the control (A) and dosed (B) 
conventional animals. PC scores plot of all regions (brain stem (box) cerebellum (cross) cortex (diamond) 
hippocampus (triangle)) from control and dosed conventional brains (D) (Q2 = 0.49). Scores plot comparing the 
control (black closed triangles) and dosed (red closed triangles) hippocampus (E) (Q2 = 0.28) and the corresponding 
loadings plot (C). GABA, y-aminobutyric acid, gln, glutamine, glu, glutamate, NAA, N-acetyl-aspartate, pchol, 
phosphocholine. 
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Metabolite differences were found in the hippocampal region of conventional animals 
after hydrazine dosing (figure 5.16d). The other regions remained similar between 
the two animal groups. Inspection of the hippocampus found that 96 hours after a 
sub-toxic dose of hydrazine there was increased alanine, taurine, aspartate, 
glutamate, lactate, and creatine and reduced amounts of N-acetyl-aspartate. Low 
concentrations of 2-AA could be observed in the dosed hippocampus, whereas this 
metabolite could not be seen in the control animals. 
5.4.5.3 Metabonomic analysis of germ-free animals administered 
hydrazine 
5.4.6.3.1 Metabonomic analysis of the effect of hydrazine on the urinary 
metabolic profile of germ-free animals 
From the trajectory scores plot shown in figure 5.17, it can be observed that a 
number of changes occurred in the urinary composition. Taurine and 2-AA were 
noted to increase eight hours after dosing whilst 2-oxoglutarate, creatinine, and 
succinate decreased. Visual inspection of the spectra from the dosed germ free 
animals revealed that the hydrazine metabolites, acetyl-hydrazine, diacetyl- 
hydrazine, and THOPC, had been excreted. At this time point, animal 10, which 
exhibited a different response to hydrazine treatment, excreted higher concentrations 
of acetyl-hydrazine, 2-AA and taurine than the other group members. 
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Figure 5.17: Metabonomic analysis of the effect of hydrazine dosing upon the germ-free urinary 
metabolic profile. 1H NMR spectra of control (A) and dosed (B) urine 24 hours into the study. PCA 
trajectory scores plot (C) showing the metabolic profile fluctuations occurring in the urine from control 
and individual germ-free dosed rats, animal 10 (red), 11 (blue), 12 (green) (Q2 = 0.54). Coloured lines 
indicate how the metabolic profiles of the individual animals alter over time. Loadings plot (D) explaining 
time-dependent distribution of samples in scores plot. 2-AA, 2-aminoadipate, 2-OG, 2-oxoglutarate, 
DMG, dimethyiglycine, PAG, phenylacetyl-glycine. 
The metabolite profile of animal 10 at the 24 hour sampling point was beginning to 
resemble the control germ-free profiles, with creatine and creatinine starting to return 
to pre-dose concentrations. At this sampling point, the metabolite profile of animal 11 
was similar to the profile sampled at eight hours, with the exception of a slight 
increase in amino acid excretion. In contrast the metabolite profile of animal 12 
showed no sign of metabolic normalisation and travelled further from the control 
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germ free animals, explained by further reduction in betaine, creatine, creatinine, 
succinate, and 2-oxoglutarate, and elevated concentrations of valine, lactate, and D- 
3-hydroxybutyrate, the increase in 3-hydroxybutyrate, lactate, and valine being 
suggestive of a renal tubular effect, consistent with histopathological findings in this 
animal. 
After the 24 hour sampling point animals 11 and 12 were removed from the study 
due to adverse effects of hydrazine dosing and so urine sampling ceased at this 
point. Animal 10 however, showed no such effects and completed the study. Citrate, 
succinate, and 2-oxoglutarate concentrations increased in this animal over the 
remaining time points whereas creatine and betaine were observed to decrease. 
Argininosuccinate, 2-AA, and citrulline, proposed biomarkers of hydrazine toxicity, 
were also noted to gradually decrease from 24 hours over the remaining time course. 
5.4.5.3.2 Metabonomic analysis of the effect of hydrazine dosing on the 
plasma metabolic profile of germ-free animals 
Metabonomic analysis of the plasma collected eight hours after hydrazine 
administration showed marked differences from control plasma (figure 5.18). Dosing 
caused elevations in creatine, citrulline, and glucose concentrations and decreases in 
lipoproteins. Free amino acids, alanine, 2-AA, lysine, and tyrosine, were also 
observed to be increased, consistent with the reported effect of hydrazine inhibiting 
aminotransferase function as reported previously in the literature. 
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Figure 5.18: Metabonomic analysis of the impact of hydrazine upon the plasma metabolic profile of 
germ-free rats. Typical 'H NMR spectra obtained from the plasma from control (A) and dosed (B) germ- 
free animals sampled at eight hours. PC scores plot comparing the undosed (black open triangles) and 
dosed (red open triangles) plasma metabolite profiles at eight hours (Q2 = 0.55) (C) and the metabolites 
that altered following dosing (D). 2-AA, 2-aminoadipate, HDL, high density lipoprotein, LDL, low density 
lipoprotein, VLDL, very low density lipoprotein. 
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5.4.5.3.3 Metabonomic analysis of the effect of hydrazine dosing on the 
hepatic metabolic profile of germ-free animals 
The PCA scores plot of the CPMG spectra from the liver tissues of all germ free 
animals (figure 5.19d) showed those animals prematurely removed from the study to 
separate from the other animals. Animal 10, the surviving germ-free animal treated 
with hydrazine, clustered with the control germ free animals. This separation was 
explained by increased signal intensities for lipids, valine, and alanine with respect to 
the germ-free control group and decreased glucose, glycogen, taurine, TMAO, 
choline, and phosphocholine. Characteristic of hydrazine toxicity an increase in an w- 
3 type of fatty acid was observed indicating severe impedance of liver function. As 
noted with the conventional dosed animals' initial stages of steatosis could be seen in 
all dosed animals including, to a lesser extent, animal 10. 
195 
6 
D) 
a 
2 
t 
8 
animal 10 
A 
'4) leu 0 20 40 
all 
Os 
Cý 05 
04 
03 
E 02 
a 
0.1 
OA 
-0.1 
-02 
E) 
r A 
-30 20 10 0 in 
F? 
4-I 
t(1] 
"324 
betaine 
alanine 
betaine/ 
3 28 . 1-48 TMAO a 
. 32choline 
A0 saline 
. _ý lipid "! v. f HO 96 
61.32 
,. - r glucose/ ". 
. 0.92 .. 
lipid lipid 
gl cpýen Y3 84' . & 3.680 *s ' 
ý3.4ia un e 
al. 4 4j. 3 . 0-2 -01 
B) 
tyrosine 
A 
lipid 
-CH=CH- 
r! 
0.0 0.1 
Plil 
glucose 
betaIne 
A) 
glycogen 
glucose/ 
glycoger 
-L- ------M 
02 03 Q4 05 
lipid 
CH3-(CH2)n- 
lipid alanine 
-CH2-CH=CH- 
lipid 
=CH-CH2-CH= (t)-3 lipid 
.. Ir, -I 
ý. 
betaine 
taurine 
11 
phosphocholine 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm 
Figure 5.19: Metabonomic analysis of the effect of hydrazine dosing on the germ-free hepatic metabolic 
profile. 'H MAS NMR spin-echo spectra of liver tissue from control (A) and dosed (B) germ-free animals. 
Scores plot of spin-echo (D) liver spectra from control (black open triangles) and dosed (red open 
Mangles) animals (Q2 = 0.92) and the corresponding loadings plot (C). Scores plot constructed from the 
diffusion edited (E) spectra of the same animals (Q2 = 0.95). 
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5.4.5.3.4 Metabonomic analysis of the effect of hydrazine dosing on the 
brain metabolic profiles of germ-free animals 
All brain regions from animals 11 and 12 separated from all other animals, including 
the other dosed animals (figure 5.20d). The loadings plot shown in figure 5.20c 
indicates this was due to an increase in the amino acids GABA, alanine, and 
glutamine, and a decrease in phosphocholine, N-acetyl-aspartate, glutamate, myo- 
inositol and in some regions taurine. An interesting point is that the metabolite 
profiles of the brain regions from animals 11 and 12 clustered by animal, whereas in 
the other animals these profiles clustered by brain region (figure 5.20d). 
The spectra of the hippocampus from a germ-free control and germ-free dosed 
animal (animal 11) are given in figure 5.20a and 5.20b respectively. The scores plot 
comparing the hippocampal region of all study animals (figure 5.20e) indicates that 
animal 10 clustered with the conventional dosed hippocampus profiles and these in 
turn separated from the control animals, whereas the two animals 11 and 12 
separated further from all animals. This suggests that at 96 hours there was little 
difference in the hippocampus profiles of the conventional dosed animals and animal 
10. The hippocampal region of animals 11 and 12 had higher GABA, glutamine, 
alanine, 2-AA, tyrosine and decreased lactate, NAA, glutamate, and phosphocholine 
compared to the other dosed animals. 
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Figure 5.20: Metabonomic analysis of the effect of hydrazine upon the germ-free brain metabolic profile. 
'H NMR spectra of the aqueous extract from the hippocampus region of control (A) and dosed (B) germ- 
free animals. PCA scores plot of all brain regions (BS, brain stem, CE, cerebellum, CO, cortex, HC, 
hippocampus) from conventional control (black closed triangles), and dosed (red closed triangles) 
animals and germ-free control (black open triangles) and dosed (red open triangles) animals (D) (Q2 = 
0.46). Corresponding loading plot (C). Scores plot comparing the metabolite profiles of the hippocampus 
across all animal groups (E) (Q2 = 0.25) (scheme same as in D). GABA, y-aminobutyric acid, gin, 
glutamine, glu, glutamate, NAA, N-acetyl-aspartate, pchol, phosphocholine. 
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5.4.5.4 Metabonomic analysis comparing the responses of the two 
animal strains to hydrazine treatment 
5.4.5.4.1 Metabonomic analysis comparing the urinary metabolic profiles 
of germ-free and conventional animals administered hydrazine 
Figure 5.21 compares the urine sampled from all dosed animals 24 hours post 
dosing. Here the two animal strains separate clearly (figure 5.21c) and interestingly 
animal 10 separates distinctly with animals 11 and 12. The loadings responsible for 
separation related to increased citrate, succinate, formate and 2-oxoglutarate in the 
germ free animals and in the conventional animals there was increased excretion of 
hydrazine-related metabolites, 2-AA, citrulline, N-acetyl-citru I line at 24 hours. 
Additionally, there was greater excretion of creatine, creatinine, taurine, TMAO and 
hippurate in the conventional animals after dosing with hydrazine. 
Visual inspection of the spectra revealed the germ-free animals also excreted greater 
fumarate and malate, whilst the conventional animals excreted higher concentrations 
of hydrazine metabolites acetyl-, and diacetyl-hydrazine, and THOPC. 
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Figure 5.21: Metabonomic analysis comparing the effect of hydrazine dosing on the germ-free and 
conventional urinary metabolic profiles. 1H NMR spectra of typical urine from conventional (A) and germ- 
free (B) animals administered hydrazine. PCA scores plot of conventional (red closed triangles) and 
germ-free (red open triangles) dosed animals (C) (Q2 = 0.2) and matching loadings plot (D). 
5.4.5.4.2 Metabonomic analysis comparing the effect of hydrazine dosing 
on the germ-free and conventional plasma metabolic profiles 
It is only possible to apply an n of 2 at the 24 hour time point for the plasma from the 
germ-free animals dosed with hydrazine. PCA analysis of the plasma taken at 8 and 
24 hours from all dosed animals revealed no separation to occur between the two 
animal strains. 
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5.4.5.4.3 Metabonomic analysis comparing the hepatic metabolic profiles 
of germ-free and conventional animals administered hydrazine 
There was no difference in the CPMG and diffusion edited spectra of the livers from 
the two animal strains after dosing. The spectra indicated a mild hepatotoxic effect 
had occurred in both strains following the sub-toxic dose of hydrazine, and this 
suggests that hepatotoxicity was not responsible for the enhanced response in 
animals 11 and 12. Comparison to the controls revealed that an accumulation of 
lipids had occurred in both animal groups administered hydrazine, but given that not 
all animals exhibited abnormal behaviour, this may be excluded from being causal to 
the marked response in animals 11 and 12. 
5.4.5.4.4 Metabonomic analysis comparing the effect of hydrazine on the 
brain metabolic profiles of conventional and germ-free animals 
As shown in figure 5.20d, those germ-free animals exhibiting an enhanced response 
to hydrazine, separate from the other dosed animals due to increased amino acids, 
namely GABA, and alanine. The remaining group animal shared a metabolite profile 
similar to the conventional dosed animals. From these data it was not possible to 
determine whether the profiles of the other dosed animals were the same as animals 
11 and 12 at 24 hours, and that subsequent recovery occurred towards the control 
profiles by 96 hours or that these profiles were genuinely different to those of animals 
11 and 12 at 24 hours. 
The abnormal behaviour witnessed in animals 11 and 12 was possibly related to 
neurotoxicity. Animal 10 did not exhibit such a response and the difference in this 
metabolite profile may reflect this. The peripheral neurotoxin 2-AA could be observed 
in all dosed animals but visual inspection revealed this metabolite to be higher in 
animals 11 and 12. 
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5.4.6 Investigation into pyridoxal 5-phosphate concentration 
in control and dosed animals from both conventional 
and germ-free strains 
There was a trend for PLP to be higher in the conventional liver compared to the 
germ-free liver, although this difference was not statistically significant (p = 0.15) 
(figure 5.22). Hepatic PLP concentration appeared lower after hydrazine treatment in 
the conventional animals but this was also not statistically significant (p = 0.26). Due 
to the variable response across the germ-free dosed group, PLP data are shown for 
the individual animals. In the germ-free animals the dosing induced a large increase 
in hepatic PLP in animal 10 but there was no apparent change in animal 11. Limited 
sample availability meant a reading was unable to be obtained for animal 12. 
50 
40 
C) 
0 30 
J 20 
CL 
10 
0 
Figure 5.22: Hepatic pyridoxal 5-phosphate (PLP) concentrations. Comparison of PLP concentration in 
the liver of conventional (CVC) and germ-free control (GFC) animals, and conventional dosed (CVD) 
animals. Values are mean + SD. Also shown are animals 10 and 11 from the germ-free dosed group. 
There was no difference in the concentration of PLP in the brain cortex between the 
two animal strains or in the conventional animals after hydrazine dosing (figure 
5.23). Hydrazine dosing does appear to have perturbed the concentration of PLP in 
the brain cortex of the germ-free animals causing an increase from the controls 
although it is not possible to ascertain statistical significance due to animals 11 and 
12 representing different time-points (figure 5.23). 
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Figure 5.23: Brain cortex PLP concentrations. Comparison of PLP concentration in conventional control 
(CVC), germ-free control (GFC) conventional dosed (CVD) animals. Values are mean + SD. Also shown 
are the individual animals from the germ-free dosed group. 
5.4.7 Aminotransferase and pyridoxal 5-phosphate 
observations made in the naive germ-free animals 
Naive germ-free and conventional animals discussed in chapter three were 
investigated to observe if the differences in the acclimatising animals were due to 
bacterial colonisation. Figure 5.24 shows that there was no observable difference in 
the transcripts coding for ALT between the two animal strains. PLP concentration 
was significantly higher in the naive germ-free liver. Overall there appears to be a 
minor trend for ALT expression and activity and PLP concentration to be higher in the 
germ-free animals which is the inverse of what was observed after four days of 
colonisation. 
1500 
,2 
1000 
b- C4 
t- 0 "ý 
K J 4) 500 
0 
B A 
40 
M Conventional 
= Germ-free 
30 
Ö 
E 
20 
a J 
a 10 
0 
Figure 5.24: Hepatic ALT transcript expression (A) and hepatic PLP concentrations (B) from nave 
conventional and germ-free animals. Values are mean + SD. Significant difference from conventional 
animals by Student's t test, p=*: 5 0.05, **: 5 0.01, ***: 5 0.001. 
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5.5 Discussion 
It was evident that whilst a 60 mg/kg dose of hydrazine induced minimal toxicity in 
conventional animals, the toxicity was markedly more severe in animals without an 
established microflora. 
5.5.1 Acclimatising Model 
Transcriptomic, metabonomic, and biochemical findings from the acclimatising germ- 
free model are summarised in table 5.8. 
Table 5.8: Transcript, metabolite and biochemical findings in the acclimatising germ-free 
animal comparative to the conventional animal. Arrows indicate direction of change in germ-free 
relative to the conventional control animals. 
Biological Function Transcriptomics Metabonomics Biochemical techniques 
Bacterial colonisation 
Inflammation 
Lipid metabolism and bile 
acid synthesis 
Immune transcripts 
(T37 113) 
-T Lipocalin 2 
-T LPS-binding protein 
Inflammatory transcripts 
-T arachidonic acid 
metabolism 
Lipid transcripts 
(T12,126) 
T Hippurate, 3-HPPA, 
4-HPPA, TMAO [Urine] 
T Glycine conjugated bile 
acids in GF animals [Liver] 
T Taurine conjugated bile 
acids in CV animals [Liver] 
Aminotransferase 
PLP concentration 
ALT transcripts 
Serine dehydratase 
. 
ALT activity 
No observed difference in 
brain or liver 
Hippocampus metabolite T Taurine, myo-inositol, 
differences creatine 
ý NAA, choline, GABA 
The lack of microbial-derived metabolites (including hippurate, 3-HPPA, and 4- 
HPPA) in the pre-dose urine profiles provides strong evidence that at the beginning 
of the study the germ-free animals were truly sterile. The trajectory scores plot of the 
urine spectra show a gradual increase in these bacterial-derived metabolites over the 
course of the study signifying bacterial colonisation was occurring. Transcript data 
also indicates colonisation, most notably with the high lipocalin 2 transcripts. 
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Lipocalin 2 is secreted by an infected host and binds to iron when this element is 
associated with a bacterial siderophore. Siderophores are proteins secreted by 
bacteria to scavenge iron under iron-limiting conditions and the secretion of lipocalin 
2 prevents this bacterial iron uptake222 
Inflammation often accompanies colonisation due to host exposure to toxins 
produced by micro-organisms, specifically, Iipopolysaccharide (LPS). Exposure of the 
acclimatising rats to LPS was suggested by the greater transcripts for LPS-binding 
protein (LBP) at 96 hours compared to the conventional animals. LBP is required to 
transfer LPS to pattern recognition receptors (CD14 and toll like receptor 4 (TLR4)) 
and results in the release of inflammatory mediators223. These mediators include 
prostaglandins, leukotrienes, and thromboxanes; these are metabolites of 
arachidonic acid, and several transcripts in arachidonic acid metabolism and 
prostaglandin synthesis were up-regulated in the germ-free animals compared to the 
conventional animals. Thromboxane A2 and prostacyclin have been shown to be 
increased in rodents, sheep and dogs after administration of LPS224. 
Genes relating to lipid metabolism were differentially transcribed in germ-free 
animals, including those related to lipid (ATP binding cassette G5) and lipoprotein 
(apolipoprotein A-IV) transport, transcription regulation (SREBP2) and steroid 
biosynthesis. A selection of transcripts relating to lipid metabolism has been mapped 
onto their respective pathways (figure 5.25). 
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Interestingly, the transcriptomic data revealed no difference in cholesterol 
biosynthesis between the two strains, which was found to be perturbed in the naive 
germ-free animals from chapter three. This most likely corresponds to acclimatisation 
in the germ-free animals with an adjustment in cholesterol homeostasis more 
reflective of a conventional animal. Differences were still noted in bile acid 
biosynthesis however, indicating that after four days acclimatisation these germ-free 
rats did not yet fully resemble a conventional biological system. 
Inspection of the bile acids revealed glycine-conjugation was predominant in the 
germ-free animals, whilst conventional animals had taurine-conjugated bile acids. 
These findings may relate to the higher betaine seen in the germ-free liver and 
plasma, and represent basal differences in the glycine pathway. Figure 5.26 displays 
the glycine pathway; absence of the gut microflora prevents the conversion of choline 
to trimethylamine (TMA) biasing the pathway towards catabolism to glycine, via 
betaine. Greater abundance of hepatic glycine in the germ-free animals may explain 
their preference towards conjugating their bile acids with glycine. The potential 
implication of this bile acid difference in cholesterol absorption and phase II drug 
metabolism remains unclear but warrants further investigation. 
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Figure 5.26: Glycine pathway. 
One of the most intriguing discoveries of this investigation was the difference 
in the 
metabolite profiles of the hippocampus between the germ-free and conventional 
animals. The hippocampus is predominantly involved in memory formation and 
spatial navigation. Taurine, myo-inositol, and creatine were observed to 
be higher in 
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germ-free animals and N-acetyl-aspartate (NAA) was lower. Taurine is considered to 
hold a functional role in osmoregulation in the CNS, and creatine acts via 
phosphocreatine as a good store of high energy phosphate in the brain. At birth 
concentrations of NAA are observed to be low with concentrations increasing during 
development. Given the lower concentrations of NAA in the germ-free hippocampus 
it is feasible that this developmental increase may correlate with microbial 
colonisation and establishment. The hippocampus has been implicated in autism and 
is one of the first regions of the brain to suffer damage in Alzheimer's disease, with 
NAA observed to decrease in the case of Alzheimer's disease. In epilepsy, NAA is 
also noted to decrease whilst creatine is increased225. These cases may argue that 
the presence of gut microflora could afford protection to the host from some 
neurological disorders. This demonstrates the far-reaching influence of the 
indigenous flora and it's participation in the gut-brain axis; however a detailed 
investigation into the influence of the microbiota on neuro-metabolites extends 
beyond the scope of this thesis. 
Transcripts for two PLP-dependent enzymes, ALT and serine dehydratase, were 
significantly lower in the acclimatising germ-free control animals compared to the 
conventional control animals. This manifested in a functional difference, with hepatic 
ALT activity significantly lower in germ-free control animals, indicating basal 
differences in aminotransferase proteins between the two animal strains. 
Interestingly, plasma ALT activity was observed to be reduced from the control 
animals in the re-colonising antibiotic treated rats from chapter three although no 
differences were observed at the transcriptional level. 
Whilst utilisation of microfloral PLP is negligible226, a study by Ikeda et al. found that 
germ-free rats fed a vitamin B6 restricted diet endured a more severe degree of 
vitamin B6 deficiency than conventional animals fed the same diet227. This suggested 
that the host is able to utilise floral PLP when levels are exhausted and served as 
motivation to explore PLP concentrations in the germ-free animals. Inflammation has 
also been shown to cause a tissue specific decrease in PLP levels228. PLP 
concentrations, however, did not appear to differ between the two animal groups 
suggesting in this study the lack of an established microflora did not have a 
noticeable effect on host PLP concentration. This also indicated that 
aminotransferase differences between the strains were not caused by differing PLP 
concentrations. 
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5.5.2 Effect of hydrazine dosing in conventional animals 
The response of the conventional animals to the hydrazine treatment was in 
agreement with previous hydrazine studies"', 
114,115,214 
A 60 mg/kg dose of 
hydrazine was estimated to induce mild toxicity in the rat and the maximum response 
was observed 48 hours post dosing, with subsequent recovery of metabolite profiles 
towards pre-dose by 96 hours. This apparent recovery by 96 hours may explain why 
the transcript profile of the dosed animals showed only slight perturbation, possibly 
reflecting the final stages of normalisation in the liver. A summary of the findings 
investigating the impact of hydrazine dosing in the conventional animal is given in 
table 5.9. 
Table 5.9: Summary of the transcriptomic, metabonomic, and biochemical results 
investigating the effect of hydrazine on the conventional animals. Arrows indicate direction of 
change in conventional dosed relative to the conventional control animals. 
Biological Function Transcriptomics Metabonomics Biochemical technique 
Lipid metabolism Lipid metabolism and T Lipids I Choline [Liver] 
transport transcripts ý Lipoprotein [Plasma] 
0 15) 
Aminotransferase 
inhibition 
PLP concentration 
Energy metabolism 
Defensive response to 
hepatotoxicity 
T 2-AA [Urine/Plasma] No difference in hepatic 
T Alanine [Plasma/Hippocampus] ALT activity at 96 hours 
T Tyrosine, valine [Plasma] 
No observed difference 
in liver or brain PLP 
concentration 
I Glucose 6- Glucose/glycogen [Urine/Liver] 
phosphatase [ Citrate [Urine] 
Succinate, 2-oxoglutarate [Urine] 
Creatine, taurine [Urine/Plasma] 
Urea cycle disruption T N-acetyl-citrulline, 
argininosuccinate [Urine] 
Microfloral perturbation T Hippurate, TMAO [Urine] 
The majority of hydrazine metabolites, acetyl-hydrazine, diacetyl hydrazine, and 
THOPC, were excreted in the first eight hours post dosing in the conventional dosed 
animals. 
Characteristic of hydrazine treatment, the amino acid 2-aminoadipate (2-AA) was 
elevated in the urine and plasma. This is a glial toxin known to perturb the 
CNS 
causing limbic seizures229, and is most likely due to reduced activity of 
2-AA 
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aminotransferase (2-AAT)"'. Hydrazine has been reported to disturb the activity of 
many aminotransferases and may also account for the increased amino acids, 
alanine, tyrosine, and valine in the plasma. Assessment of ALT gene expression and 
activity, and brain PLP concentrations in the conventional dosed animals indicated 
that at 96 hours these components were comparable to the control animals. Hepatic 
PLP concentrations were slightly reduced although this was not statistically 
significant. These findings most likely correspond to recovery of the conventional 
dosed animals 96 hours after the hydrazine insult. 
Creatinuria and taurinuria are frequently observed as a defensive response to 
overcome hepatotoxicity230,231 After exposure to a hepatotoxin, hepatic glutathione 
and taurine concentrations are actively increased. These are cysteine dependent 
defensive processes and require up-regulation of hepatic cysteine synthesis. As a 
consequence of increased cysteine synthesis, creatine production is also increased 
via the intermediate guanidinoacetic acid232. TCA cycle intermediates, citrate, 
succinate, and 2-oxoglutarate are often reduced following toxicological challenges 
and may simply reflect metabolic or physiological stress in the animal214. The 
decreased 2-oxoglutarate may additionally be linked to the formation of THOPC215 
Decreased amounts of glucose and glycogen in the liver could be connected to 
reduced gluconeogenesis, a further consequence of reduced aminotransferase 
function. Glucose is unable to be replenished via gluconeogenesis as inhibition of 
aminotransferases prevents the catabolism of alanine and aspartate in the liver to the 
gluconeogenic substrates, pyruvate and oxaloacetate114 Decreases in glucose and 
glycogen may also relate to reduced food intake in response to toxicity. Increased N- 
acetyl-citrulline and argininosuccinate may arise from hydrazine-induced disruption to 
the urea cycle111, and decreased hippurate and TMAO is consistent with microbiota 
1 perturbation15,233,234 
Although metabolic recovery appeared to have occurred in the conventional dosed 
animals by 96 hours, as evidenced by the urinary metabolite profile matching that of 
the control animals, the accumulation of lipids, characteristic of hydrazine dosing, 
persisted. PCA analysis of the liver profiles showed that the low molecular weight 
metabolite differences between the control and dosed livers did not differ markedly in 
their global profile. The accumulation of fat in the liver is considered a consequence 
of possibly reduced lipid transport from the liver, increased influx or synthesis of 
hepatic lipids or reduced utilisation of lipids by the liver. The hepatic transcript profile 
after hydrazine treatment showed disruption to lipid metabolism and transport. 
In the 
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plasma there was a decrease in lipoproteins (very low density lipoproteins (VLDL) 
and low density lipoproteins (LDL)) an indication of decreased lipid transport from the 
liver. Reduced transport of lipids was corroborated by the down-regulation of 
transcripts coding for apolipoprotein I-IV. Lipids from the liver are solubilised in 
lipoprotein complexes with apolipoproteins contained within the membrane. These 
are transported to extrahepatic tissue with excess cholesterol being transported back 
to the liver. Prior to transport, lecithin: cholesterol acyl transferase (LCAT) acylates 
cholesterol to cholesteryl ester which becomes attached to high density lipoprotein 
(HDL) particles. Apolipoprotein I-IV can activate LCAT, and therefore, down- 
regulation of apolipoprotein I-IV protein may reduce LCAT activation, lowering the 
transport of cholesterol back to the liver. Apolipoprotein A-IV has also been observed 
to be down-regulated by Kleno et al. after hydrazine dosing' 4. However in both this 
study and the work by Kleno et al, no differences were witnessed in transcripts for 
LCAT. The decrease in hepatic choline is also consistent with lipid accumulation, 
where decreased choline leads to the impairment of phosphatidylcholine synthesis, 
235 which is essential for the secretion of hepatic VLDL' 
236 
The conventional animals appeared behaviourally normal following hydrazine dosing 
with no apparent neurotoxicity. PCA analysis revealed the hippocampus metabolite 
profile to alter following dosing. This region has been previously identified to be 
susceptible to 2-AA toxicity however only negligible amounts were seen at 96 
hours237. Consistent with the literature, alanine, aspartate, and creatine were 
increased and NAA was decreased following dosing in the conventional animals. 
Raised GABA has been previously observed in the hippocampus after hydrazine 
treatment but this was not observed at this dose level. Both 2-AA and GABA are 
implicated in the neurotoxic effects of hydrazine' 5, but it cannot be stated whether 
these metabolites were raised at peak toxicity. It has been stipulated that elevated 
aspartate may cause CNS effects, although the apparent normality of these animals 
suggests higher concentrations are required to manifest such an effect238. This 
reinforces the probability that a 60 mg/kg dose of hydrazine is sub-toxic in 
conventional animals and that the rats have largely recovered by the 96 hour time 
point. 
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5.5.3 Effect of hydrazine dosing in germ-free animals 
The differential response between animals 11 and 12 to animal 10 indicates the 
effect of hydrazine to be variable in the acclimatising germ-free animal. Lipocalin 2 
transcripts and those related to immune response and bacterial colonisation were 
lower in animals 11 and 12 than the controls, reflecting that at 24 hours there was 
less exposure to bacterial colonisation in these animals. The effects of hydrazine on 
animals 11 and 12 are summarised in table 5.10. 
Table 5.10: Summary of the results investigating the impact of hydrazine on the acclimatising 
germ-free animals 11 and 12 (24 hours after treatment). Arrows indicate direction of change in 
germ-free dosed relative to the germ-free control animals (96 hours). 
Biological Function Transcriptomics Metabonomics Biochemical technique 
Lipid metabolism and Lipid metabolism and T Lipids [Liver] 
transport transport (T4 112) 1 Lipoprotein [Plasma] 
Aminotransferase T ALT T Alanine [Plasma/Liver/Brain] No difference in hepatic 
Inhibition ALT activity 
T Tyrosine aminotransferase T Tyrosine [Plasma] 
T 2-AA [Urine/Plasma/Brain] 
T GABA [Brain] 
T Valine [Urine/Liver] 
,J 
Glutamate [Brain] 
PLP concentration 
Energy metabolism Energy metabolism 
transcripts (T4 ý1) 
Bacterial colonisation I Lysozyme 
I Lipocalin 2 
Inflammatory/Immune 
transcripts (T3 12) 
Potential GABA metabolism 
neurotoxicity GABA transport 
No difference in hepatic 
PLP concentration 
Slight increase in PLP 
concentration in brain 
cortex 
j Glucose/glycogen [Liver] 
T Glucose [Plasma] 
2-OG, succinate [Urine] 
T GABA [Brain] 
T 2-AA [Urine/Plasma/Brain] 
Glutathione synthetase transcripts were increased whilst transcripts for glutathione 
S- 
transferase Yc2 subunit were decreased in the germ-free animals 24 hours after 
dosing compared to the germ-free control animals. Glutathione (GSH) is a substrate 
in both conjugation and reduction reactions, and is known to be depleted in a 
dose- 
dependent manner by hydrazine239. GSH exhaustion may have occurred in the dosed 
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animals and the alterations in these transcripts may reflect an attempt to replenish 
GSH. Glutathione S-transferase catalyses the conjugation of xenobiotics with GSH 
and facilitates their excretion from the body. Depletion of GSH contributes to 
oxidative stress and transcripts relating to this consequence were also perturbed in 
animals 11 and 12. Work by Martin et al. found decreased GSH concentrations in 
mice harbouring human baby flora82 suggesting a floral influence in GSH 
concentration, however, no difference was observed between the naive germ-free 
and conventional rats in chapter three. 
The germ-free dosed animal not to elicit a toxic response (animal 10) appeared to 
excrete higher amounts of hydrazine-related metabolites up to 24 hours post dose 
than the other two group members. This animal additionally excreted relatively higher 
creatine and taurine than animals 11 and 12 which may indicate a stronger defensive 
response in this animal. Fatty accumulation was also not present to the same extent 
in animal 10 at 96 hours compared to animals 11 and 12 at 24 hours. Animal 12 was 
observed by histopathology to suffer kidney toxicity consistent with S3 proximal 
tubular injury. This was unique to this animal and was reflected in the urinary 
metabolite profile with increased valine, lactate, and D-3-hydroxybutyrate. 
Up-regulation of aminoadipate-semialdehyde synthase transcripts was observed in 
animals 11 and 12. This enzyme is involved in the catabolism of lysine to the 
peripheral neurotoxin 2-AA. Increased 2-AA was found in the urine, plasma, and in 
animals 11 and 12, the hippocampus. The increased 2-AA is considered to arise 
through the inhibition of 2-AAT however this suggests potential up-regulation of 2-AA 
synthesis may contribute to the increase in this metabolite. Raised 2-AA in the 
hippocampus is considered to reduce kynurenic acid (KYNA) concentration. KYNA is 
associated with a neuroprotective role, reducing seizures. It is thought that 2-AA 
competitively inhibits kynurenine aminotransferase II, as this aminotransferase is 
identical to 2-AAT, and prevents KYNA formation from kynurenine and can result in a 
neurotoxic response. 
Transcripts relating to GABA metabolism and transport were down regulated in the 
livers of animals 11 and 12 after dosing. This excitatory amino acid was seen to 
be 
increased in all brain regions from animals 11 and 12. Elevated GABA has been 
shown to arise from reduced GABA aminotransferase activity240 and is implicated 
in 
the neurotoxicity induced by hydrazine. Such increases were not observed at 
96 
hours in animal 10. Reduced aminotransferase function may explain elevated alanine 
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and tyrosine with up-regulation of transcripts for ALT and tyrosine aminotransferase 
in animals 11 and 12. In animal 10, transcripts for ALT were unperturbed. These 
findings may relate to the difference in events occurring at 24 and 96 hours, however, 
ALT activity did not appear perturbed in any of the germ-free dosed animals. 
Decreased glutamate in the brain is also suggestive of aminotransferase inhibition; 
the reactions catalysed by a selection of aminotransferase enzymes are given in 
figure 5.27. 
Alanine aminotransferase + PLP 
Alanine + 2-oxoglutarate Pyruvate + glutamate 
2-aminoadipate aminotransferase + PLP 
2-aminoadipate + 2-oxoglutarate 2-oxoadipate + glutamate 
GABA-aminotransferase + PLP 
GABA + 2-oxoglutarate Succinate semialdehyde + glutamate 
Figure 5.27: Reactions catalysed by the aminotransferase enzymes, alanine aminotransferase, 2- 
aminoadipate aminotransferase, and GABA aminotransferase. 
Hepatic PLP concentration was increased in animal 10; this may relate to lowered 
consumption due to slow-binding inhibition of aminotransferases by hydrazine and 
may explain the higher PLP concentrations at 96 hours compared to animal 11 at 24 
hours. ALT activity was also lowest in animal 10 for all the germ-free dosed animals. 
No difference was found in the hepatic PLP concentration of animal 11 compared to 
the control animals, indicating depletion of hepatic PLP was not a mechanism of 
toxicity. 
5.5.3 Comparison of the germ-free dosed animals with the 
conventional dosed animals 
By contrasting the responses of the two strains some observations may be drawn 
regarding how the gut bacteria may modulate the response of a rat model to 
hydrazine treatment. Animals 11 and 12 (germ-free) appear to endure the same 
degree of lipid accumulation as animals 8 and 9 (conventional), whereas animals 7 
(conventional) and 10 (germ-free) display a lesser effect. Fatty accumulation, 
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therefore, does not appear to be the cause of the poor condition in animals 11 and 12 
this is confirmed by the lack of findings by histopathology. Adverse behaviour and 
speed of response suggest neurotoxicity is more probable than hepatotoxicity 
Excretion of hydrazine metabolites was greater in the conventional animals up to 24 
hours post dosing. Additionally, these animals excreted greater amounts of 2-AA, N- 
acetyl-citrulline, creatine, taurine, and argininosuccinate. This may represent greater 
efficiency in the handling of the consequences of hydrazine in conventional animals. 
Interestingly, animal 10, the only surviving member of the germ-free dose group, at 
24 hours was observed to excrete hydrazine-related metabolites faster than other 
group members. Animals from both groups excreted acetyl-hydrazine, diacetyl- 
hydrazine, and THOPC after hydrazine dosing implying there was no significant 
difference in the metabolism of hydrazine between the conventional and germ-free 
group. This indicates that the microflora did not influence the metabolic fate of this 
hepatotoxin either directly or through the modulation of the host drug metabolising 
enzymes. This is most likely due to the small size of the hydrazine compound 
permitting rapid absorption and distribution. 
The increased amounts of citrate, succinate, 2-oxoglutarate, malate, and fumarate in 
the urine of the germ-free dosed group may correspond to lower energy consumption 
in these animals. There appears to be a greater disturbance to the urea cycle of the 
conventional animals after hydrazine administration possibly owing to a difference in 
basal mitochondrial metabolism between germ-free and conventional animals241. This 
suggests that disturbance of the urea cycle by hydrazine is not causal to the poor 
condition of two members of the three germ-free animals. Higher creatine and taurine 
excretion in the conventional urine after dosing implies increased GSH and taurine 
concentrations in these animals suggestive of a stronger defensive response 
compared to the germ-free dosed animals. 
The different response observed in animal 10 indicates that the basal differences 
noted in the hippocampal regions between germ-free and conventional animals may 
not contribute to the enhanced toxic response. This neurological impact is most likely 
related to increases in the inhibitory neurotransmitter, GABA or the peripheral 
neurotoxin 2-AA. Conventional dosed animals were observed to excrete 
higher 
concentrations of 2-AA quicker than the germ-free dosed animals which could 
potentially reduce the concentration of 2-AA in the hippocampus at peak 
toxicity. 
Elevated GABA is considered the primary factor in neurotoxicity, as this metabolite 
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was present in significantly higher concentrations in all brain regions of animals 11 
and 12. As other dosed animals did not elicit neurological abnormalities it may be 
proposed that greater inhibition of these aminotransferases may have occurred in the 
germ-free animals. Increased excretion of alanine and valine in the germ-free dosed 
animals adds further evidence to this proposition. 
It follows then that if aminotransferase function or abundance was naturally lower in 
the acclimatising germ-free animals, then these animals would be more susceptible 
to the aminotransferase inhibiting effects of hydrazine. Increased 2-oxoglutarate in 
the germ-free dosed group compared to the conventional dosed group may be linked 
to reduced aminotransferase activity, which utilises 2-oxoglutarate for 
transaminations. 
5.5.4 Aminotransferase and PLP investigation in the naive germ- 
free animals 
To ascertain whether the low ALT gene expression observed in the acclimatised 
germ-free animal was consistent in a truly germ-free animal, ALT gene expression 
and PLP concentrations were measured in the liver tissue of the naive germ-free rats 
studied in chapter three. No difference existed in hepatic ALT gene expression in the 
germ-free animals compared to the conventional animals but hepatic PLP 
concentrations were slightly higher in the germ-free animals. These findings suggest 
that the lower hepatic ALT activity in the acclimatising germ-free animals were not 
due to the germ-free state of the animal but more likely a consequence of bacterial 
colonisation of these animals. This proposition is reinforced by the decrease in 
plasma ALT activity in the re-colonising antibiotic treated rats. 
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5.6 Conclusions 
Differential exposure to bacterial colonisation may have induced a differing degree of 
inflammation to occur in the germ-free animals. In the model proposed by Roth2os, 2 
the toxic response of the system towards a compound can be enhanced when the 
system is in a state of inflammation. 
PLP was explored as a potential mechanism for the variable response to hydrazine in 
the acclimatising germ-free animals but was shown not to be causal to the response. 
Inflammation may have contributed to sensitising the germ-free animal towards 
hydrazine toxicity, possibly through modulation of aminotransferase 
expression/activity, although the mechanism for this has yet to be elucidated. 
If aminotransferase activity in germ-free rats was perturbed by both bacterial 
colonisation/inflammation and hydrazine treatment, compared to conventional 
animals whose aminotransferase function was perturbed only by hydrazine 
treatment, the consequences of reduced aminotransferase function would be more 
pronounced in the germ-free animals. Such consequences may result in the 
observed neurotoxicity due to increased GABA in the brains of animals 11 and 12, 
and may explain the variable response to hydrazine in the germ-free dosed group, 
with the germ-free animals undergoing differing degrees of colonisation/inflammation. 
These findings highlight how the microbial flora can influence host susceptibility in 
xenobiotic metabolism, demonstrating how bacterial presence can influence the 
degree or nature of response to hydrazine and that toxic responses can be diverse in 
the absence of a functional microbiome. This supports the concept that microfloral 
variation can be a component in inter-individual variability in drug responses and 
potentially idiosyncratic toxicity. It further emphasises the need to comprehensively 
understand the influence of extended genomic interactions in drug metabolism and 
toxicity. 
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Chapter Six: General discussion 
6.1 Use of systems biology techniques 
Systems biology approaches were applied to investigate microfloral-mammalian 
interactions and mechanisms of drug toxicity. In the case of methapyrilene toxicity in 
the conventional animal, a previous multi-omic approach generated a global view of 
the biological system and highlighted a urea cycle protein, CPS I, to be potentially 
implicated as a mechanism of methapyrilene toxicity. Using hypothesis-led 
approaches, CPS I protein structure and function were investigated as part of this 
thesis, and were found to be altered following methapyrilene dosing with modification 
occurring either prior to, or at the onset of toxicity. Using metabonomics in parallel, 
metabolites related to the urea cycle and energy metabolism were able to be 
monitored through the evolution of toxicity. This provided an insight into the 
consequence of CPS I protein modulation and the chain of events that preceded and 
evolved through toxicity, allowing inferences to be made regarding the possibility for 
CPS I alterations to form part of the mechanism of methapyrilene toxicity. This 
demonstrated the use of applying omic technologies to explore mechanisms of drug 
toxicity, in both hypothesis generation and hypothesis investigation. 
Integrated transcriptomic and metabonomic techniques provided a useful tool to 
explore microfloral-mammalian interactions. This top-down approach allowed the 
microfloral influence on the host to be studied globally at two levels of biomolecular 
organisation and in a variety of sample types. These techniques were complimentary, 
with the transcriptomic approach providing an end-point view of the host 
transcriptome, and for certain samples a `through-time' assessment of the biological 
system was obtained via the metabonomic technique. This was of particular use for 
studying the extent of bacterial colonisation in the acclimatising germ-free animals 
and ascertaining the degree of bacterial suppression in the antibiotic-treated animal 
model. The two techniques also proved useful to identify biological events unable to 
be detected by the other, illustrated by the suggestion of inflammation in the 
transcriptomic data from the acclimatising germ-free animals and the detection of 
metabolite differences in the brains of the germ-free and conventional animals. 
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6.2 Influence of the gut microbiota on host metabolism and 
toxicity 
The influence of the gut microflora on the mammalian metabolic system was 
investigated, with specific interest in the metabolism and toxicity of xenobiotics. 
Examination of the germ-free rat model identified microfloral absence to have a 
profound effect on host metabolism at both the transcriptome and metabonome level. 
Gene expression data showed that microfloral presence was able to modulate the 
expression of drug metabolising enzymes in the host GI tract, and to a lesser extent 
in the liver. Given the importance of the small intestine in the first pass metabolism of 
orally ingested drugs161, it is likely that the gut bacteria can influence the 
biotransformation and absorption of many xenobiotics through both direct microbial 
action, and also through the modulation of host enzymes and transporters. 
It was found that through the provision of microbial products, such as SCFA, and the 
bacterial metabolism of bile acids, the gut bacteria also influenced endogenous host 
processes such as energy and lipid metabolism. Bacterial de-conjugation of bile 
acids modulated the expression of genes involved in cholesterol and bile acid 
biosynthesis and in the acclimatising germ-free animals, the absence of an 
established microflora modified bile acid conjugation. Differences in bile acid 
biosynthesis and conjugation have the potential to induce individual differences in the 
enterohepatic circulation, an important component of drug metabolism and toxicity. 
Research into to the functional impact of these bile acid differences would be an 
interesting area for future work and is necessary to draw further conclusions. It is 
clear that gut bacteria and their products contribute towards a conventional metabolic 
phenotype, and differences in microbial composition could feasibly modulate the 
overall metabolic capacity of a biological system. 
In the subtle, antibiotic treated animal model the effect of short-term microbial 
suppression did not have a pronounced effect on the host biological system. Lack of 
disruption to the gut and liver transcriptome implies the conventional animal system 
is adept at managing temporary reductions in the microbiota. Despite the 
decrease in 
microbial-derived metabolites in the urine following microbial suppression, 
there did 
not appear to be a marked effect on the host metabonome. A greater 
impact on the 
host metabolic system was observed when the suppressed microflora re-established. 
Bacterial recolonisation in the antibiotic treated rats caused a small number of 
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transcripts encoding drug metabolising enzymes (CYP 2D9,2D22,4B1) to be down- 
regulated in the large intestine. These genes were noted to be expressed at a higher 
level in the germ-free animals compared to the conventional animals giving a strong 
indication that their expression was modulated by the gut bacteria. 
Investigation into the influence of the microbiota on the metabolism and toxicity of 
hydrazine highlighted the variable responses that can occur in the absence of a 
stable microbiota. This study revealed that an established, stable microflora abated 
the toxicity of the hydrazine whereas in acclimatising animals with dynamic 
microbiota the response was variable and markedly more severe. The microbiota did 
not modulate the manner in which the hydrazine was metabolised, presumably due 
to the simplicity and rapid absorption of the compound; instead the gut microflora 
appeared to influence host susceptibility to hydrazine toxicity through host exposure 
to microbial factors. Increased host susceptibility to hydrazine toxicity was most likely 
due to an inflammatory response to the colonisation of the germ-free GI tract. These 
findings considered with the work of others208,211 indicate the potential for variations 
in the gut microflora to produce idiosyncratic toxicity and stress the importance for a 
stable, established microflora in the host. 
It is clear that the microflora has an influence on the conditional metabolic phenotype 
of the host and ultimately the metabolic fate and toxicity of a drug. Gut microflora can 
influence the conditional metabolic phenotype of the host through the following 
interactions: 
1. Direct interaction - enzymes and pathways encoded in the microbiome. 
2. Modulation of host xenobiotic metabolism - regulation of host drug 
metabolising enzymes and transporters in the small intestine and to a lesser 
extent in the liver. 
3. Influence of the overall metabolic state of the host - microfloral action and 
products contribute towards host energy and lipid metabolism and potentially 
influence enterohepatic circulation. 
4. Host susceptibility - bacterial factors, such as LPS, can 
increase the 
susceptibility and sensitivity of the host system towards the toxic effects of a 
xenobiotic. 
In this thesis, interaction types 2-4 have been explored. 
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Gut microfloral composition is highly specific to the host and differences in this 
composition may modulate the host metabolic phenotype and contribute to inter- 
individual variation in metabolism and toxicity. It is also feasible, that subtle 
disruptions to the microbiome of an individual, possibly induced by lifestyle choices 
such as diet, alcohol consumption and hygiene, could modify the individual's 
xenobiotic metabolism. 
Gut microflora are one factor that contribute to the metabolic capacity of the host. 
Inherent host variables, such as the genotype, also determine the conditional 
metabolic phenotype. Microfloral and mammalian factors that contribute to the 
conditional metabolic phenotype of the host are displayed in figure 6.1; by 
considering both contributions the mammalian metabolic system may be better 
understood. 
Conditional 
metabolic 
phenotype 
Host genetic constitution 
Interspecies variations and 
individual SNP variations 
Specific drug metabolizing " . 
enzyme complement 
(CYP450) poiymorphisms 
U 
Tissue specific CYP450 " . induction state 
(e. g., in liver and gut) 
Metabolic fate 
and toxicity 
of drug 
Gut microbiome constitution 
Individual microbial species variation 
and abundance 
1 
Current nutritional status 
and dietary composition 
Figure 6.1: Factors that contribute to the conditional metabolic phenotype and ultimately 
the metabolic 
fate and toxicity of a drug242. 
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6.3 Future directions 
The differences found in the brain metabolite profiles of the acclimatising and 
conventional animals require further assessment to gain a greater understanding of 
the gut-brain axis, especially given the links between the gut microflora and autism. 
Autism is a spectrum of developmental disorders, affecting imaginative, 
communicative and social development. This is a prevalent condition (1/200)243 yet 
remains poorly understood. Many autistic sufferers are noted to endure severe 
dietary and/or GI problems, including constipation, diarrhoea, bloating, and lactose 
intolerance. Parents of autistic children often claim that behavioral symptoms and GI 
problems occur in parallel and with matching intensity244. Significant differences have 
been shown in the composition of the gut microflora between autistic and control 
patients, with clostridia, a bacterial group known to produce strong neurotoxins245, 
present in higher levels in autistic samples244' 246,247 It is obvious therefore that 
greater understanding of the gut-brain axis and the various interactions occurring 
may increase our knowledge of the aetiology of autistic spectrum disorders. 
Depression in the host has also been linked with the gut bacteria248 and stress has 
been shown to alter microbial composition, with lactobacilli and bifidobacteria 
observed to be reduced in acute and long-term emotional stress249. Understanding 
how microfloral-mammalian interactions impact upon the mental state of the host 
would be an interesting area of research to pursue and transcriptomic and 
metabonomic approaches would also be ideally suited to investigate this relationship. 
The response of germ-free animals maintained under sterile conditions to hydrazine 
dosing would be an interesting and necessary future directive. It would be possible to 
determine whether the inflammatory episode contributed to the differential response 
in these animals or another unaccounted for microbial-related variable. It would also 
be interesting to study the effects of hydrazine in the antibiotic treated animals, to 
observe if microfloral suppression did modulate the response to hydrazine. 
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6.4 Conclusions 
It is evident that the gut microflora is a significant component of mammalian 
biocomplexity and it is important to account for this variable when modelling the 
mammalian biological system. This enteric ecosystem contributes, directly and 
indirectly, to the overall metabolic capacity of the host. It has an influence on host 
xenobiotic metabolism and has the potential to regulate host susceptibility towards 
toxicity. 
Recently a move towards personalised healthcare has been proposed, incorporating 
host-specific variables into tailor-made drug therapies74. This has the potential to 
improve drug efficacy and reduce the frequency and severity of adverse drug 
reactions. Pharmacogenomics, correlating an individual's genetic inheritance with a 
drug's efficacy or toxicity, was an initial attempt at personalised healthcare; however 
as seen from figure 6.1 considering the host genotype alone is not sufficient to 
encapsulate the mammalian biological system and environmental factors such as the 
microbiome must also be factored in. 
This thesis has explored a variety of analytical tools that clearly enable insights to be 
gained into microfloral-mammalian interactions and mechanisms of drug toxicity. A 
wealth of information has been gleaned from these tools relating to a diverse range 
of biological functions, and these have raised potential areas for future research. By 
building upon these findings and with the inclusion of future techniques, such as 
liquid chromatography-mass spectrometry and improved bioinformatics, the influence 
of the microflora on the host can be further explored. 
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